{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6bba9de0",
   "metadata": {},
   "source": [
    "# SMM4H 2026 Task 1 — Multilingual ADE Detection (EN/DE train, FR zero-shot)\n",
    "\n",
    "This notebook implements the full exercise end-to-end in a **single file**:\n",
    "\n",
    "- **Task 1.1**: Language selection (EN/DE train, FR eval-only), train/val/test splits (dev→test), preprocessing, EN→FR translation of **6000 EN train** samples stratified by label.\n",
    "- **Task 1.2**: Multilingual exploration (label distribution, size differences, text length/type characteristics, manual inspection).\n",
    "- **Task 1.3**: Modeling with the **same backbone** across setups (default: `xlm-roberta-base`):\n",
    "  - Monolingual EN, monolingual DE\n",
    "  - Multilingual EN+DE\n",
    "  - Translation-trained (EN→FR translated train)\n",
    "- **Task 1.4**: Evaluation (F1/precision/recall/accuracy, confusion matrices, per-language results) + cross-lingual error analysis.\n",
    "\n",
    "## Model backbone swap (XLM-R → Microsoft multilingual model)\n",
    "This notebook uses a single config variable `MODEL_NAME`. To switch to Microsoft’s multilingual model later:\n",
    "\n",
    "- Change `MODEL_NAME = \"xlm-roberta-base\"` to:\n",
    "  - `MODEL_NAME = \"microsoft/mdeberta-v3-base\"` (recommended)\n",
    "  - or `MODEL_NAME = \"microsoft/mdeberta-v3-large\"` (heavier)\n",
    "\n",
    "No other code changes should be required.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "7d433246",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "torch: 2.9.1\n",
      "cuda available: True\n",
      "gpu: NVIDIA RTX 2000 Ada Generation Laptop GPU\n",
      "device: cuda\n",
      "{\n",
      "  \"seed\": 42,\n",
      "  \"model_name\": \"xlm-roberta-base\",\n",
      "  \"max_length\": 256,\n",
      "  \"val_fraction\": 0.1,\n",
      "  \"batch_size\": 16,\n",
      "  \"epochs\": 10,\n",
      "  \"early_stopping_patience\": 3,\n",
      "  \"lr\": 2e-05,\n",
      "  \"weight_decay\": 0.01,\n",
      "  \"train_langs\": [\n",
      "    \"en\",\n",
      "    \"de\"\n",
      "  ],\n",
      "  \"zero_shot_lang\": \"fr\",\n",
      "  \"translate_n\": 6000,\n",
      "  \"translation_model\": \"Helsinki-NLP/opus-mt-en-fr\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "# Environment & reproducibility\n",
    "import os\n",
    "import re\n",
    "import json\n",
    "import math\n",
    "import random\n",
    "from dataclasses import dataclass\n",
    "from pathlib import Path\n",
    "from typing import Dict, Iterable, List, Optional, Tuple\n",
    "\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "\n",
    "import torch\n",
    "\n",
    "from sklearn.model_selection import StratifiedShuffleSplit\n",
    "from sklearn.metrics import (\n",
    "    accuracy_score,\n",
    "    precision_recall_fscore_support,\n",
    "    confusion_matrix,\n",
    ")\n",
    "\n",
    "from datasets import Dataset\n",
    "from transformers import (\n",
    "    AutoTokenizer,\n",
    "    AutoModelForSequenceClassification,\n",
    "    DataCollatorWithPadding,\n",
    "    EarlyStoppingCallback,\n",
    "    TrainingArguments,\n",
    "    Trainer,\n",
    "    set_seed,\n",
    ")\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "print(\"torch:\", torch.__version__)\n",
    "print(\"cuda available:\", torch.cuda.is_available())\n",
    "if torch.cuda.is_available():\n",
    "    print(\"gpu:\", torch.cuda.get_device_name(0))\n",
    "\n",
    "SEED = 42\n",
    "set_seed(SEED)\n",
    "random.seed(SEED)\n",
    "np.random.seed(SEED)\n",
    "\n",
    "auto_device = \"cuda\" if torch.cuda.is_available() else \"cpu\"\n",
    "print(\"device:\", auto_device)\n",
    "\n",
    "ROOT = Path(\".\").resolve()\n",
    "DATASET_DIR = ROOT / \"dataset\"\n",
    "ARTIFACTS_DIR = ROOT / \"artifacts\"\n",
    "ARTIFACTS_DIR.mkdir(exist_ok=True)\n",
    "\n",
    "# Core experiment config\n",
    "MODEL_NAME = \"xlm-roberta-base\"  # swap to \"microsoft/mdeberta-v3-base\" later\n",
    "MAX_LENGTH = 256\n",
    "VAL_FRACTION = 0.1\n",
    "BATCH_SIZE = 16\n",
    "EPOCHS = 10\n",
    "EARLY_STOPPING_PATIENCE = 3\n",
    "LR = 2e-5\n",
    "WEIGHT_DECAY = 0.01\n",
    "\n",
    "TRAIN_LANGS = [\"en\", \"de\"]\n",
    "ZERO_SHOT_LANG = \"fr\"\n",
    "\n",
    "TRANSLATE_N = 6000\n",
    "TRANSLATION_MODEL_NAME = \"Helsinki-NLP/opus-mt-en-fr\"  # offline MT via MarianMT\n",
    "\n",
    "# If you need a quick smoke run, set this to True (uses smaller subsets)\n",
    "DEBUG_SMALL = False\n",
    "\n",
    "cfg = {\n",
    "    \"seed\": SEED,\n",
    "    \"model_name\": MODEL_NAME,\n",
    "    \"max_length\": MAX_LENGTH,\n",
    "    \"val_fraction\": VAL_FRACTION,\n",
    "    \"batch_size\": BATCH_SIZE,\n",
    "    \"epochs\": EPOCHS,\n",
    "    \"early_stopping_patience\": EARLY_STOPPING_PATIENCE,\n",
    "    \"lr\": LR,\n",
    "    \"weight_decay\": WEIGHT_DECAY,\n",
    "    \"train_langs\": TRAIN_LANGS,\n",
    "    \"zero_shot_lang\": ZERO_SHOT_LANG,\n",
    "    \"translate_n\": TRANSLATE_N,\n",
    "    \"translation_model\": TRANSLATION_MODEL_NAME,\n",
    "}\n",
    "print(json.dumps(cfg, indent=2))\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "88a0cd40",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "div.dataframe {\n",
       "  overflow-x: auto;\n",
       "}\n",
       "div.dataframe table {\n",
       "  width: 100%;\n",
       "  table-layout: fixed;\n",
       "}\n",
       "div.dataframe td, div.dataframe th {\n",
       "  vertical-align: top;\n",
       "}\n",
       "div.dataframe td {\n",
       "  white-space: pre-wrap;\n",
       "  word-break: break-word;\n",
       "}\n",
       "</style>\n"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Pandas/Jupyter display tweaks: wrap long text and allow horizontal scrolling\n",
    "from IPython.display import HTML, display\n",
    "\n",
    "# Prevent pandas from truncating long strings (e.g., the `text` column)\n",
    "pd.set_option(\"display.max_colwidth\", None)\n",
    "\n",
    "# Make rendered DataFrame tables wrap text and scroll horizontally if needed\n",
    "display(HTML(\"\"\"\n",
    "<style>\n",
    "div.dataframe {\n",
    "  overflow-x: auto;\n",
    "}\n",
    "div.dataframe table {\n",
    "  width: 100%;\n",
    "  table-layout: fixed;\n",
    "}\n",
    "div.dataframe td, div.dataframe th {\n",
    "  vertical-align: top;\n",
    "}\n",
    "div.dataframe td {\n",
    "  white-space: pre-wrap;\n",
    "  word-break: break-word;\n",
    "}\n",
    "</style>\n",
    "\"\"\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1378923",
   "metadata": {},
   "source": [
    "## Task 1.1 — Load CSVs (train) + redefine dev as test\n",
    "\n",
    "We keep **French (fr)** as evaluation-only (zero-shot), and train only on **English (en)** and **German (de)**.\n",
    "\n",
    "Preprocessing decisions (minimal, ADE-preserving):\n",
    "- Normalize user mentions to `@USER`.\n",
    "- Normalize URLs to `HTTPURL`.\n",
    "- Normalize forum placeholder `<user>` to `@USER`.\n",
    "- Do **not** lowercase (multilingual casing can matter).\n",
    "- Keep punctuation/negations/dosage strings intact.\n",
    "- TODO: What about emojis? For now, we keep them as-is (they can carry sentiment/ADE cues), but we could consider mapping them to text labels in future iterations.\n",
    "- TODO: What about hashtags? Should we strip the `#` symbol? \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "0cf8f6d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "train rows: 46737\n",
      "test rows: 8033\n",
      "columns: ['id', 'text', 'label', 'origin', 'type', 'language', 'split']\n",
      "train languages:\n",
      "language\n",
      "en    17128\n",
      "de     1482\n",
      "fr      976\n",
      "Name: count, dtype: int64\n",
      "test languages:\n",
      "language\n",
      "en    888\n",
      "de    634\n",
      "fr    418\n",
      "Name: count, dtype: int64\n",
      "train label distribution (overall):\n",
      "label\n",
      "0    0.931022\n",
      "1    0.068978\n",
      "Name: proportion, dtype: float64\n",
      "test label distribution (overall):\n",
      "label\n",
      "0    0.935052\n",
      "1    0.064948\n",
      "Name: proportion, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "TRAIN_PATH = DATASET_DIR / \"train_data_SMM4H_2026_Task_1.csv\"\n",
    "TEST_PATH = DATASET_DIR / \"dev_data_SMM4H_2026_Task_1.csv\"  # treated as TEST\n",
    "\n",
    "assert TRAIN_PATH.exists(), f\"Missing {TRAIN_PATH}\"\n",
    "assert TEST_PATH.exists(), f\"Missing {TEST_PATH}\"\n",
    "\n",
    "train_raw = pd.read_csv(TRAIN_PATH)\n",
    "test_raw = pd.read_csv(TEST_PATH)\n",
    "\n",
    "print(\"train rows:\", len(train_raw))\n",
    "print(\"test rows:\", len(test_raw))\n",
    "print(\"columns:\", list(train_raw.columns))\n",
    "\n",
    "\n",
    "def _coerce_label(x) -> int:\n",
    "    # labels are floats (0.0/1.0) in CSV\n",
    "    if pd.isna(x):\n",
    "        return 0\n",
    "    return int(float(x))\n",
    "\n",
    "\n",
    "USER_RE = re.compile(r\"@USER_+\")\n",
    "HTTP_RE = re.compile(r\"HTTPURL_+\")\n",
    "UNICODE_U4_RE = re.compile(r\"\\\\u([0-9a-fA-F]{4})\")\n",
    "UNICODE_U8_RE = re.compile(r\"\\\\U([0-9a-fA-F]{8})\")\n",
    "\n",
    "\n",
    "def _unescape_unicode(text: str) -> str:\n",
    "    # Only unescape explicit unicode escape sequences like \"\\\\u3000\".\n",
    "    text = UNICODE_U4_RE.sub(lambda m: chr(int(m.group(1), 16)), text)\n",
    "    text = UNICODE_U8_RE.sub(lambda m: chr(int(m.group(1), 16)), text)\n",
    "    return text\n",
    "\n",
    "\n",
    "def normalize_text(text: str) -> str:\n",
    "    if not isinstance(text, str):\n",
    "        text = \"\" if text is None else str(text)\n",
    "\n",
    "    text = USER_RE.sub(\"@USER\", text)\n",
    "    text = HTTP_RE.sub(\"HTTPURL\", text)\n",
    "\n",
    "    # Forum placeholder\n",
    "    text = text.replace(\"<user>\", \"@USER\")\n",
    "\n",
    "    # Some rows contain escaped unicode sequences like \\u3000 (ideographic space)\n",
    "    if \"\\\\u\" in text or \"\\\\U\" in text:\n",
    "        text = _unescape_unicode(text)\n",
    "\n",
    "    # Collapse whitespace\n",
    "    text = re.sub(r\"\\s+\", \" \", text).strip()\n",
    "    return text\n",
    "\n",
    "\n",
    "def prepare_df(df: pd.DataFrame) -> pd.DataFrame:\n",
    "    out = df.copy()\n",
    "    out[\"label\"] = out[\"label\"].map(_coerce_label).astype(int)\n",
    "    out[\"text\"] = out[\"text\"].map(normalize_text)\n",
    "    out[\"language\"] = out[\"language\"].astype(str)\n",
    "    out[\"type\"] = out.get(\"type\", \"\").astype(str)\n",
    "    out[\"origin\"] = out.get(\"origin\", \"\").astype(str)\n",
    "    return out\n",
    "\n",
    "\n",
    "train_df = prepare_df(train_raw)\n",
    "test_df = prepare_df(test_raw)\n",
    "\n",
    "# Focus only on the requested languages\n",
    "train_df = train_df[train_df[\"language\"].isin(TRAIN_LANGS + [ZERO_SHOT_LANG])].reset_index(drop=True)\n",
    "test_df = test_df[test_df[\"language\"].isin(TRAIN_LANGS + [ZERO_SHOT_LANG])].reset_index(drop=True)\n",
    "\n",
    "print(\"train languages:\")\n",
    "print(train_df[\"language\"].value_counts())\n",
    "print(\"test languages:\")\n",
    "print(test_df[\"language\"].value_counts())\n",
    "\n",
    "print(\"train label distribution (overall):\")\n",
    "print(train_df[\"label\"].value_counts(normalize=True))\n",
    "print(\"test label distribution (overall):\")\n",
    "print(test_df[\"label\"].value_counts(normalize=True))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c008c787",
   "metadata": {},
   "source": [
    "### Create validation split from train (stratified by language × label)\n",
    "\n",
    "We train only on EN/DE, so validation is created from EN/DE **only** (French stays eval-only)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "2477e3fe",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "train_en_de: 16749\n",
      "val_en_de: 1861\n",
      "Train (EN/DE) distribution:\n",
      "label         0     1\n",
      "language             \n",
      "de         1259    75\n",
      "en        14337  1078\n",
      "Val (EN/DE) distribution:\n",
      "label        0    1\n",
      "language           \n",
      "de         140    8\n",
      "en        1593  120\n",
      "Test distribution (EN/DE/FR):\n",
      "label       0   1\n",
      "language         \n",
      "de        599  35\n",
      "en        827  61\n",
      "fr        388  30\n"
     ]
    }
   ],
   "source": [
    "def make_val_split(\n",
    "    df: pd.DataFrame,\n",
    "    train_langs: List[str],\n",
    "    val_fraction: float,\n",
    "    seed: int,\n",
    ") -> Tuple[pd.DataFrame, pd.DataFrame]:\n",
    "    base = df[df[\"language\"].isin(train_langs)].copy().reset_index(drop=True)\n",
    "    strat = base[\"language\"].astype(str) + \"__\" + base[\"label\"].astype(str)\n",
    "\n",
    "    splitter = StratifiedShuffleSplit(n_splits=1, test_size=val_fraction, random_state=seed)\n",
    "    idx_train, idx_val = next(splitter.split(base, strat))\n",
    "\n",
    "    train_part = base.iloc[idx_train].reset_index(drop=True)\n",
    "    val_part = base.iloc[idx_val].reset_index(drop=True)\n",
    "    return train_part, val_part\n",
    "\n",
    "train_en_de, val_en_de = make_val_split(train_df, TRAIN_LANGS, VAL_FRACTION, SEED)\n",
    "\n",
    "print(\"train_en_de:\", len(train_en_de))\n",
    "print(\"val_en_de:\", len(val_en_de))\n",
    "\n",
    "print(\"Train (EN/DE) distribution:\")\n",
    "print(train_en_de.groupby([\"language\", \"label\"]).size().unstack(fill_value=0))\n",
    "\n",
    "print(\"Val (EN/DE) distribution:\")\n",
    "print(val_en_de.groupby([\"language\", \"label\"]).size().unstack(fill_value=0))\n",
    "\n",
    "# Test is the provided dev file\n",
    "print(\"Test distribution (EN/DE/FR):\")\n",
    "print(test_df.groupby([\"language\", \"label\"]).size().unstack(fill_value=0))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "55e12e77",
   "metadata": {},
   "source": [
    "## Task 1.2 — Multilingual data exploration (EN / DE / FR)\n",
    "\n",
    "This section produces quick exploratory summaries to understand:\n",
    "- dataset size differences per language\n",
    "- label imbalance per language\n",
    "- platform/type mixture differences\n",
    "- basic length distributions\n",
    "\n",
    "Then we manually inspect examples across languages.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "5b7765b1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Train (filtered to EN/DE/FR) ===\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>n</th>\n",
       "      <th>pos_rate</th>\n",
       "      <th>avg_words</th>\n",
       "      <th>p95_words</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>train_language</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>en</th>\n",
       "      <td>17128</td>\n",
       "      <td>0.069944</td>\n",
       "      <td>16.546707</td>\n",
       "      <td>27.00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>de</th>\n",
       "      <td>1482</td>\n",
       "      <td>0.056005</td>\n",
       "      <td>100.806343</td>\n",
       "      <td>275.90</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>fr</th>\n",
       "      <td>976</td>\n",
       "      <td>0.071721</td>\n",
       "      <td>105.807377</td>\n",
       "      <td>313.25</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                    n  pos_rate   avg_words  p95_words\n",
       "train_language                                        \n",
       "en              17128  0.069944   16.546707      27.00\n",
       "de               1482  0.056005  100.806343     275.90\n",
       "fr                976  0.071721  105.807377     313.25"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== Test (dev-as-test, filtered to EN/DE/FR) ===\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>n</th>\n",
       "      <th>pos_rate</th>\n",
       "      <th>avg_words</th>\n",
       "      <th>p95_words</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>test_language</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>en</th>\n",
       "      <td>888</td>\n",
       "      <td>0.068694</td>\n",
       "      <td>16.247748</td>\n",
       "      <td>26.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>de</th>\n",
       "      <td>634</td>\n",
       "      <td>0.055205</td>\n",
       "      <td>100.746057</td>\n",
       "      <td>278.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>fr</th>\n",
       "      <td>418</td>\n",
       "      <td>0.071770</td>\n",
       "      <td>107.653110</td>\n",
       "      <td>295.6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 n  pos_rate   avg_words  p95_words\n",
       "test_language                                      \n",
       "en             888  0.068694   16.247748       26.0\n",
       "de             634  0.055205  100.746057      278.0\n",
       "fr             418  0.071770  107.653110      295.6"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAxYAAAGGCAYAAADmRxfNAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjgsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvwVt1zgAAAAlwSFlzAAAPYQAAD2EBqD+naQAATDJJREFUeJzt3QmcjXX/+P/3mGEY+74TkcSQLUu2st0iSXfq1kIoNZYUkZSQrGG6CSllu6WVtNxli7LdMWWtUGQpEsluhnH+j/f7+7vO/5wzM8zMmZkzM+f1fDyu5pzrfM51russut7X5/3+fEJcLpdLAAAAAMAPOfx5MgAAAAAQWAAAAABIE/RYAAAAAPAbgQUAAAAAvxFYAAAAAPAbgQUAAAAAvxFYAAAAAPAbgQUAAAAAvxFYAAAAAPAbgQWAdBESEpKsZc2aNX6/1vnz52XkyJHJ3tavv/5qrz137twUv5a+hj73gw8+SMWeXn2bqX0v9Dj0+XpcjpYtW9qSEj/88IO9j57bSQ7f13Le31deeUXS0tixY2Xp0qVp/v75Q4+7Zs2a6f461113nfTo0SPdXwcA/BHm17MBIAkbN270uv/SSy/JV199JatXr/Zaf9NNN6VJYDFq1Ci7ndKT6exqxowZKX6OBhb6Pup7qCey6flaqQ0s/vnPf0rnzp291tetW9e+b2nxXQIApB6BBYB00ahRI6/7xYsXlxw5ciRYj/SRESfZGtBFREQE/IS+QIECfK8AIBMgFQpAwMTFxcmYMWPkxhtvlPDwcAs+HnnkEfnzzz+92mkvh15FL1q0qOTJk0cqVKgg99xzj53YatqNPk/p1XYnxSqlaSM///yzvXbVqlXtZLls2bJy5513yo4dOxJtf/HiRXn66aelVKlStk8tWrSQ77//PkG7LVu2SKdOnaRIkSKSO3duqVOnjrz33nuSWps2bZJbb73VtlWmTBkZNmyYXLp0KUG7xFKhZs6cKbVr15Z8+fJJ/vz57X1/7rnn3OlU9957r92+7bbb3O+jky7mpPx8/fXX0qRJE3uPevbsmeRrqStXrsjLL79sn5fub/369WXVqlVebfRzSqx3RFOy9PUdevvcuXMyb9489745r5lUKtSyZcukcePGtq96vG3atEnQk+a8zq5du+Rf//qXFCxYUEqWLGnHdurUKUmub775xoIb/S7od+eFF16Q+Ph4e8zlctn3ql27dgmed/bsWXvNvn37Skro92/QoEFy88032/P1+6XH+vHHHydoq8fXr18/WbBggVSvXt3eD/0efPrppwna6vNr1aplv8fKlSvLq6++muCzuFoqoa7X9qn5Xeln0LZtW2unv2l9Tz777LNEP9uVK1dKq1atLKjU9vqb8P1uAch4BBYAAkJPOu+66y4ZP368dOvWzU4g9PaKFSvshPHChQvuk5gOHTpIrly55K233pIvvvjC2uXNm9cCk9KlS9s61atXLztx1EVP7FLi999/t8BFt63be+211yQsLEwaNmwou3fvTtBeT8j37dsnb775pi36fN1vXefQ1C894fn7779l1qxZdtKmJ4L33Xdfquo7NFVJT6Z0e/p83aYGMxqcXcvixYslKirKAqAlS5ZYrcJTTz1lJ+tK32NNNVJ67M77qOsdR44ckQcffNA+r88//9y2dzXTp0+39zI6OloWLlxoPVbt27dPcHKfHPocPWm/44473Pt2tRSsRYsW2fdLTzzfeecdmTNnjpw8edI+o3Xr1iVor4HqDTfcIB9++KE8++yz9nx9f5Lj6NGjcv/998sDDzxgn7Gma+ln8uSTT9rjemLcv39/+27v3bvX67nz58+X06dPpziwiI2Nlb/++ksGDx5sn6UeY9OmTaVLly62TV/6+9LPY/To0XaMGojcfffdXt9X/az0+fo7ePfdd2XixIm2XQ3mUiu5vyv9bul3U9dpAKzHcObMGQuIfOl3SQMQ/Wx13zRQ1+PRwI3gAggwFwBkgO7du7vy5s3rvv/OO++49J+gDz/80Kvd5s2bbf2MGTPs/gcffGD3t27dmuS2//zzT2vz4osvJmtf9u/fb+3ffvvtJNtcvnzZFRcX56patarrqaeecq//6quv7Ll169Z1Xblyxb3+119/deXMmdPVu3dv97obb7zRVadOHdelS5e8tt2xY0dX6dKlXfHx8V7b1L9Xc99997ny5MnjOnr0qNd+6uvo8/W4HC1atLDF0a9fP1ehQoWuuv33338/yf3Qbeljq1atSvQxz9dy3t8yZcq4Lly44F5/+vRpV5EiRVytW7f2+l5UrFgxwTb1s/T9X5R+f7S9L9/3T99Xfe3IyEj3e6zOnDnjKlGihKtJkyYJXmfixIle24yKinLlzp3b6zNOjPO+fPzxx17rH330UVeOHDlcBw4ccB97/vz5XU8++aRXu5tuusl12223ua5F36PEjt3ze6Dfs169etl3zpPuX8mSJW0fHPod0v0bN26ce12DBg1c5cuXd8XGxnq9Z0WLFvX6LK72+7nW7zCp39UzzzzjCgkJce3atcurfbt27bw+23Pnztl36M477/Rqp59z7dq1XbfcckuSrw0g/dFjASAgNA2jUKFClhZx+fJl96JX9DW9yEl90PvaW/HYY4/Z1UnPK6xpSV9br9hrvYC+nl5V1b96hfnHH39M0F6v2numh1SsWNFShLSXwkkB+emnn+wqtrN9Z9Gr7nqFNrGekKvRbWuPhabqOEJDQ60H5FpuueUW6+nQdB+9qn78+HFJqcKFC8vtt9+e7PZ69VtToByajqSft6ZTOWlC6UHfV71S/tBDD1kviUNTwLRnQtPJNI3Ok6aredJ0IE03Onbs2DVfT4/L9/n6/dBeOT1Wp42mBGlPk9NLpCl+2guV2FX55Hj//fetR0yPS7+vOXPmtJ6ZxL6vmt6m++DQ71CJEiXkwIEDdl/3SdP2tDBev/cO3bZ+Zun9u1q7dq2l2vnW6+j31dOGDRusp6Z79+5evyl9r//xj3/I5s2b3e8vgIxHYAEgIP744w870dWTDD0h8lw0tcQ58b3++ustn1pPgjRdRO/rornfaUnrJTR9Sk+sPvnkE/nf//5nJymai+6kZXnS4CexdSdOnHAfn9JUFd/jc1KIUnpyr9tO6nWvRU+yNZVMTyT15FrfT01H0fSc5NK0s5RIal81hU1rC9KL8xkktr9al6InoZoW5UnTdTxpjYFK7LP35Rno+R67sy9K06E0vec///mP3dfUpHLlylnKVkp99NFH0rVrV6tZ0NQgTQ3T76vWhmhA5Mv3+JxjdI5P3w/tcEjsWBJbl9a/K32fkvPazu9K0818f1cTJkywY9DAA0BgMCoUgIAoVqyYnew49RG+PK+uNmvWzBa9yq1XVadNmyYDBw60kw7NbU8LenL28MMPu+sMHHryrz0rvjT4SWydcwKnx6e0uFqv3CemWrVqKdpH3XZSr5scesVcF72iq1fSX3zxRenYsaPs2bPHelyuxbOHJjmS2lcNJvVKuNIeDa0X8JWaHhWH8xlor5Av7cnQXgztfUkrzsluYsfueUJfpUoVqzHROgP9q8XlOuCA9jql5vtaqVIlq4Xw/FwSey+TQ98P3c7VjsXh9EL5vpZnEJXS35W+T8l5bed3pf8GJDXCnD+BEAD/0GMBICD0hFZPRDRY0NGCfJfETrr1BEyvsuuJmfruu+9SfHU5KXpS5WzHs+D1t99+S7S9FrX+X0r5/9GeAE3TcEYq0v3XkXC2bduW6PHp4hk8JYems2hxqucJmL5/enKZElr4rie2w4cPt94DHY0nrd5H36vqnlfP9Wq9XrXWINE5mdYRoTTdyPOYdJ++/PLLq15hvxp97/VKvhZge35GGlBp4bIzUlRa0ePSIMGTvrYGMM2bN/darwXd27dvt1QefQ8effTRVH9fNUDzDCr0JDyxUaGS+53Q76QWguv779CeJd/Ro/TEXYMLPQ5PSY1IlZzflRZu79y501LDfAcd8KSpXxqQaLukfleeqVwAMhY9FgACQnsaNCVE6w30ZEtrADSd4fDhw1ZLoOkhOmqNjnykueg6OpEOW6onqprSo1q3bm1/9QRdr7jriY3WIOgIMXplMyWTvGmgo/nvOgSr5tfHxMTIpEmTLFUlMXoyrPunJ4Y6LKle/deTLe2hcLz++ut2Aq+j1eiwqnqyq2kamluuQZHmyKfE888/byewWucwYsQIOznWICs5OeW6nzqqkp6YaYqQnoSOGzfOhipt0KCBtXFmkJ49e7a9p3o8elU8sTSa5NATZx3iVdNhNP1IU1V0BCRnMkOl9SF6LPp9eOaZZ+zz/fe//51oDUZkZKTV3mhwoseg+5hYAKon9Dqikda36Ofap08fu7qun6em3+kIRWlJ358nnnhCDh48aCNL6YhZb7zxhq3T76wnfT+0jkC/4zrClqakpYYelwZumlanaUGHDh2ySSj1ffEdeSq5dMQo/Z3p91V/k/oZ6HumvUue6UUaLOi+6+9Q0xI1renbb7+1YCq1vyvtgdTt6e9F90ODF92e1ikpp1ZG90V7KzQw033SY9f3UIeo1iBe/+qoUgACJAMKxAEgwahQSkexeeWVV2w0Fx2BJ1++fDbCUZ8+fVx79+61Nhs3bnTdfffdNipOeHi4jVCjI/EsW7bMa1srV6600XC0jf7TdrURdBIb1ebkyZM2oo6OGhQREeFq2rSp65tvvkkw4pEzAtGCBQtcAwYMcBUvXtxes1mzZq4tW7YkeK1t27a5unbtatvVUaNKlSrluv32212zZs1KsM1rjQql1q9f72rUqJG9pm5LR9OZPXv2NUeFmjdvno0+pKMD5cqVy0ZN0v3avn271/ajo6NdlSpVcoWGhnq9R7qtGjVqJLpPSY0KNWHCBNeoUaNc5cqVs9fUz+fLL79M8PzPP//cdfPNN9uIV5UrV3ZNnz490VGhdGSwW2+91T4ffcx5zaTev6VLl7oaNmxo3y397rVq1creP0/O6+jIYp70uH3f06SOXd+XNWvWuOrXr2+fi4749dxzzyUYDcwxcuRI2/amTZtcyZXYqFDjx493XXfddfaa1atXd73xxhuJvm96v2/fvsna5pIlS2w0Lf28KlSoYK+h3/PChQt7tTt16pSNgKbfJ31vdZQmHRnNd1So5P6u1M6dO23EMP28dOQnfZ5+b3Wb+jvytHbtWleHDh2snf6uypYta/d1ZDMAgROi/wlUUAMAQLDRdB296q9FzJmdTr6oI7Npb9vy5csz/PV1NDhNO9S0SVKcgMyPVCgAANKZpoBpDYHWK2g6kE5SmBnpJJOaruWky2kqoqbupfUobInRFCgdtUtn/HZqO3TySU0BJKgAsgYCCwAA0pnW1GjxvdZjaD2ODr+aGWkhug6RrLUKWvNUt25dqxlx6pnSk76e1l9onZXOTaGDH0yZMsU9gzmAzI9UKAAAAAB+Y7hZAAAAAH4jsAAAAADgNwILAAAAAH6jeFvEJm76/fffbbIlz1lMAQAAgGDmcrlsYAcdtc2ZrDIpBBYiFlSUL18+oz4fAAAAIEs5dOiQlCtX7qptCCxErKfCecMKFCiQMZ8OAPiIj4+XJk2aSIcOHWTYsGHy66+/2rCkI0eOlHvvvVd2795t/6jnzZtXjh8/Lj169JAWLVrIM888k+h7uWzZMru6tGbNGruAsmjRIvdjf/zxhzRq1Eg2btwoW7dulVGjRtltpcN7NmjQQB588EE+IwAIcqdPn7YL8M758tUQWOiYu/8v/UmDCgILAIHyww8/yN69e2Xs2LE2IZjOedC7d29ZsGCBTVymJ/uO2NhYG/f/4MGDSf675QQGe/bskWPHjnm100nPbrjhBlsqVKhgQYo+vn79etvm22+/nQFHDADIKpJTLkDxNgBkonovJ5/Vc9327dvd98ePH29XjUqUKCHbtm2T/v37p+q1dPKx/fv322RkK1askMjISLl06ZIMGDBAZs6cmQZHAwAINgQWAJBJVKtWTSpVqiQjRoywHoldu3bJW2+9Zd3QjmeffdaK6LR34/HHH5dSpUql6rWKFCki06ZNs1SrqVOnyptvvikTJkyw+xpgtG/fXlq2bClLlixJwyMEAGRnBBYAkEloapPWRWjNg9ZSPPDAA/LII49YSpSv6tWrS+3atS2FKbW0bmPLli2yevVqyZ07twURQ4cOtbQrrfHQ+9qDcfLkST+PDAAQDKixAIBMRAOGL7/80n1fT/S1QDsx2rOgNRlpISoqSl599VWr7dAUq4YNG0p4eLgFOPoat9xyS5q8DgBk1cE19N/c7HpRKzQ0NE22RWABAJmI1lNcf/319g/9p59+aqlQq1atkrNnz8r7778vd999txQsWFB27twpY8aMkXbt2iW5rcuXL7sXrdW4ePGijRKlwYOnefPmSeXKlaVp06Z2X29r3UXdunWt8LtixYrpftwAkBlpzdvRo0fl77//luysUKFCllrr73xuBBYAkIm89957MmPGDKux0FSnpUuXSq1ateTcuXM2XOzgwYPtMS3evueee2yYWIfWXKhZs2bZXw08PB/PkyeP9X7o8LOOEydOyCuvvCLffPONe91rr70mPXv2tGBGh7otWbJkBh09AGQuTlCh/+ZGRERku4mUXS6XnD9/3kYOVKVLl/ZreyEuz+FHgpQWRuoVwFOnTjHcLAAAACz9SXttNahIrNYtOzlx4oQFFzoEuW9aVErOkyneBgAAAHw4NRXaU5HdRfy/Y/S3joTAAgAAAEhCdkt/Ss9jJLAAAAAA4DcCCwAAACANtWzZUgYOHJistjqghvYY+Dvy1HXXXSfR0dESSAQWAAAAAPzGcLMAkIR6z8znvQmQmEkP894DQBZDjwUAAACQThYuXCj169eX/Pnz2yR03bp1c88b4Wn9+vU2f1Hu3LmlYcOGsmPHDq/HN2zYIM2bN7c5icqXLy8DBgywOY4yEwILAAAAIJ3ExcXJSy+9JNu2bbNJT/fv3y89evRI0O6ZZ56xCUs3b95sc2d06tTJPfyrBhnt2rWTLl26yPbt2+Xdd9+VdevWSb9+/TLV50YqFAAAAJBOevbs6b5duXJl+fe//y233HKLnD17VvLly+d+7MUXX5Q2bdrY7Xnz5km5cuVkyZIl0rVrV5k0aZL1dDgF4VWrVrXttGjRQmbOnGm9HJkBPRYAAABAOvn+++/lrrvukooVK1o6lI4YpQ4ePOjVrnHjxu7bRYoUkWrVqsmPP/5o92NiYmTu3LkWiDiL9mBcuXLFekAyi4AGFpcvX5bnn39eKlWqZPliGsWNHj3a3iSHy+WSkSNHSpkyZayNfhi7du3y2k5sbKz0799fihUrJnnz5rWuo8OHDwfgiAAAAID/ozUQbdu2tUBAay00zUl7IZwUqeROXKfnxn369JGtW7e6F02t2rt3r1x//fWSWQQ0FWrChAkya9Ys6+6pUaOGbNmyRR555BEpWLCgPPnkk9Zm4sSJMmXKFIvSbrjhBhkzZox1E+3evduiPqXdQp988oksXrxYihYtKoMGDZKOHTtadBcaGhrIQwQAAECQ+umnn+T48eMyfvx4K7hWer6bmE2bNkmFChXs9smTJ2XPnj1y44032v26devahfUqVapIZhbQHouNGzda11CHDh1sUo9//vOfFtU5b7j2VuhEH8OHD7dilZo1a1oQcv78eVm0aJG1OXXqlMyZM0cmT54srVu3ljp16lhEqEUuK1euDOThAQAAIIhVqFBBcuXKJdOmTZN9+/bJsmXLrJA7MZq1s2rVKtm5c6cVd2smTufOne2xoUOH2nlz3759rbdCeyp0W5qxk5kENLBo2rSpvYEakSnt0tEK9zvuuMPua87Y0aNHLdhwhIeHW6GKDrmltFdCK+Y922jalAYhThtfmjp1+vRprwUAAABIS8WLF7esm/fff19uuukm67nQkZ8So49pxk69evXkyJEjFjhoUKJq1aola9eutYCiWbNmdiH9hRdekNKlS2eqDyygqVAafWmPg3bzaMpSfHy8vPzyy/Kvf/3LHtegQpUsWdLreXr/wIED7jb6phcuXDhBG+f5vsaNGyejRo1Kp6MCAABAMFuzZo37tp7XOue2Ds3KcWj9sHNfU/mT0qBBA1m+fHmSj//6668S1D0WOgavpi1pWtN3331naU4axenfxApXHPrm+67zdbU2w4YNs4DGWQ4dOpQGRwMAAAAEr4D2WOhEIM8++6zcf//9dj8yMtJ6IrRHoXv37jY7odKeB8+uHp2t0OnF0DZaVa9FLp69FtqmSZMmib6uplPpAgAAACAb9FhoEXaOHN67oClRznCzOgytBg4rVqxwP65BhOaYOUGD5qHlzJnTq43mpWnhS1KBBQAAAIBs1GNx5513Wk2FVszrcLM6gYgOLevMUKipTDqU7NixY22GQV30dkREhM0+qHRo2l69etkQszrUrE4oMnjwYOv90FGiAAAAAGTzwEKH3tKK9qioKEtd0tGcdPKPESNGuNsMGTJELly4YG003alhw4ZWuOLMYaGmTp0qYWFhNuW5tm3VqpVV4DOHBQAAAJAxQlyeZelBSoeb1Z4PLeQuUKBAoHcHQCZR75n5gd6FoBUz6eFA7wKAIHfx4kWb+kBT83Pnzi3BeqynU3CeHNAaCwAAAADZA4EFAAAAAL8RWAAAAADwG4EFAAAAgKw9KhQAAACQ1WT04B4xqRjQYsaMGTJp0iSb302ndYiOjpZmzZpJeqLHAgAAAMhG3n33XZsLbvjw4TZPnAYU7du3l4MHD6br6xJYAAAAANnIlClTbALp3r17S/Xq1a23onz58jJz5sx0fV0CCwAAACCbiIuLk5iYGGnbtq3Xer2/YcOGdH1tAgsAAAAgmzh+/LjEx8dLyZIlvdbr/aNHj6braxNYAAAAANlMSEiI132Xy5VgXVojsAAAAACyiWLFikloaGiC3oljx44l6MVIawQWAAAAQDaRK1cuqVevnqxYscJrvd5v0qRJur4281gAAAAA2cjTTz8tDz30kNSvX18aN24ss2fPtqFmH3/88XR9XQILAAAAIBu577775MSJEzJ69GibIK9mzZry+eefS8WKFdP1dQksAAAAgHSeCTujRUVF2ZKRqLEAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAAkLUDi+uuu05CQkISLH379rXHXS6XjBw5UsqUKSN58uSRli1byq5du7y2ERsbK/3795dixYpJ3rx5pVOnTnL48OEAHREAAAAQnMIC+eKbN2+W+Ph49/2dO3dKmzZt5N5777X7EydOlClTpsjcuXPlhhtukDFjxtjju3fvlvz581ubgQMHyieffCKLFy+WokWLyqBBg6Rjx44SExMjoaGhATs2AAAAZE8HR0dm6OtVGLEjRe2//vprmTRpkp0PHzlyRJYsWSKdO3eWbN1jUbx4cSlVqpR7+fTTT+X666+XFi1aWG9FdHS0DB8+XLp06SI1a9aUefPmyfnz52XRokX2/FOnTsmcOXNk8uTJ0rp1a6lTp44sXLhQduzYIStXrgzkoQEAAAABce7cOaldu7ZMnz49OGss4uLiLCjo2bOnpUPt379fjh49Km3btnW3CQ8Pt6Bjw4YNdl+jsEuXLnm10bQpDUKcNgAAAEAwad++vWX66MX5oEmF8rR06VL5+++/pUePHnZfgwpVsmRJr3Z6/8CBA+42uXLlksKFCydo4zw/MVqXoYvj9OnTaXosAAAAQLDJND0WmtKk0ZX2OHjS3gtPmiLlu87XtdqMGzdOChYs6F7Kly/v594DAAAAwS1TBBbaA6E1Eb1793av05oL5dvzcOzYMXcvhrbRFKqTJ08m2SYxw4YNs/oMZzl06FAaHxEAAAAQXDJFYPH2229LiRIlpEOHDu51lSpVssBhxYoV7nUaRKxdu1aaNGli9+vVqyc5c+b0aqOV7zq6lNMmMVqrUaBAAa8FAAAAQBausbhy5YoFFt27d5ewsP9/dzSVSYeSHTt2rFStWtUWvR0RESHdunWzNprG1KtXLxtiVoeaLVKkiAwePFgiIyNtlCgAAAAAQRJYaArUwYMHbTQoX0OGDJELFy5IVFSUpTs1bNhQli9f7p7DQk2dOtUCkq5du1rbVq1a2bwXzGEBAACAYHT27Fn5+eef3fd1tNWtW7faRfgKFSqk2+uGuLTSOcjpqFDa+6H1FqRFAXDUe2Y+b0aAxEx6mPceQEBdvHjRTsg1PT937txZaoK8NWvWyG233ZZgvWYI6QX4lBxrSs6TA95jAQAAAGQlKT3Rz2gtW7a0UVKDsngbAAAAQNZGYAEAAADAbwQWAAAAAPxGYAEAAADAbwQWAAAAAPxGYAEAAABcZTLn7O5KGh0jw80CAAAAPnLlyiU5cuSQ33//XYoXL273Q0JCstX75HK5JC4uTv788087Vj1GfxBYAAAAAD70RFsnjDty5IgFF9lZRESEzcitx+wPAgsAAAAgEXoFX0+4L1++LPHx8dnyPQoNDZWwsLA06Y0hsAAAAACSoCfcOXPmtAVXR/E2AAAAAL8RWAAAAADwG4EFAAAAAL8RWGRjv/zyi7Rv314KFy4sZcuWlYkTJyZoc+HCBalSpYoUKlToqtvq0aOHFTDly5fPvWzcuNH9eHR0tJQoUcK29fXXX7vX//3331KjRg0bxgwAAADZF4FFNqUjF3Tq1Enq1q0rx44dk9WrV8v06dNl0aJFXu1GjBgh5cqVS9Y2o6Ki5OzZs+6lcePGtv7o0aMyZswY2bZtmwUYffv2dT9n6NChMnjwYBv/GQAAANkXgUU2tXv3bltefPFFG8WgWrVq0qtXL5k9e7a7zXfffSeff/65DBs2zK/XOnDggFStWlVKly4trVu3tp4StX79evn555/lkUce8ft4AAAAkLkRWGTzqdl1RkXPddu3b7fbOh7zo48+Kq+99pqEh4cna5vz58+XIkWKWGrT5MmT3a+hQcX+/fvl8OHDsmLFComMjJRLly7JgAEDZObMmelyfAAAAMhcCCyyKe2h0NkiNdUpNjZWdu3aJW+99ZacPn3aHtfAoFatWtKyZctkbU+DBO0B0VqJOXPmyKuvvmqL0mBj2rRp0rlzZ5k6daq8+eabMmHCBLuvAYbWeejrLFmyJF2PGQAAAIHDBHnZlKY/LVu2TAYOHGg1FFq8rSlJr7/+uqUqaU/F999/n+ztaa2Go1GjRvLss89aD8ZTTz1l6+69915b1N69ey2I0OLu5s2bW9G49mI4gYwWkwMAACB7occiG6tevbp8+eWX1suwdetW67lo0aKFfPPNN7ZOU5pKlSolXbp0sZ4Mvf3tt98ma9s5cuS4apG39mboKFJa0N2wYUMLJjTA0aADAAAA2Q89FtmY1lNcf/311nvx6aefWirUqlWrrCbiH//4h7vdhg0brDdDg4+iRYsmuq333nvPnpM/f36JiYmR8ePHe43+5Jg3b55UrlxZmjZtavf1ttZdaI/Hnj17pGLFiul4xAAAAAgUAotsTIOBGTNmWE9F7dq1ZenSpZaOpPLkyeNupzUSISEh1mPhePzxx+3vrFmz7K8OVfvYY49Z0bemVWmvxKBBg7xe78SJE/LKK69Yj4hDU6569uxpw9OOHDlSSpYsme7HDQAAgIwX4vIcNihIaRpQwYIF5dSpU1KgQIFA7w6ATKLeM/MDvQtBK2bSw4HeBQCApOw8mRoLAAAAAH4LeGDx22+/yYMPPmi5/REREXLzzTdbDr9DO1Q0haZMmTKWvqOjCunQqZ401ad///5SrFgxyZs3r804rXMqAAAAAAiCwOLkyZNy6623WnHxf//7X/nhhx9sfoVChQq52+hQpVOmTLEc/82bN1sdQJs2beTMmTPuNjqkqg5vunjxYlm3bp3l83fs2FHi4+MDdGQAAABAcAlo8bZOola+fHl5++233euuu+46r96K6OhoGT58uA2J6ow6pAXAixYtkj59+li+l07YtmDBAmndurW1WbhwoW135cqV0q5duwAcGQAAABBcAtpjoRO41a9f3yZWK1GihNSpU0feeOMN9+P79++Xo0ePStu2bd3rwsPDbS4GHSJVadqUzu7s2UbTpmrWrOlu40tTp7QQxXMBAAAAkEV7LPbt2yczZ86Up59+Wp577jmbnG3AgAEWPDz88MMWVCjfIUr1/oEDB+y2ttGJ2Hxnc9Y2zvN9jRs3TkaNGiUZidFlAofRZQAAALJ5j8WVK1ds4rSxY8dab4WmNj366KMWbHjSORY8aYqU7zpfV2szbNgwS6FylkOHDqXB0QAAAADBK6CBRenSpeWmm27yWle9enU5ePCg3XYmbPPteTh27Ji7F0PbxMXFWSF4Um18aY+IjsPruQAAAADIooGFjgi1e/dur3V79uyRihUr2u1KlSpZ4LBixQr34xpErF27Vpo0aWL369WrZ6NKebY5cuSI7Ny5090GAAAAQDausXjqqafs5F9Tobp27Wo1FrNnz7ZFaSqTDiWrj1etWtUWva3zXXTr1s3a6EyAvXr1kkGDBtlcGEWKFJHBgwdLZGSke5QoAAAAANk4sGjQoIHNP6E1D6NHj7YeCh1e9oEHHnC3GTJkiFy4cEGioqIs3alhw4ayfPlyyZ8/v7vN1KlTJSwszIITbduqVSuZO3euhIaGBujIAAAAgOAS4tIq5yCnw81qz4cWcqdXvQWjQgUOo0IhtfjdBg6/WwDIeufJAa2xAAAAAJA9EFgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAA8BuBBQAAAAC/EVgAAAAAyNqBxciRIyUkJMRrKVWqlPtxl8tlbcqUKSN58uSRli1byq5du7y2ERsbK/3795dixYpJ3rx5pVOnTnL48OEAHA0AAAAQvALeY1GjRg05cuSIe9mxY4f7sYkTJ8qUKVNk+vTpsnnzZgs62rRpI2fOnHG3GThwoCxZskQWL14s69atk7Nnz0rHjh0lPj4+QEcEAAAABJ+wgO9AWJhXL4Vnb0V0dLQMHz5cunTpYuvmzZsnJUuWlEWLFkmfPn3k1KlTMmfOHFmwYIG0bt3a2ixcuFDKly8vK1eulHbt2mX48QAAAADBKOA9Fnv37rVUp0qVKsn9998v+/bts/X79++Xo0ePStu2bd1tw8PDpUWLFrJhwwa7HxMTI5cuXfJqo9uqWbOmu01iNH3q9OnTXgsAAACALBpYNGzYUObPny9ffvmlvPHGGxZINGnSRE6cOGG3lfZQeNL7zmP6N1euXFK4cOEk2yRm3LhxUrBgQfeiPRwAAAAAsmhg0b59e7nnnnskMjLSUpk+++wzd8qTQwu6fVOkfNf5ulabYcOGWRqVsxw6dMjvYwEAAACCWcBToTzpqE4aZGh6lFN34dvzcOzYMXcvhraJi4uTkydPJtkmMZpSVaBAAa8FAAAAQDYJLLT24ccff5TSpUtbzYUGDitWrHA/rkHE2rVrLV1K1atXT3LmzOnVRkeW2rlzp7sNAAAAgGw+KtTgwYPlzjvvlAoVKlgvw5gxY6yQunv37pbKpEPJjh07VqpWrWqL3o6IiJBu3brZ87U+olevXjJo0CApWrSoFClSxLbppFYBAAAACILAQiey+9e//iXHjx+X4sWLS6NGjWTTpk1SsWJFe3zIkCFy4cIFiYqKsnQnLfZevny55M+f372NqVOn2pC1Xbt2tbatWrWSuXPnSmhoaACPDAAAAAguIS6tdE6h22+/XT766CMpVKiQ13rtbejcubOsXr1ashLdb+390ELu9Kq3qPfM/HTZLq4tZtLDvE1IFX63gcPvFgCy3nlyqmos1qxZY/UOvi5evCjffPNNajYJAAAAIFhSobZv3+6+/cMPP3iN2BQfHy9ffPGFlC1bNm33EAAAAED2CixuvvlmK6rWRdOhfOXJk0emTZuWlvsHAAAAILsFFvv377fJ5ypXrizffvutFVw7dAbsEiVKUDQNAAAABKEUBRbOaE1XrlxJr/0BAAAAEEzDze7Zs8eKuHX+Cd9AY8SIEWmxbwAAAACyc2DxxhtvyBNPPCHFihWz2bG15sKhtwksAAAAgOCSqsBCZ8h++eWXZejQoWm/RwAAAACynFTNY6GzYN97771pvzcAAAAAgiew0KBi+fLlab83AAAAAIInFapKlSrywgsvyKZNmyQyMlJy5szp9fiAAQPSav8AAAAAZNfAYvbs2ZIvXz5Zu3atLZ60eJvAAgAAAAguqQosdKI8AAAAAPCrxgIAAAAA/O6x6Nmz51Uff+utt1KzWQAAAADBFFjocLOeLl26JDt37pS///5bbr/99rTaNwAAAADZObBYsmRJgnVXrlyRqKgoqVy5clrsFwAAAIBgrLHIkSOHPPXUUzJ16tS02iQAAACAYCze/uWXX+Ty5ctpuUkAAIBMTc9/2rdvL4ULF5ayZcvKxIkTbX1sbKw8+uijUqlSJcmfP7/ceOON16xD/e2336Rz585StGhRKVasmE1K/Mcff7gfj46OlhIlSticYl9//bV7vaaj16hRQ/788890PFIgHVKhnn76aa/7LpdLjhw5Ip999pl07949NZsEAADIcuLj46VTp04WDCxbtkz27dsnbdq0kXLlysldd90lpUuXlpUrV1qq+P/+9z8LQPSxtm3bJro9TSvXOcEOHDhg51cPPPCAPPnkk7J48WI5evSojBkzRnbs2CExMTHSt29fu62GDh0qgwcPluLFi2fwOwD42WPx/fffey3bt2+39ZMnT7ZIGgAAIBjs3r3blhdffFFy5swp1apVk169etlkwnnz5pXRo0fL9ddfb8FCo0aN5LbbbpN169Zdda6wrl272kTE2stx33332QA5SoONqlWrWrDSunVr6ylR69evl59//lkeeeSRDDtuIM16LL766qvUPA0AACBb0cFrlPYueK5zLrp6unjxonz77bfSrVu3q2aFvP/++9KhQwfb5jvvvGO3lQYVGngcPnzYLuxGRkbayJwDBgywdkCWrrHQPD6NujVSJqcPAAAEG+2h0BqKESNGWE3Frl27rI7i9OnTXu00SOjdu7cFB126dElye7feeqscO3bM6jWKFCkif/31lzz//PP2mN6fNm2apV3pYDlvvvmmTJgwwe5rgKFpVi1btkx09E4g0wYW586ds0nytCuuefPm0qxZMylTpox1/Z0/fz7t9xIAACAT0vQnra3YunWr1U5oTYSmJGnxtWdQ8cQTT1jK1NKlS20kzcRoT4fWZ2hwcfbsWVuaNm0q7dq1c7fRYu4tW7bI6tWrJXfu3BZEaH2FnoMNGzbM7msPhu+cY0CmDSy0m27t2rXyySef2CgEunz88ce2btCgQanakXHjxln+4cCBA71+iCNHjrSgJU+ePBaF65UAT3p1oH///jZyguYyagGVdhECAABkhOrVq8uXX35p2RsaYOi5SYsWLdznMlpkrSlQy5cvl4IFCya5He2d0DoKDQwiIiJs0XOcjRs3yvHjxxMt9H711VclV65csm3bNmnYsKH1dGiAs3fv3nQ9ZiDNAosPP/xQ5syZY11uBQoUsOWOO+6QN954Qz744IMUb2/z5s1W5FSrVi2v9Tpc25QpU2T69OnWplSpUhbJnzlzxt1GAxGNznW0BE3L0ui+Y8eONkoDAABAetN6Cs3miIuLk48++shSoZz0pX79+lnK+IoVK+yk/2r0IqkOI/vaa69ZPYYuelsDBX3M07x582ykKe3RUHpbX+P333+XPXv2SMWKFdPxiIE0DCw03alkyZIJ1uu4yilNhdJAQLsNNSjx/MFphK8jTA0fPtxyEWvWrGk/It3+okWLrM2pU6cswNHRqHR0hDp16sjChQtt6DUd2g0AACC9vffee1K+fHk7j3nllVcs3Ukvlmrvw4wZMywFSk/0daQnXR5//HH3c/W2533NAPnuu+9sPgxNOdeeDk218nTixAl7Ha2vcGgAoj0dN998s2V7JHaeBqS3EJfnMAbJ1KpVK8sdnD9/vuX3qQsXLtgcFtqNl5KTen2OFiNpEZKmOukPQgMKHQdah2fTH5cGDA4dE7pQoUIWZGh+oe6LvqZnUFK7dm0rZBo1alSy9kELrLRrUgMV7X1JD/WemZ8u28W1xUx6mLcJqcLvNnD43QJA5pCS8+RUDTerJ/7OBC96Eq+1EZpTGB4ebvmDyaXpSxo4aJqTL50ERvlG3HpfrwA4bTSv0LdrUds4z0+M5j7q4vAduQEAAABAyqQqsNBxk7UoSNOOfvrpJ0tbuv/++y2lSYusk+PQoUM2k6QGIk6vR2I0aPGkr+W7zte12miheHJ7MwAAAACkU2ChJ+baK/Doo496rddiJR0RQYc9uxadil7Haa5Xr557nRZcf/3111asrfmISnseNMfQoc9xejG0mFsLpXRINc9eC23TpEmTJF9bh2PTka08eyw0NxIAAABABhZvv/7663LjjTcmWF+jRg2ZNWtWsrahtRFaZK0pVM5Sv3596/XQ2zq6gQYOOsKBQ4MIHdLWCRo0KNHxoz3bHDlyRHbu3HnVwEJTtpzRrJwFAAAAQAb3WPj2IjiKFy9uJ/bJkT9/fhvpyZPOQ6FF4c56HUp27NixNkulLnpbx3Tu1q2bPa6FJDohjM6doc/TIvDBgwdbqpaOEgUAAAAgEwcWmjakYzLrFPaedJ1OZpdWhgwZYqNN6QQwmu6kE79oTYYGJQ4dTSosLEy6du1qbbUnZO7cuRIaGppm+wEAALIGRnMLHEZzQ6oCi969e1tvwqVLl+T222+3datWrbJAILUzb6s1a9Z43dcCbB2LWZekaOH3tGnTbAEAAACQhQILDSB07gjtSdC6B+cEX4u2tTAaAAAAQHBJVWChPQk62+MLL7wgP/74ow0xqzUQWhQNAAAAIPikKrBw6LT0DRo0SLu9AQAAABA8w80CAAAAgCcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAA4DcCCwAAAAB+I7AAAAAAkLUDi5kzZ0qtWrWkQIECtjRu3Fj++9//uh93uVwycuRIKVOmjOTJk0datmwpu3bt8tpGbGys9O/fX4oVKyZ58+aVTp06yeHDhwNwNAAAAEDwCmhgUa5cORk/frxs2bLFlttvv13uuusud/AwceJEmTJlikyfPl02b94spUqVkjZt2siZM2fc2xg4cKAsWbJEFi9eLOvWrZOzZ89Kx44dJT4+PoBHBgAAAASXgAYWd955p9xxxx1yww032PLyyy9Lvnz5ZNOmTdZbER0dLcOHD5cuXbpIzZo1Zd68eXL+/HlZtGiRPf/UqVMyZ84cmTx5srRu3Vrq1KkjCxculB07dsjKlSsDeWgAAABAUMk0NRbaw6C9DufOnbOUqP3798vRo0elbdu27jbh4eHSokUL2bBhg92PiYmRS5cuebXRtCkNQpw2AAAAANJfmASY9i5oIHHx4kXrrdC0pptuuskdGJQsWdKrvd4/cOCA3dbAI1euXFK4cOEEbfSxpGhdhi6O06dPp/FRAQAAAMEl4D0W1apVk61bt1r60xNPPCHdu3eXH374wf14SEiIV3tNkfJd5+tabcaNGycFCxZ0L+XLl0+DIwEAAACCV8ADC+1xqFKlitSvX99O+GvXri2vvvqqFWor356HY8eOuXsxtE1cXJycPHkyyTaJGTZsmNVnOMuhQ4fS5dgAAACAYBHwwCKx3gZNU6pUqZIFDitWrHA/pkHE2rVrpUmTJna/Xr16kjNnTq82R44ckZ07d7rbJEZrNZwhbp0FAAAAQBatsXjuueekffv2loqkQ8hq8faaNWvkiy++sFQmHUp27NixUrVqVVv0dkREhHTr1s2er2lMvXr1kkGDBknRokWlSJEiMnjwYImMjLRRogAAAAAEQWDxxx9/yEMPPWS9DBok6GR5GlToXBVqyJAhcuHCBYmKirJ0p4YNG8ry5cslf/787m1MnTpVwsLCpGvXrta2VatWMnfuXAkNDQ3gkQEAAADBJaCBhc5BcTXaa6Ezb+uSlNy5c8u0adNsAQAAABAYma7GAgAAAEDWQ2ABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAACydmAxbtw4adCggeTPn19KlCghnTt3lt27d3u1cblcMnLkSClTpozkyZNHWrZsKbt27fJqExsbK/3795dixYpJ3rx5pVOnTnL48OEMPhoAAAAgeAU0sFi7dq307dtXNm3aJCtWrJDLly9L27Zt5dy5c+42EydOlClTpsj06dNl8+bNUqpUKWnTpo2cOXPG3WbgwIGyZMkSWbx4saxbt07Onj0rHTt2lPj4+AAdGQAAABBcwgL54l988YXX/bffftt6LmJiYqR58+bWWxEdHS3Dhw+XLl26WJt58+ZJyZIlZdGiRdKnTx85deqUzJkzRxYsWCCtW7e2NgsXLpTy5cvLypUrpV27dgE5NgAAACCYZKoaCw0SVJEiRezv/v375ejRo9aL4QgPD5cWLVrIhg0b7L4GIZcuXfJqo2lTNWvWdLfxpalTp0+f9loAAAAAZIPAQnsnnn76aWnatKkFBUqDCqU9FJ70vvOY/s2VK5cULlw4yTaJ1XYULFjQvWjvBgAAAIBsEFj069dPtm/fLu+8806Cx0JCQhIEIb7rfF2tzbBhw6x3xFkOHTrk594DAAAAwS1TBBY6otOyZcvkq6++knLlyrnXa6G28u15OHbsmLsXQ9vExcXJyZMnk2zjS9OpChQo4LUAAAAAyKKBhfYqaE/FRx99JKtXr5ZKlSp5Pa73NXDQEaMcGkToaFJNmjSx+/Xq1ZOcOXN6tTly5Ijs3LnT3QYAAABANh4VSoea1dGdPv74Y5vLwumZ0LoHnbNCU5l0KNmxY8dK1apVbdHbERER0q1bN3fbXr16yaBBg6Ro0aJW+D148GCJjIx0jxIFAAAAIBsHFjNnzrS/Oumd77CzPXr0sNtDhgyRCxcuSFRUlKU7NWzYUJYvX26BiGPq1KkSFhYmXbt2tbatWrWSuXPnSmhoaAYfEQAAABCcwgKdCnUt2muhM2/rkpTcuXPLtGnTbAEAAAAQpMXbAAAAALI2AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAfiOwAAAAAOA3AgsAAAAAWTuw+Prrr+XOO++UMmXKSEhIiCxdutTrcZfLJSNHjrTH8+TJIy1btpRdu3Z5tYmNjZX+/ftLsWLFJG/evNKpUyc5fPhwBh8JAAAAENwCGlicO3dOateuLdOnT0/08YkTJ8qUKVPs8c2bN0upUqWkTZs2cubMGXebgQMHypIlS2Tx4sWybt06OXv2rHTs2FHi4+Mz8EgAAACA4BYWyBdv3769LYnR3oro6GgZPny4dOnSxdbNmzdPSpYsKYsWLZI+ffrIqVOnZM6cObJgwQJp3bq1tVm4cKGUL19eVq5cKe3atcvQ4wEAAACCVaatsdi/f78cPXpU2rZt614XHh4uLVq0kA0bNtj9mJgYuXTpklcbTZuqWbOmu01iNH3q9OnTXgsAAL6WLVsmN998s6Xa6v9fZs2aleib9Msvv9iFssKFC0vZsmWtx92TXigrUaKEVKlSxdKAHX///bfUqFFD/vzzT958AFlepg0sNKhQ2kPhSe87j+nfXLly2T/kSbVJzLhx46RgwYLuRXs4AADw9MUXX0hUVJQFBXoBSmv8tNbPl6bean1f3bp15dixY7J69WpL4dXedef/VWPGjJFt27bZtvr27et+7tChQ2Xw4MFSvHhx3nwAWV6mDSwcWtTtmyLlu87XtdoMGzbM0qic5dChQ2m2vwCA7OGFF16QESNGWDARGhpqF7FuvPHGBO12795ty4svvig5c+aUatWqSa9evWT27Nn2+IEDB6Rq1apSunRpS9vV3g21fv16+fnnn+WRRx7J8GMDgKAKLLRQW/n2POjVIKcXQ9vExcXJyZMnk2yTGE2pKlCggNcCAIDn4CKabqs9FRpM6P9v7rvvvkR7w69cueK+qOW5bvv27XZbgwpN79URC1esWCGRkZGWxjtgwACZOXMmbzqAbCPTBhaVKlWyf8j1H2GHBhFr166VJk2a2P169erZ1SHPNkeOHJGdO3e62wAAkFJ6wUoDBR0c5Msvv7SeBf3/zUMPPZSgrfZQ6P+ztHdDa/g0Zeqtt95y1+8VKVJEpk2bJp07d5apU6fKm2++KRMmTLD7GmBobYb2iugIhwCQlQV0VCgdGlb/sXboFZ2tW7faP8IVKlSwoWTHjh1rV3t00dsRERHSrVs3a6/1EdrdPGjQIClatKg9T3NV9WqQM0oUAAAplS9fPvurvQoVK1a026NGjbL/F2lvhhZzOzTg0CJv/X9WuXLlrHhb05tef/11d5t7773XFrV3714LIjZu3CjNmze3Qm/9/1atWrUswPCtGwSArCKggcWWLVvktttuc99/+umn7W/37t1l7ty5MmTIELlw4YIVz+nVo4YNG8ry5cslf/787ufo1Z+wsDDp2rWrtW3VqpU9V/NhAQBIjUKFCtkFrsTq9TxTnhzVq1e3ng3PomwdxTAx+v+0V1991QYf0YJu/X+bpuhqUKJBxy233MKHBiBLCmhgoVdmEvsH2qH/oOvM27okJXfu3NbFrAsAAGnlsccek3//+982J5L2iI8ePdouXjm9GZ60nuL666+33otPP/3UUqFWrVqVoJ3Ox1S5cmVp2rSp3dfbms6rI0rt2bPH3TsCAFlRQAMLAAAyq2effVb++usvqV27tt3XHnatuVCPP/64/XXmtXjvvfdkxowZVmOh7ZcuXWqpTZ5OnDghr7zyinzzzTfuda+99pr07NnTUoP1ItrVBh4BgMwu0xZvA9lJjx49LO1Br3Q6i+ZXp7Y9k20B6U9TaidPnizHjx+35f3333ePWKgBhedkeTpPhQYhWn+hE7TeeuutCbantYA7duywNCvPnvt9+/bZaIb9+/fnYwWQpRFYABlE86r1qqSzNG7cOFXtmWwLAABkRgQWQBbDZFsAACTOs6dfF6178k1LdGjq4qOPPmrDRevAQDpnjdZHeSJDIGUILIAMMn/+fCsArVGjhqVXOJNqpbQ9k20BAJA4z55+XXTEtvvvvz/RtpcvX5bSpUvLypUrbd4ZHVVUpzDQEUgVGQIpR2ABZAAdC3/37t3y559/ypw5c2yoSV1S057JtgAAuLZvv/1WfvjhB6tbTIzOR6OjvemIbjoSaaNGjWyQhnXr1tnjZAikHIEFkAF0KMnixYtbMaj+w6Wjzbz77rupbq8Tbek8MKtXr7Yhl3WyLR03XyeMHDZsmN3X4ETnfwEAIBjphTmd2b5MmTLJan/x4kULRpzUKTIEUo7hZoEAyJEjR5q1Z7ItZEcHR0cGeheCVoUROwK9C4Dfzp8/L4sXL7a04uTQedV69+5twUSXLl0SZAgUKFBA3nzzTZkwYYLdv3TpkgUtOjnzk08+KXfffTefGj0WQMbQMe41f1P/4dKehvHjx8s999zjd/ukJtv6/fffmWwLABC09P+jERER0qFDh2u21f/XPvHEE5aCrHPQeF7MI0MgZeixADLA9OnTbRZfLRQrW7as9TJogZjDd7Kta7VXTLYFAEDitHehe/fuEhYWds2gom/fvpYCtWrVKilYsGCSbckQuDYCCyADfP3111d93HOireS095xsy5Mz2RYAAMFKex50okrfoWMT069fP1m/fr3VLBYuXDjJdkllCGhN5J49e6RixYppegxZFYEFAAAAslXRdrNmzeSGG25I8JhnhoCO+jRjxgwJDw/3CgwefPBBrwt+ZAgkH4EFAAAAso2JEycm+ZhnwKDBhKZCXQsZAsnHcLMAAAAA/EZgAQAAAMBvBBYAAAAA/EaNBbI9JtoKHCbaAgAgeNBjAQAAAMBv9FgAAADAb2QIBE5myRCgxwIAAACA3wgsAAAAAPiNwAIAAACA3wgsAAAAAPiNwAIAAACA37JNYDFjxgypVKmS5M6dW+rVqyfffPNNoHcJAAAACBrZIrB49913ZeDAgTJ8+HD5/vvvpVmzZtK+fXs5ePBgoHcNAAAACArZIrCYMmWK9OrVS3r37i3Vq1eX6OhoKV++vMycOTPQuwYAAAAEhSwfWMTFxUlMTIy0bdvWa73e37BhQ8D2CwAAAAgmWX7m7ePHj0t8fLyULFnSa73eP3r0aKLPiY2NtcVx6tQp+3v69Ol028/42Avptm1c3Zmc8bxFAZKev6mMwO82cPjdBg6/W6QWv9vs+bt1tu1yubJ/YOEICQnxuq8H77vOMW7cOBk1alSC9Zo+heynZqB3IJiNKxjoPUAWxe82gPjdIpX43Wbv3+2ZM2ekYMGC2TuwKFasmISGhibonTh27FiCXgzHsGHD5Omnn3bfv3Llivz1119StGjRJIMRZE0aZWvAeOjQISlQoECgdwdAMvC7BbIefrfZl16s16CiTJky12yb5QOLXLly2fCyK1askLvvvtu9Xu/fddddiT4nPDzcFk+FChVK931F4GhQQWABZC38boGsh99t9nStnopsE1go7X146KGHpH79+tK4cWOZPXu2DTX7+OOPB3rXAAAAgKCQLQKL++67T06cOCGjR4+WI0eOSM2aNeXzzz+XihUrBnrXAAAAgKCQLQILFRUVZQvgSVPeXnzxxQSpbwAyL363QNbD7xYqxJWcsaMAAAAAIDtPkAcAAAAg8AgsAAAAAPiNwALZVsuWLWXgwIGB3g0AALIlzaZ/7LHHpEiRIjYP2NatWwO9SwiwbFO8DQAAgIzzxRdfyNy5c2XNmjVSuXJlm7QYwY3AAgAAACn2yy+/SOnSpaVJkyaJPh4XF2cTGSN4kAqFbOHcuXPy8MMPS758+ewfucmTJyf4x23IkCFStmxZyZs3rzRs2NCusAAIbBrFxIkT7Upnnjx5pHbt2vLBBx/YY/r71NSKVatW2eSnERERdvKye/duPjIgE+jRo4f079/fJiTW3+p1111nKcj9+vWziYu196JNmzaB3k1kMAILZAvPPPOMfPXVV7JkyRJZvny5nZTExMS4H3/kkUdk/fr1snjxYtm+fbvce++98o9//EP27t0b0P0Ggtnzzz8vb7/9tsycOVN27dolTz31lDz44IOydu1ad5vhw4fbhYItW7ZIWFiY9OzZM6D7DOD/vPrqqzYxcbly5Wxy4s2bN9v6efPm2W9V/5/7+uuv83YFGeaxQJZ39uxZKVq0qMyfP99mYVd//fWX/WOnRWV6RaVq1apy+PBhKVOmjPt5rVu3lltuuUXGjh0bwL0HgreXUa9orl69Who3buxe37t3bzl//rz9dm+77TZZuXKltGrVyh77/PPPpUOHDnLhwgXJnTt3APcegIqOjrbl119/tfvaY3Hq1Cn5/vvveYOCFDUWyBY5nprq5HlyoiNUVKtWzW5/9913lnJxww03eD0vNjbWAhIAGe+HH36QixcvJkiV0N9ynTp13Pdr1arlvq1pjurYsWNSoUKFDNxbAMmlqYsIXgQWyPKuNXn8lStXJDQ01FKj9K8nrckAkPH0d6k+++wzq33yFB4ebhcMVM6cOd3rNY/b87kAMh+tY0TwIrBAllelShU7+di0aZP7KubJkydlz5490qJFC7v6GR8fb1c5mzVrFujdBSAiN910kwUQWvipv1NfTmABAMg6CCyQ5WmvQ69evayAW1ObSpYsaQWfOXL839gEmgL1wAMP2KhRWgSqgcbx48cttzsyMlLuuOOOQB8CEHTy588vgwcPtoJt7YFo2rSpnD59WjZs2GC/6YoVKwZ6FwEAKURggWxh0qRJVsTdqVMnO2EZNGiQFZA5dOSZMWPG2PrffvvNAhCtySCoAALnpZdekhIlSsi4ceNk3759UqhQIalbt64899xzpDsBQBbEqFAAAAAA/MY8FgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgAAAAD8RmABAAAAwG8EFgCARLVs2VIGDhzIuwMASBYCCwAAAAB+I7AAAAAA4DcCCwDANS1cuFDq168v+fPnl1KlSkm3bt3k2LFj7sfXrFkjISEhsmrVKmsXEREhTZo0kd27d3ttZ8yYMVKiRAnbTu/eveXZZ5+Vm2+++arpV507d5YePXoke1/UsmXLpGrVqpInTx657bbbZN68ebZ/f//9t7vNhg0bpHnz5tamfPnyMmDAADl37hzfBgBIJQILAMA1xcXFyUsvvSTbtm2TpUuXyv79+71O9h3Dhw+XyZMny5YtWyQsLEx69uzpfuw///mPvPzyyzJhwgSJiYmRChUqyMyZM9N8X3799Vf55z//aQHJ1q1bpU+fPrZfnnbs2CHt2rWTLl26yPbt2+Xdd9+VdevWSb9+/fg2AEAqhbhcLldqnwwAyL6090B7E6KjoxM8tnnzZrnlllvkzJkzki9fPuux0J6BlStXSqtWrazN559/Lh06dJALFy5I7ty5pVGjRtbTMH36dPd2mjZtKmfPnrUAIKnX1AChUKFCMnfu3ET303dftBfks88+s+DB8fzzz1tQc/LkSdvWww8/bD0Vr7/+uruNBhYtWrSwXgvdXwBAytBjAQC4pu+//17uuusuqVixoqUgaQCgDh486NWuVq1a7tulS5e2v06akqZFaQDgyfd+WuyLvk6DBg2u+jraY6KBigYizqI9GFeuXLEeEABAyoWl4jkAgCCiV/Dbtm1ri9Y3FC9e3E7i9URc05I85cyZ031baxqUnqz7rnP4dprnyJEjwbpLly6laF/0+dd6Hd0nTZHSugpfmqIFAEg5AgsAwFX99NNPcvz4cRk/frwVOSutoUipatWqybfffisPPfSQe53vdjRQOHLkiPt+fHy87Ny509KskrsvN954o6VhefJtU7duXdm1a5dUqVIlxccBAEgcqVAAgKvSK/i5cuWSadOmyb59+2zEJS2eTqn+/fvLnDlzbISmvXv32ghRWjjt2btw++23W32ELhpEREVFeY3klJx90Z4Ife7QoUNlz5498t5777nrM5zX0sc2btwoffv2tfoO3R/dlu4jACB1CCwAAFelvQh6Yv7+++/LTTfdZL0Fr7zySorftQceeECGDRsmgwcPth4DZzQnz0JpHUWqe/fuVlythdSVKlVy91Ykd1/0OR988IF89NFHVvOhI085o0KFh4fbX12/du1aCyiaNWsmderUkRdeeMFdFwIASDlGhQIABEybNm1sLooFCxak6+voiFCzZs2SQ4cOpevrAEAwo8YCAJAhzp8/byf3WmgdGhoq77zzjg1Pu2LFijR/rRkzZtjIUEWLFpX169fLpEmTmKMCANIZgQUAIENofYMWVWttRWxsrBVzf/jhh9K6des0fy2nhuOvv/6yuoxBgwZZGhYAIP2QCgUAAADAbxRvAwAAAPAbgQUAAAAAvxFYAAAAAPAbgQUAAAAAvxFYAAAAAPAbgQUAAAAAvxFYAAAAAPAbgQUAAAAAvxFYAAAAABB//X+4jptcN0DXaAAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 800x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "def describe_split(df: pd.DataFrame, name: str) -> pd.DataFrame:\n",
    "    tmp = df.copy()\n",
    "    tmp[\"len_chars\"] = tmp[\"text\"].astype(str).str.len()\n",
    "    tmp[\"len_words\"] = tmp[\"text\"].astype(str).str.split().map(len)\n",
    "\n",
    "    summary = (\n",
    "        tmp.groupby(\"language\")\n",
    "        .agg(\n",
    "            n=(\"id\", \"count\"),\n",
    "            pos_rate=(\"label\", \"mean\"),\n",
    "            avg_words=(\"len_words\", \"mean\"),\n",
    "            p95_words=(\"len_words\", lambda s: float(np.percentile(s, 95))),\n",
    "        )\n",
    "        .sort_values(\"n\", ascending=False)\n",
    "    )\n",
    "    summary.index.name = f\"{name}_language\"\n",
    "    return summary\n",
    "\n",
    "print(\"=== Train (filtered to EN/DE/FR) ===\")\n",
    "display(describe_split(train_df, \"train\"))\n",
    "\n",
    "print(\"=== Test (dev-as-test, filtered to EN/DE/FR) ===\")\n",
    "display(describe_split(test_df, \"test\"))\n",
    "\n",
    "\n",
    "def _label_dist_plot(df: pd.DataFrame, title: str):\n",
    "    \"\"\"Bar plot of label counts per language with percentage annotations.\"\"\"\n",
    "    fig, ax = plt.subplots(figsize=(8, 4))\n",
    "    sns.countplot(data=df, x=\"language\", hue=\"label\", ax=ax)\n",
    "    ax.set_title(title)\n",
    "\n",
    "    # Compute totals per language for percentage calculation\n",
    "    lang_totals = df[\"language\"].value_counts().to_dict()\n",
    "\n",
    "    for container in ax.containers:\n",
    "        for bar in container:\n",
    "            count = int(bar.get_height())\n",
    "            if count == 0:\n",
    "                continue\n",
    "            # Identify the language for this bar from its x position\n",
    "            tick_idx = round(bar.get_x() + bar.get_width() / 2)\n",
    "            lang = ax.get_xticklabels()[tick_idx].get_text() if tick_idx < len(ax.get_xticklabels()) else None\n",
    "            # Fall back: match bar centre to tick positions\n",
    "            if lang is None or lang not in lang_totals:\n",
    "                xticks = ax.get_xticks()\n",
    "                centre = bar.get_x() + bar.get_width() / 2\n",
    "                closest = int(np.argmin(np.abs(np.array(xticks) - centre)))\n",
    "                lang = ax.get_xticklabels()[closest].get_text()\n",
    "            pct = 100 * count / lang_totals.get(lang, count)\n",
    "            ax.text(\n",
    "                bar.get_x() + bar.get_width() / 2,\n",
    "                bar.get_height() + ax.get_ylim()[1] * 0.01,\n",
    "                f\"{pct:.1f}%\",\n",
    "                ha=\"center\", va=\"bottom\", fontsize=9,\n",
    "            )\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "# Label distribution plots\n",
    "_label_dist_plot(\n",
    "    train_df[train_df[\"language\"].isin(TRAIN_LANGS + [ZERO_SHOT_LANG])],\n",
    "    \"Train label distribution by language\",\n",
    ")\n",
    "_label_dist_plot(test_df, \"Test label distribution by language\")\n",
    "_label_dist_plot(val_en_de, \"Validation label distribution by language\")\n",
    "\n",
    "# Type mix\n",
    "plt.figure(figsize=(10, 4))\n",
    "plot_df = train_df[train_df[\"language\"].isin(TRAIN_LANGS + [ZERO_SHOT_LANG])]\n",
    "order = plot_df[\"type\"].value_counts().head(8).index\n",
    "sns.countplot(data=plot_df[plot_df[\"type\"].isin(order)], y=\"type\", hue=\"language\")\n",
    "plt.title(\"Top text types in train (EN/DE/FR)\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Length distributions\n",
    "plt.figure(figsize=(10, 4))\n",
    "plot_df = train_df[train_df[\"language\"].isin(TRAIN_LANGS + [ZERO_SHOT_LANG])].copy()\n",
    "plot_df[\"len_words\"] = plot_df[\"text\"].astype(str).str.split().map(len)\n",
    "sns.histplot(data=plot_df, x=\"len_words\", hue=\"language\", bins=60, element=\"step\", stat=\"density\", common_norm=False)\n",
    "plt.xlim(0, 200)\n",
    "plt.title(\"Word length distribution (train)\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e35457e5",
   "metadata": {},
   "source": [
    "### Manual inspection across languages\n",
    "\n",
    "The following cell samples a few **positive** and **negative** examples per language for manual inspection.\n",
    "Look for:\n",
    "- negation and sarcasm\n",
    "- dosage/medical abbreviations\n",
    "- implicit adverse events vs explicit side effects\n",
    "- annotation ambiguity\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "c9278263",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== EN (NEG) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>7587</th>\n",
       "      <td>en_9488</td>\n",
       "      <td>en</td>\n",
       "      <td>0</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>Can off label use of #Letrozole in #PCOS be recommended? HTTPURL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14727</th>\n",
       "      <td>en_9279</td>\n",
       "      <td>en</td>\n",
       "      <td>0</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>@USER d: do you need a lozenge? or maybe drink lukewarm water?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2092</th>\n",
       "      <td>en_2109</td>\n",
       "      <td>en</td>\n",
       "      <td>0</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>without boniva sally would be just a mumbling pile of shattered bone. #blessed #oscars</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10820</th>\n",
       "      <td>en_1057</td>\n",
       "      <td>en</td>\n",
       "      <td>0</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>(This morning's cocktail of meds: 150mg pregabalin, 40mg fluoxetine, 50mg losartan, 500mg amoxicillin, multivitamin. It's fun!)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11955</th>\n",
       "      <td>en_11378</td>\n",
       "      <td>en</td>\n",
       "      <td>0</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>Fibro Question: Who has been on the Drug Merry-Go Round? (Vicodin to Lyrica to Elavil to Lunesta to Cymbalta to Lexipro on and on.)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             id language  label   type          origin  \\\n",
       "7587    en_9488       en      0  tweet  previous_SMM4H   \n",
       "14727   en_9279       en      0  tweet  previous_SMM4H   \n",
       "2092    en_2109       en      0  tweet  previous_SMM4H   \n",
       "10820   en_1057       en      0  tweet  previous_SMM4H   \n",
       "11955  en_11378       en      0  tweet  previous_SMM4H   \n",
       "\n",
       "                                                                                                                                      text  \n",
       "7587                                                                      Can off label use of #Letrozole in #PCOS be recommended? HTTPURL  \n",
       "14727                                                                       @USER d: do you need a lozenge? or maybe drink lukewarm water?  \n",
       "2092                                                without boniva sally would be just a mumbling pile of shattered bone. #blessed #oscars  \n",
       "10820      (This morning's cocktail of meds: 150mg pregabalin, 40mg fluoxetine, 50mg losartan, 500mg amoxicillin, multivitamin. It's fun!)  \n",
       "11955  Fibro Question: Who has been on the Drug Merry-Go Round? (Vicodin to Lyrica to Elavil to Lunesta to Cymbalta to Lexipro on and on.)  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== EN (POS) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>19270</th>\n",
       "      <td>en_16052</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>#restlesslegs #quetiapine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16755</th>\n",
       "      <td>en_10231</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>tysabri bruises are the best HTTPURL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1590</th>\n",
       "      <td>en_9952</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>@USER i know. i just realised with everything else - i haven't taken the sodding quetiapine yet!! wondered why i wasn't drowsy doh!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7042</th>\n",
       "      <td>en_4786</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>vyvanse makes my brain crazier than it already is.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>897</th>\n",
       "      <td>en_1080</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>slept 11 hours last night on seroquel o.o</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             id language  label   type          origin  \\\n",
       "19270  en_16052       en      1  tweet  previous_SMM4H   \n",
       "16755  en_10231       en      1  tweet  previous_SMM4H   \n",
       "1590    en_9952       en      1  tweet  previous_SMM4H   \n",
       "7042    en_4786       en      1  tweet  previous_SMM4H   \n",
       "897     en_1080       en      1  tweet  previous_SMM4H   \n",
       "\n",
       "                                                                                                                                      text  \n",
       "19270                                                                                                            #restlesslegs #quetiapine  \n",
       "16755                                                                                                 tysabri bruises are the best HTTPURL  \n",
       "1590   @USER i know. i just realised with everything else - i haven't taken the sodding quetiapine yet!! wondered why i wasn't drowsy doh!  \n",
       "7042                                                                                    vyvanse makes my brain crazier than it already is.  \n",
       "897                                                                                              slept 11 hours last night on seroquel o.o  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== DE (NEG) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8924</th>\n",
       "      <td>de_1272</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Hallo @USER Viel Frauen hier im Forum haben eine Chemo bekommen, aber ich hab noch nie davon gehört, dass man danach Impfungen auffrischen oder wiederholen muss. Ich bin fest der Meinung, dass die Ärzte einen darauf hinweisen würden........aber naja, am besten du fragst deinen Arzt danach. Ich hab zwe wirklich gute Ärzte, die mehr als nur die normalen Untersuchungen machen, aber keiner hat etwas dazu gesagt. Was man aber machen sollte, sich im Herbsz gegen die Grippe impfen lassen, da man nach eine Chemo noch sehr wenig Abwehrstoffe hat. Ich wünsch dir alles Gute, viel Glück und ein langes Leben @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8233</th>\n",
       "      <td>de_885</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Liebe @USER danke für deinen Bericht. Das ist manchmal wirklich ein wochenweiser Wechsel. Erst warens die &lt;Finger, jetzt die Knie. Mal sehen was morgen ist.... Ich wünsche &gt;Dir nochen einen schönen Sonntag Lg @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1494</th>\n",
       "      <td>de_656</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Hallo ihe Lieben, nachdem es mir ein Tage wirklich richig gut ging, kamen ein paar Tage voller Stress auf mich zu - Geburtstag des Sohnes, Streitereien familienintern weil, mein eigener Geburtstag und wieder ein Jahr älter hat ich innerlich so aufgewühlt, dass ich nachts wachwerde und erst nach einer Stunde lesen wieder einschlafen kann. Heute Morgen dann, an meinem Geburtstag versuchte ich zarte Fühler nach dem eigentlich doch schönen Tag auszustrecken, doch ließ die innere Unruhe nicht nach. Als ich im Badezimmer das Waschbecken putzte, überkam mich plötzlich ein Schwindel wie ich ihn so nicht kennengelernt hatte..es zog mir regelrecht vom Hinterkopf hoch und ich dachte echt, dass ich vornüber ins Wachbecken kippe. Prompt meldete sich meine Panik, mein Puls schnellte hoch, Blutdruck trotz Pille war auf 160/100 und ich dachte, dass ich an meinem Geburtstag dahingerafft werde. Bin dann sicherheitshalber zum Arzt, der meinte es läge an meinem inneren Stress, solche Familienfeste können sich krass aufs Gemüt legen so man nicht stabil und entspannt ist. Ich solle mich entspannen und gab mir Globuli gegen den Stress und die Angst. Nun gehts mir wieder besser, Blutdruck normal und auch kein Schwindel mehr, doch steckt mir der Schreck noch in den Gliedern. Wann hört das nur auf. Liegts an meiner Dünnhäutigkeit die durch die WJ verursacht werden oder ist da was Organisches? Warum haben so viele Frauen Schwindelzustände in den WJ, was genau geschieht dann? Haben gleich ne kleine Kaffeerunde und ich hoffe, dass ich das gut überstehen werde... so ein Mist..positiv denken ist manchmal garnicht so leicht. LG @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6046</th>\n",
       "      <td>de_982</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Das hat mich erschreckt: Gestern auf Sat3 kamen zwei Sendungen: Gefährliche Umwelthormone und Im Takt der Hormone. Vielleicht hat es jemand geschaut? Leider kann man die Sendung im Internet nicht noch mal schauen. Vor allem ging es um die Hormonwirkung von Stoffen, die sich im Plastik befinden. Allem voran Bisphenol A. Diese Stoffe docken an Östrogenrezeptoren an und verändern die körpereigene Produktion. Es wurden zahlreiche wissenschaftliche Versuche gezeigt und erklärt. Bisphenol A und andere hormonähnliche Stoffe in Kunststoff werden mit vielen Krankheiten in Verbindung gebracht. Auch mit verfrühten WJ. Aber auch mit Fettleibigkeit, Diabetes, Allergien, ADHS, Autismus, Unfruchtbarkeit, verminderter Intelligenz...etc. pp. Für Kinder sind die Folgen richtig schlimm!!!! Ich verzichte ja schon geraume Zeit (möglichst) auf Nahrung und Getränke in Plastikverpackungen, benutze keine Tupperdosen, Frischhaltefolie etc. und ich denke, es wäre einen Versuch wert, diese hormonähnlichen Stoffe in der Ernährung zu minimieren. Aber auch Thermopapiere: Faxe, Kassenbons, Parkzettel....enthalten hohe Werte von Bisphenol A und sie gelangen durch Anfassen in den Körper..... Hier ein link: &lt;url&gt; Wenn man googelt, findet man viele weitere Infos. Ich wünsche allen geplagten Frauen hier ein schönes Wochenende. Habe Urlaub und werde ab Sonntag 8 Tage unterwegs sein mit dem Motorrad. Bis dann @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2784</th>\n",
       "      <td>de_1321</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Hallo @USER, auch ich laufe seit nunmehr 2 Jahren mit einem unerklärlichen Ohrgeräusch herum. Von HNO-ärztlicher Seite ist alles ok., MRT vom Schäden auch o. B., vielleicht könnte man das auch Flackern nennen, ich weiss nicht recht. Für mich ist es auch ein Druckgefühl, das manchmal da ist und dann wieder auch nicht. Hast Du schon alles abklären lassen? Evtl. auch die HWS? Schreib doch mal zurück, wann und wie lange Du diese Symptome schon hast. Liebe Grüße @USER</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           id language  label        type    origin  \\\n",
       "8924  de_1272       de      0  forum post  LREC2022   \n",
       "8233   de_885       de      0  forum post  LREC2022   \n",
       "1494   de_656       de      0  forum post  LREC2022   \n",
       "6046   de_982       de      0  forum post  LREC2022   \n",
       "2784  de_1321       de      0  forum post  LREC2022   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               text  \n",
       "8924                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Hallo @USER Viel Frauen hier im Forum haben eine Chemo bekommen, aber ich hab noch nie davon gehört, dass man danach Impfungen auffrischen oder wiederholen muss. Ich bin fest der Meinung, dass die Ärzte einen darauf hinweisen würden........aber naja, am besten du fragst deinen Arzt danach. Ich hab zwe wirklich gute Ärzte, die mehr als nur die normalen Untersuchungen machen, aber keiner hat etwas dazu gesagt. Was man aber machen sollte, sich im Herbsz gegen die Grippe impfen lassen, da man nach eine Chemo noch sehr wenig Abwehrstoffe hat. Ich wünsch dir alles Gute, viel Glück und ein langes Leben @USER  \n",
       "8233                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Liebe @USER danke für deinen Bericht. Das ist manchmal wirklich ein wochenweiser Wechsel. Erst warens die <Finger, jetzt die Knie. Mal sehen was morgen ist.... Ich wünsche >Dir nochen einen schönen Sonntag Lg @USER  \n",
       "1494  Hallo ihe Lieben, nachdem es mir ein Tage wirklich richig gut ging, kamen ein paar Tage voller Stress auf mich zu - Geburtstag des Sohnes, Streitereien familienintern weil, mein eigener Geburtstag und wieder ein Jahr älter hat ich innerlich so aufgewühlt, dass ich nachts wachwerde und erst nach einer Stunde lesen wieder einschlafen kann. Heute Morgen dann, an meinem Geburtstag versuchte ich zarte Fühler nach dem eigentlich doch schönen Tag auszustrecken, doch ließ die innere Unruhe nicht nach. Als ich im Badezimmer das Waschbecken putzte, überkam mich plötzlich ein Schwindel wie ich ihn so nicht kennengelernt hatte..es zog mir regelrecht vom Hinterkopf hoch und ich dachte echt, dass ich vornüber ins Wachbecken kippe. Prompt meldete sich meine Panik, mein Puls schnellte hoch, Blutdruck trotz Pille war auf 160/100 und ich dachte, dass ich an meinem Geburtstag dahingerafft werde. Bin dann sicherheitshalber zum Arzt, der meinte es läge an meinem inneren Stress, solche Familienfeste können sich krass aufs Gemüt legen so man nicht stabil und entspannt ist. Ich solle mich entspannen und gab mir Globuli gegen den Stress und die Angst. Nun gehts mir wieder besser, Blutdruck normal und auch kein Schwindel mehr, doch steckt mir der Schreck noch in den Gliedern. Wann hört das nur auf. Liegts an meiner Dünnhäutigkeit die durch die WJ verursacht werden oder ist da was Organisches? Warum haben so viele Frauen Schwindelzustände in den WJ, was genau geschieht dann? Haben gleich ne kleine Kaffeerunde und ich hoffe, dass ich das gut überstehen werde... so ein Mist..positiv denken ist manchmal garnicht so leicht. LG @USER  \n",
       "6046                                                                                                                                                                                                                                        Das hat mich erschreckt: Gestern auf Sat3 kamen zwei Sendungen: Gefährliche Umwelthormone und Im Takt der Hormone. Vielleicht hat es jemand geschaut? Leider kann man die Sendung im Internet nicht noch mal schauen. Vor allem ging es um die Hormonwirkung von Stoffen, die sich im Plastik befinden. Allem voran Bisphenol A. Diese Stoffe docken an Östrogenrezeptoren an und verändern die körpereigene Produktion. Es wurden zahlreiche wissenschaftliche Versuche gezeigt und erklärt. Bisphenol A und andere hormonähnliche Stoffe in Kunststoff werden mit vielen Krankheiten in Verbindung gebracht. Auch mit verfrühten WJ. Aber auch mit Fettleibigkeit, Diabetes, Allergien, ADHS, Autismus, Unfruchtbarkeit, verminderter Intelligenz...etc. pp. Für Kinder sind die Folgen richtig schlimm!!!! Ich verzichte ja schon geraume Zeit (möglichst) auf Nahrung und Getränke in Plastikverpackungen, benutze keine Tupperdosen, Frischhaltefolie etc. und ich denke, es wäre einen Versuch wert, diese hormonähnlichen Stoffe in der Ernährung zu minimieren. Aber auch Thermopapiere: Faxe, Kassenbons, Parkzettel....enthalten hohe Werte von Bisphenol A und sie gelangen durch Anfassen in den Körper..... Hier ein link: <url> Wenn man googelt, findet man viele weitere Infos. Ich wünsche allen geplagten Frauen hier ein schönes Wochenende. Habe Urlaub und werde ab Sonntag 8 Tage unterwegs sein mit dem Motorrad. Bis dann @USER  \n",
       "2784                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Hallo @USER, auch ich laufe seit nunmehr 2 Jahren mit einem unerklärlichen Ohrgeräusch herum. Von HNO-ärztlicher Seite ist alles ok., MRT vom Schäden auch o. B., vielleicht könnte man das auch Flackern nennen, ich weiss nicht recht. Für mich ist es auch ein Druckgefühl, das manchmal da ist und dann wieder auch nicht. Hast Du schon alles abklären lassen? Evtl. auch die HWS? Schreib doch mal zurück, wann und wie lange Du diese Symptome schon hast. Liebe Grüße @USER  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== DE (POS) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6427</th>\n",
       "      <td>de_497</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_test</td>\n",
       "      <td>Hallo, @USER! Dasselbe Problem hatte ich auch, bin richtig davon überrannt worden. Psychische Probleme kannte ich bis dato gar nicht. Das war auch mit ein Grund, die HET abzusetzen, weil ich zuletzt überhaupt nicht mehr damit klar kam. Ich denke heute, dass es einfach daran lag, dass mein Gyn mich mit Östrogen vollgepumpt hat, obgleich meine Progesteronwerte seit Jahren im Keller waren. Die Ö-Werte waren unter der HET in den letzten Jahren immer schön im grünen Bereich, die P-Werte aber gleich 0, somit lag eine fette Östrogendominanz vor! Das Gleichgewicht unter den Hormonen fehlte und hat dafür gesorgt, dass ich richtig, richtig Probleme bekommen habe. Bin ja jetzt erst mit der P-Creme angefangen, und gestern hatte ich mal wieder einen kleinen Rückschlag, aber ich bin guter Dinge, dass es eigentlich nur besser werden kann, wenn das P-Depot erst einmal wieder aufgebaut wurde. Bevor Du jetzt mit der P-Creme loslegst, würde ich aber auf jeden Fall empfehlen, erst einmal Deine Hormonwerte ermitteln zu lassen. Aber nachdem, was Du jetzt geschrieben hast, gehe ich davon aus, dass Dein P-Spiegel ebenfalls im Keller ist, weil der Körper einfach zum Zeitpunkt der Menopause kein P mehr produziert, aber Ö ist immer noch in geringen Mengen vorhanden. Also lass Dich nicht unterkriegen. Wenn Du vor der Menopause keine psychischen Probleme hattest, warum dann auf einmal? Ich werde auch derzeit von körperlichen Problemen regelrecht überfahren. Manchmal kenne ich mich selbst nicht mehr wieder. Herzrythmusstörungen, Depri etc. etc., das sind alles Sachen, worüber ich früher nur gelesen und leise geschmunzelt habe. Ich kann mich noch daran erinnern, dass wir in jungen Jahren über ältere Damen, die völlig durch den Wind waren, nur gelacht haben und immer kam der Spruch: 'Ach, die ist bestimmt in den WJ'! Also Kopf hoch, bisher haben es noch alle überlebt! LG @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>de_935</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Hallo @USER, du brauchst dich doch nicht zu entschuldigen. Ich habe 2015 ganz kurz Hormone probiert, aber das war in der Phase, in der ich selbst noch sehr verunsichert war ob meine Symptome wirklich von den Wechseljahren kommen. Hatte Gynokadin Gel und Famenita, war nicht so toll. Danach Tabletten, bekam nur Blutungen und Schmerzen. Jetzt werde ich ein Kombi Hormonpflaster ausprobieren. Werde dir berichten. Hatte mir geschworen, nur mit AD da durchzugehen, da ich von Frauen gelesen habe , die nach Absetzen der Hormone wieder richtig schlimme Symptome bekommen haben. Die Probleme wurden nur hinausgezögert. Da mir das AD momentan nicht so hilft ( hoffe es kommt noch die Erhöhung ist ja erst 2 Wochen her) werde ich die Hormone zumindest probieren. In der Apotheke meinten sie vielleicht verstoffwechsle ich schnell und daher hat die ganz niedrige Dosis AD nicht so angeschlagen. Mein Wirkspiegel ( habe das testen lassen) war nach 12 Wochen noch im unteren Bereich. Nein, wir haben noch keine Ferien. Noch eine Woche! Geht es dir heute besser? Bei mir la la. Wurschtle mich so durch. liebe Grüße @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4628</th>\n",
       "      <td>de_1176</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Als ich damals mal Opri probiert habe, stand ich völlig neben mir. So richtig benebelt. . . . Wie durch Watte durch den Tag. . . Durch die Dämpfung fährt ja auch der Blutdruck bisschen runter und dann noch ein Senker obendrauf? Wäre für mich eine Erklärung, das du so neben der Spur bist. . . Wechselwirkungen? Sprich Bitte mit der Ärztin. . . .LG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6522</th>\n",
       "      <td>de_1124</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Macht euch alle keine Sorgen, ich habe nur durch ziemliche Schmerzen zur Zeit, weil sich die Muskeln immer so verkrampfen und die Schmerztabletten und Valium hauen mir die Schuhe weg. Ich melde mich aber auf jeden Fall, ich habe ja nun eure E-Mail-Adressen. Bitte, mach dir keine Sorgen. Gruß @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3559</th>\n",
       "      <td>de_117</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Hallo @USER, habe die Cerazette nur 4 Wochen genommen und nach 1 Woche ebenfalls 2 Tage leichte Blutungen gehabt, Jetzt eine Woche weiter schmerzen und vergössern sich meine Brüste, ich habe Hitzewallungen und Stimmungsschwankungen. Bin gespannt wie es weiter geht. Würde mich als ebenfalls Leidende freuen, zu hören wie es sich bei Dir weiterentwickelt hat. Liebe Grüsse @USER PS: Hatte vielleicht jemand nach absetzen der Cerazette ähnliche Symptome?</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           id language  label        type             origin  \\\n",
       "6427   de_497       de      1  forum post   SMM4H_24_de_test   \n",
       "46     de_935       de      1  forum post  SMM4H_24_de_train   \n",
       "4628  de_1176       de      1  forum post  SMM4H_24_de_train   \n",
       "6522  de_1124       de      1  forum post  SMM4H_24_de_train   \n",
       "3559   de_117       de      1  forum post  SMM4H_24_de_train   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       text  \n",
       "6427  Hallo, @USER! Dasselbe Problem hatte ich auch, bin richtig davon überrannt worden. Psychische Probleme kannte ich bis dato gar nicht. Das war auch mit ein Grund, die HET abzusetzen, weil ich zuletzt überhaupt nicht mehr damit klar kam. Ich denke heute, dass es einfach daran lag, dass mein Gyn mich mit Östrogen vollgepumpt hat, obgleich meine Progesteronwerte seit Jahren im Keller waren. Die Ö-Werte waren unter der HET in den letzten Jahren immer schön im grünen Bereich, die P-Werte aber gleich 0, somit lag eine fette Östrogendominanz vor! Das Gleichgewicht unter den Hormonen fehlte und hat dafür gesorgt, dass ich richtig, richtig Probleme bekommen habe. Bin ja jetzt erst mit der P-Creme angefangen, und gestern hatte ich mal wieder einen kleinen Rückschlag, aber ich bin guter Dinge, dass es eigentlich nur besser werden kann, wenn das P-Depot erst einmal wieder aufgebaut wurde. Bevor Du jetzt mit der P-Creme loslegst, würde ich aber auf jeden Fall empfehlen, erst einmal Deine Hormonwerte ermitteln zu lassen. Aber nachdem, was Du jetzt geschrieben hast, gehe ich davon aus, dass Dein P-Spiegel ebenfalls im Keller ist, weil der Körper einfach zum Zeitpunkt der Menopause kein P mehr produziert, aber Ö ist immer noch in geringen Mengen vorhanden. Also lass Dich nicht unterkriegen. Wenn Du vor der Menopause keine psychischen Probleme hattest, warum dann auf einmal? Ich werde auch derzeit von körperlichen Problemen regelrecht überfahren. Manchmal kenne ich mich selbst nicht mehr wieder. Herzrythmusstörungen, Depri etc. etc., das sind alles Sachen, worüber ich früher nur gelesen und leise geschmunzelt habe. Ich kann mich noch daran erinnern, dass wir in jungen Jahren über ältere Damen, die völlig durch den Wind waren, nur gelacht haben und immer kam der Spruch: 'Ach, die ist bestimmt in den WJ'! Also Kopf hoch, bisher haben es noch alle überlebt! LG @USER  \n",
       "46                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Hallo @USER, du brauchst dich doch nicht zu entschuldigen. Ich habe 2015 ganz kurz Hormone probiert, aber das war in der Phase, in der ich selbst noch sehr verunsichert war ob meine Symptome wirklich von den Wechseljahren kommen. Hatte Gynokadin Gel und Famenita, war nicht so toll. Danach Tabletten, bekam nur Blutungen und Schmerzen. Jetzt werde ich ein Kombi Hormonpflaster ausprobieren. Werde dir berichten. Hatte mir geschworen, nur mit AD da durchzugehen, da ich von Frauen gelesen habe , die nach Absetzen der Hormone wieder richtig schlimme Symptome bekommen haben. Die Probleme wurden nur hinausgezögert. Da mir das AD momentan nicht so hilft ( hoffe es kommt noch die Erhöhung ist ja erst 2 Wochen her) werde ich die Hormone zumindest probieren. In der Apotheke meinten sie vielleicht verstoffwechsle ich schnell und daher hat die ganz niedrige Dosis AD nicht so angeschlagen. Mein Wirkspiegel ( habe das testen lassen) war nach 12 Wochen noch im unteren Bereich. Nein, wir haben noch keine Ferien. Noch eine Woche! Geht es dir heute besser? Bei mir la la. Wurschtle mich so durch. liebe Grüße @USER  \n",
       "4628                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Als ich damals mal Opri probiert habe, stand ich völlig neben mir. So richtig benebelt. . . . Wie durch Watte durch den Tag. . . Durch die Dämpfung fährt ja auch der Blutdruck bisschen runter und dann noch ein Senker obendrauf? Wäre für mich eine Erklärung, das du so neben der Spur bist. . . Wechselwirkungen? Sprich Bitte mit der Ärztin. . . .LG  \n",
       "6522                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Macht euch alle keine Sorgen, ich habe nur durch ziemliche Schmerzen zur Zeit, weil sich die Muskeln immer so verkrampfen und die Schmerztabletten und Valium hauen mir die Schuhe weg. Ich melde mich aber auf jeden Fall, ich habe ja nun eure E-Mail-Adressen. Bitte, mach dir keine Sorgen. Gruß @USER  \n",
       "3559                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Hallo @USER, habe die Cerazette nur 4 Wochen genommen und nach 1 Woche ebenfalls 2 Tage leichte Blutungen gehabt, Jetzt eine Woche weiter schmerzen und vergössern sich meine Brüste, ich habe Hitzewallungen und Stimmungsschwankungen. Bin gespannt wie es weiter geht. Würde mich als ebenfalls Leidende freuen, zu hören wie es sich bei Dir weiterentwickelt hat. Liebe Grüsse @USER PS: Hatte vielleicht jemand nach absetzen der Cerazette ähnliche Symptome?  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== FR (NEG) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>18789</th>\n",
       "      <td>fr_157</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Je viens de voir que tu as répondu à ce message et que tu veux savoir comment cela se manifeste chez moi . ça a commencé dans le dos avec des petits boutons, je trouve que le soutien-gorge et le t-shirt sont laxistes sur la peau, ça frotte et ça me brûle. une fois que ça a disparu dans le dos, ça brûle sur la poitrine et maintenant c'est reparti !</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9386</th>\n",
       "      <td>fr_932</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut @USER ,c'est vrai qu'avec les changements hormonaux ou les traitements hormonaux, on peut aussi avoir une sorte de mue vocale et la voix devient plus grave et plus rauque. prenons ça calmement Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7564</th>\n",
       "      <td>fr_397</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Bonjour tabouret de bar, nous pouvons très volontiers ouvrir un fil CMD. Oui, j'ai aussi des douleurs articulaires et musculaires. En ce moment, c'est très dur. Je suis actuellement de nouveau en traitement de physiothérapie. Comme tout mon dos est raide comme une planche, de la colonne cervicale jusqu'à l'articulation ISG. D'après les analyses de sang, je n'ai pas de carence en œstrogènes. Les médecins ne te prennent vraiment plus au sérieux. Ouvre le guide sur les CMD et tu trouveras peut-être d'autres personnes qui partagent ton avis. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15758</th>\n",
       "      <td>fr_728</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Souhaite à ta chère @USER un bon rétablissement. Bises</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16857</th>\n",
       "      <td>fr_793</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut, c'est vraiment ennuyeux. Maintenant, tu as pris des vacances supplémentaires, je ne pense pas qu'une semaine suffise pour récupérer. En particulier, tu fais raffermir ta poitrine et ton ventre, non ? J'ai d'ailleurs un rendez-vous vendredi après-midi. J'espère que ça va durer. En tout cas, je te souhaite bonne chance. J'espère que tu t'en sortiras bien. Salutations :-)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           id language  label        type    origin  \\\n",
       "18789  fr_157       fr      0  forum post  LREC2022   \n",
       "9386   fr_932       fr      0  forum post  LREC2022   \n",
       "7564   fr_397       fr      0  forum post  LREC2022   \n",
       "15758  fr_728       fr      0  forum post  LREC2022   \n",
       "16857  fr_793       fr      0  forum post  LREC2022   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              text  \n",
       "18789                                                                                                                                                                                                                Je viens de voir que tu as répondu à ce message et que tu veux savoir comment cela se manifeste chez moi . ça a commencé dans le dos avec des petits boutons, je trouve que le soutien-gorge et le t-shirt sont laxistes sur la peau, ça frotte et ça me brûle. une fois que ça a disparu dans le dos, ça brûle sur la poitrine et maintenant c'est reparti !  \n",
       "9386                                                                                                                                                                                                                                                                                                                                                            Salut @USER ,c'est vrai qu'avec les changements hormonaux ou les traitements hormonaux, on peut aussi avoir une sorte de mue vocale et la voix devient plus grave et plus rauque. prenons ça calmement Bises @USER  \n",
       "7564   Bonjour tabouret de bar, nous pouvons très volontiers ouvrir un fil CMD. Oui, j'ai aussi des douleurs articulaires et musculaires. En ce moment, c'est très dur. Je suis actuellement de nouveau en traitement de physiothérapie. Comme tout mon dos est raide comme une planche, de la colonne cervicale jusqu'à l'articulation ISG. D'après les analyses de sang, je n'ai pas de carence en œstrogènes. Les médecins ne te prennent vraiment plus au sérieux. Ouvre le guide sur les CMD et tu trouveras peut-être d'autres personnes qui partagent ton avis. Bises @USER  \n",
       "15758                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Souhaite à ta chère @USER un bon rétablissement. Bises  \n",
       "16857                                                                                                                                                                                   Salut, c'est vraiment ennuyeux. Maintenant, tu as pris des vacances supplémentaires, je ne pense pas qu'une semaine suffise pour récupérer. En particulier, tu fais raffermir ta poitrine et ton ventre, non ? J'ai d'ailleurs un rendez-vous vendredi après-midi. J'espère que ça va durer. En tout cas, je te souhaite bonne chance. J'espère que tu t'en sortiras bien. Salutations :-)  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "===== FR (POS) =====\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5559</th>\n",
       "      <td>fr_575</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Bonjour, j'ai commencé à utiliser Fumaderm il y a environ un an et demi. Le succès a été incroyable, mon psoriasis a complètement disparu. Entre-temps, la dermatologue m'a réduit à une dose d'un comprimé environ cinq jours sur sept de la semaine. Les effets secondaires ont été et restent très limités pour moi. Je n'ai pas du tout eu de maux d'estomac, ni de diarrhée significative. Seulement, les jours de prise, j'ai généralement une poussée de chaleur d'environ 20 minutes. C'est désagréable, mais sans commune mesure avec l'effet positif du produit. Mes valeurs sanguines se sont même améliorées au fil du temps. Salutations @USER.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>fr_191</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut les amis, j'ai les yeux très secs depuis des années, puis le nez est venu s'ajouter et maintenant la bouche/le pharynx/les bronches aussi. Malheureusement, l'opipramol a aggravé la situation. C'est pourquoi j'ai acheté un gel hydratant (Aldiamed, flacon pulvérisateur) pour plus de 8 €. Je n'avais pas vraiment réalisé que l'ingrédient actif était un édulcorant - et je n'utilise pas d'édulcorants non plus. Maintenant, je sais pourquoi je ne le ferai pas à l'avenir : le gel était tellement sucré que j'étais complètement dégoûtée, la salive s'accumulait comme si on allait vomir. Malgré cela, la bouche était toujours sèche peu de temps après et une sensation rugueuse s'est ajoutée sur la langue (c'est également indiqué dans la notice). J'ai donc jeté le gel ... Maintenant, j'ai un petit vaporisateur en plastique vide pour 8 €... comme c'est gentil. Alors si l'une d'entre vous trouve quelque chose d'absolument neutre au niveau du goût, n'hésite pas à me le faire savoir. ( Ah oui - mon pharmacien a dit qu'il vaporisait aussi le spray nasal (sel d'Ems) dans sa bouche/gorge ... c'est ce que je fais maintenant avant de m'endormir). Amitiés @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11676</th>\n",
       "      <td>fr_626</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER Avec les suppositoires hormonaux, c'est très pratique ! On pense que si on les prend, on reste jeune et en forme ! Une erreur ! Ils passent immédiatement dans le sang et ont plusieurs effets secondaires. A cause des suppositoires, qui sont censées favoriser la circulation sanguine dans le vagin, j'ai pris beaucoup de poids (20 kilos de trop), j'ai eu beaucoup d'appetit, je n'avais plus d'énergie et mes yeux et mon visage étaient gonflés, comme si j'étais alcoolique. Sans oublier que j'avais aussi un gros myome. J'ai moi-même arrêté d'en prendre et maintenant je n'ai plus de myome, des yeux et un visage normaux et je suis comme toujours en forme, mince et pleine d'énergie. Utilise de l'huile d'amande bio !!!!! en cas de sécheresse vaginale. Mieux vaut donc ne pas la prendre ! Les gynécologues et les pharmacies font de grosses affaires et gagnent beaucoup d'argent avec ça. Les hormones pendant la ménopause NON, MERCI !</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>674</th>\n",
       "      <td>fr_151</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut tout le monde, alors la protection de l'estomac m'intéresse aussi. Je prends de la sulfasalazine depuis quelques jours maintenant, je ne ressens qu'une fatigue extrême, mais pas de nausées jusqu'à présent, je dois juste faire des rots très souvent. Faut-il prendre un protecteur d'estomac ? On ne m'en a pas prescrit, on ne m'en a pas parlé non plus. Amitiés @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14051</th>\n",
       "      <td>fr_293</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai déjà pris quelques globules, car j'ai suivi un long traitement chez une naturopathe. Mes hormones sont toutes au plus bas, il reste encore un peu d'oestrogène (15) et je transpire plus, je suis en post-ménopause, c'est-à-dire que je n'ai pas eu de règles depuis plus de 3 ans. Mais je veux être satisfaite, c'était bien pire avant, je suis sûre que ça va s'arranger, c'est ce que ma gynécologue m'a dit l'autre jour. Je ne supporte pas les hormones chimiques et naturelles comme le Gynokadin et l'Utrogest, après tellement d'essais, juste pour info. Bonne soirée, salutations, @USER.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           id language  label        type            origin  \\\n",
       "5559   fr_575       fr      1  forum post  SMM4H_24_fr_test   \n",
       "175    fr_191       fr      1  forum post  SMM4H_24_fr_test   \n",
       "11676  fr_626       fr      1  forum post  SMM4H_24_fr_test   \n",
       "674    fr_151       fr      1  forum post  SMM4H_24_fr_test   \n",
       "14051  fr_293       fr      1  forum post  SMM4H_24_fr_test   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          text  \n",
       "5559                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Bonjour, j'ai commencé à utiliser Fumaderm il y a environ un an et demi. Le succès a été incroyable, mon psoriasis a complètement disparu. Entre-temps, la dermatologue m'a réduit à une dose d'un comprimé environ cinq jours sur sept de la semaine. Les effets secondaires ont été et restent très limités pour moi. Je n'ai pas du tout eu de maux d'estomac, ni de diarrhée significative. Seulement, les jours de prise, j'ai généralement une poussée de chaleur d'environ 20 minutes. C'est désagréable, mais sans commune mesure avec l'effet positif du produit. Mes valeurs sanguines se sont même améliorées au fil du temps. Salutations @USER.  \n",
       "175    Salut les amis, j'ai les yeux très secs depuis des années, puis le nez est venu s'ajouter et maintenant la bouche/le pharynx/les bronches aussi. Malheureusement, l'opipramol a aggravé la situation. C'est pourquoi j'ai acheté un gel hydratant (Aldiamed, flacon pulvérisateur) pour plus de 8 €. Je n'avais pas vraiment réalisé que l'ingrédient actif était un édulcorant - et je n'utilise pas d'édulcorants non plus. Maintenant, je sais pourquoi je ne le ferai pas à l'avenir : le gel était tellement sucré que j'étais complètement dégoûtée, la salive s'accumulait comme si on allait vomir. Malgré cela, la bouche était toujours sèche peu de temps après et une sensation rugueuse s'est ajoutée sur la langue (c'est également indiqué dans la notice). J'ai donc jeté le gel ... Maintenant, j'ai un petit vaporisateur en plastique vide pour 8 €... comme c'est gentil. Alors si l'une d'entre vous trouve quelque chose d'absolument neutre au niveau du goût, n'hésite pas à me le faire savoir. ( Ah oui - mon pharmacien a dit qu'il vaporisait aussi le spray nasal (sel d'Ems) dans sa bouche/gorge ... c'est ce que je fais maintenant avant de m'endormir). Amitiés @USER  \n",
       "11676                                                                                                                                                                                                                           Salut @USER Avec les suppositoires hormonaux, c'est très pratique ! On pense que si on les prend, on reste jeune et en forme ! Une erreur ! Ils passent immédiatement dans le sang et ont plusieurs effets secondaires. A cause des suppositoires, qui sont censées favoriser la circulation sanguine dans le vagin, j'ai pris beaucoup de poids (20 kilos de trop), j'ai eu beaucoup d'appetit, je n'avais plus d'énergie et mes yeux et mon visage étaient gonflés, comme si j'étais alcoolique. Sans oublier que j'avais aussi un gros myome. J'ai moi-même arrêté d'en prendre et maintenant je n'ai plus de myome, des yeux et un visage normaux et je suis comme toujours en forme, mince et pleine d'énergie. Utilise de l'huile d'amande bio !!!!! en cas de sécheresse vaginale. Mieux vaut donc ne pas la prendre ! Les gynécologues et les pharmacies font de grosses affaires et gagnent beaucoup d'argent avec ça. Les hormones pendant la ménopause NON, MERCI !  \n",
       "674                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Salut tout le monde, alors la protection de l'estomac m'intéresse aussi. Je prends de la sulfasalazine depuis quelques jours maintenant, je ne ressens qu'une fatigue extrême, mais pas de nausées jusqu'à présent, je dois juste faire des rots très souvent. Faut-il prendre un protecteur d'estomac ? On ne m'en a pas prescrit, on ne m'en a pas parlé non plus. Amitiés @USER  \n",
       "14051                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Salut @USER, j'ai déjà pris quelques globules, car j'ai suivi un long traitement chez une naturopathe. Mes hormones sont toutes au plus bas, il reste encore un peu d'oestrogène (15) et je transpire plus, je suis en post-ménopause, c'est-à-dire que je n'ai pas eu de règles depuis plus de 3 ans. Mais je veux être satisfaite, c'était bien pire avant, je suis sûre que ça va s'arranger, c'est ce que ma gynécologue m'a dit l'autre jour. Je ne supporte pas les hormones chimiques et naturelles comme le Gynokadin et l'Utrogest, après tellement d'essais, juste pour info. Bonne soirée, salutations, @USER.  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "def sample_examples(df: pd.DataFrame, lang: str, label: int, n: int = 5, seed: int = 42) -> pd.DataFrame:\n",
    "    sub = df[(df[\"language\"] == lang) & (df[\"label\"] == label)].copy()\n",
    "    if len(sub) == 0:\n",
    "        return sub\n",
    "    return sub.sample(n=min(n, len(sub)), random_state=seed)[[\"id\", \"language\", \"label\", \"type\", \"origin\", \"text\"]]\n",
    "\n",
    "for lang in [\"en\", \"de\", \"fr\"]:\n",
    "    print(\"\\n=====\", lang.upper(), \"(NEG) =====\")\n",
    "    display(sample_examples(train_df, lang, 0, n=5, seed=SEED))\n",
    "    print(\"\\n=====\", lang.upper(), \"(POS) =====\")\n",
    "    display(sample_examples(train_df, lang, 1, n=5, seed=SEED))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a34d5b3",
   "metadata": {},
   "source": [
    "\n",
    "* Much smaller dataset size for DE and especially FR\n",
    "* English samples have much fewer words on average than German and French (X vs forums)\n",
    "* TODO: Address class imbalance:\n",
    "\n",
    "1. Changes During Training (Algorithm-Level)\n",
    "    - Weighted Loss Functions: Modify your loss function to penalize misclassifications of the minority class more heavily.\n",
    "    - Class Weights: Assign a higher weight to the positive class in the Binary Cross Entropy loss.\n",
    "    - Focal Loss: Use Focal Loss to down-weight \"easy\" majority examples and focus training on \"hard\" minority examples.\n",
    "    - Threshold Moving: Instead of the default 0.5 probability threshold, lower the threshold for the positive class to increase recall.\n",
    "    - Bias Initialization: Initialize the final layer's bias to \n",
    " to prevent the model from spending initial epochs learning that the majority class is simply more frequent. \n",
    "2. Changes to Data (Data-Level)\n",
    "    - Resampling:\n",
    "        - Random Undersampling: Remove majority class examples to balance the ratio. While fast, it risks losing valuable information.\n",
    "        - Random Oversampling: Duplicate minority examples. This is simple but can lead to overfitting.\n",
    "    - Text Augmentation: Use NLP-specific techniques like Back-Translation (translating text to another language and back) or Synonym Replacement to create diverse new samples for the 0.5% minority class. \n",
    "3. Changes During Evaluation\n",
    "    - Accuracy is misleading in this scenario (a model predicting \"Negative\" 100% of the time would achieve 99.5% accuracy). Instead, use: \n",
    "        - Precision-Recall (PR) Curve & AUPRC: Generally superior to ROC curves for extreme imbalance as it does not factor in True Negatives.\n",
    "        - F1-Score. Use F1 to balance Precision and Recall, or F2 if missing a positive case (Recall) is more costly than a false alarm.\n",
    "        - Confusion Matrix: Always inspect the raw counts of True Positives and False Negatives to understand the \"cost\" of the imbalance. "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b9faa8b9",
   "metadata": {},
   "source": [
    "## Task 1.1 (continued) — EN→FR translation (6000 EN samples, stratified by label)\n",
    "\n",
    "We create a subset of **exactly 6000** English training examples, stratified by ADE label, translate them to French using an **offline MT model** (`Helsinki-NLP/opus-mt-en-fr`), and cache results to disk so reruns are fast.\n",
    "\n",
    "\n",
    "Before translation we **strip `#` from hashtags** so that MarianMT translates the underlying words (e.g. `#prostatitis` → `prostatitis`) instead of passing them through verbatim."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "68640d20",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sampled EN subset for translation:\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "label\n",
       "0    5580\n",
       "1     420\n",
       "Name: count, dtype: int64"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading weights: 100%|██████████| 258/258 [00:00<00:00, 2246.00it/s, Materializing param=model.shared.weight]                                  \n",
      "The tied weights mapping and config for this model specifies to tie model.shared.weight to model.decoder.embed_tokens.weight, but both are present in the checkpoints, so we will NOT tie them. You should update the config with `tie_word_embeddings=False` to silence this warning\n",
      "The tied weights mapping and config for this model specifies to tie model.shared.weight to model.encoder.embed_tokens.weight, but both are present in the checkpoints, so we will NOT tie them. You should update the config with `tie_word_embeddings=False` to silence this warning\n",
      "Translating EN→FR: 100%|██████████| 375/375 [04:14<00:00,  1.47it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved translations to: /home/mandado/repos/advanced nlp/smm4h2026/artifacts/translations_en_fr_6000_seed42.csv\n",
      "Translated train rows: 6000\n",
      "  language translation_source\n",
      "0       fr                 en\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "label\n",
       "0        5580\n",
       "1         420\n",
       "Name: count, dtype: int64"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Sample translations (5 NEG, 5 POS) — EN vs FR side-by-side\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>label</th>\n",
       "      <th>EN</th>\n",
       "      <th>FR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>en_15060</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER The Zyprexa would be a good med to get on consistently. As an atypical anti-psychotic it's good for the manic type symptoms</td>\n",
       "      <td>@USER Le Zyprexa serait un bon médicament pour se mettre à l'aise. En tant qu'antipsychotique atypique, il est bon pour les symptômes de type maniaque</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>en_1138</td>\n",
       "      <td>0</td>\n",
       "      <td>I could make a Boniva joke but Sally Field actually just looks great #Oscars</td>\n",
       "      <td>Je pourrais faire une blague de Boniva, mais Sally Field a l'air d'être un super Oscar.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>en_11611</td>\n",
       "      <td>0</td>\n",
       "      <td>Unbelievable how research has discovered taking thalidomide affected the babies body during certain days of pregnancy #Thalidomide</td>\n",
       "      <td>Incroyable comment la recherche a découvert la prise de thalidomide a affecté le corps des bébés pendant certains jours de la grossesse Thalidomide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>en_3272</td>\n",
       "      <td>0</td>\n",
       "      <td>We’re completely alone in the bar thanks to the bartender’s nicotine addiction. Making dares to each other to go refill our beer pitcher.</td>\n",
       "      <td>Nous sommes complètement seuls dans le bar grâce au barman de la dépendance à la nicotine. Faire ose les uns aux autres pour aller remplir notre pichet à bière.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>en_9428</td>\n",
       "      <td>0</td>\n",
       "      <td>Starships, Sabers, and Scoundrels Episode 58: Padawan Lost and Found. We're talking The Clone Wars, the Thrawn cover, and George's plans for the sequels. Where is Taxus? HTTPURL HTTPURL</td>\n",
       "      <td>Starships, Sabers, and Scoundrels Episode 58: Padawan Lost and Found. Nous parlons des Clone Wars, de la couverture Thrawn, et des plans de George pour les suites. Où est Taxus? HTTPURL HTTPURL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>en_6158</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER @USER butting in....Cymbalta is no joke! I hated that medication...Once and NEVER again!</td>\n",
       "      <td>@USER @USER butting in....Cymbalta n'est pas une blague! Je détestais ce médicament... une fois et jamais!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>en_13048</td>\n",
       "      <td>0</td>\n",
       "      <td>Watching hoarders and the lady is depressed and my mom goes \"she needs cymbalta\" #jennisms @USER</td>\n",
       "      <td>Regarder les voyous et la dame est déprimée et ma mère dit \"elle a besoin de cymbalta\" jennismes @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>en_8629</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER have u took something ? #olanzapine ? #clozapine? #valium ?</td>\n",
       "      <td>@USER ont pris quelque chose ? olanzapine ? clozapine ? valium ?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>en_1566</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER CAN WE?? ill bring the miralax</td>\n",
       "      <td>@USER PEUT-ON?? mal apporter le miralax</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>en_11141</td>\n",
       "      <td>0</td>\n",
       "      <td>boniva is poison. do not take it! research it first! you are your own best advocate.. these docs do not do clinical trials. fda...hah!</td>\n",
       "      <td>Boniva est poison. ne le prenez pas! la recherche d'abord! vous êtes votre propre meilleur avocat.. ces docs ne font pas d'essais cliniques. fda...hah!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>en_17501</td>\n",
       "      <td>0</td>\n",
       "      <td>Lets start with 10 paracetamol, 10 diclofenac sodium, 10 domperidone and 10 ciprofloxacin. Eat at once then see what will happen ?</td>\n",
       "      <td>Commençons par 10 paracétamol, 10 diclofénac sodique, 10 dompéridone et 10 ciprofloxacine. Mangez à la fois puis voyez ce qui va se passer ?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>en_15925</td>\n",
       "      <td>0</td>\n",
       "      <td>*shudder* Fluoxetine, You taste HORRIBLE.</td>\n",
       "      <td>Fluoxétine, tu goûtes HORRIBLE.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>en_11864</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER Didn't Meridia dare Mara to do that?</td>\n",
       "      <td>@USER Meridia n'a pas osé Mara faire ça ?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>en_14475</td>\n",
       "      <td>0</td>\n",
       "      <td>i think i need another paxil.</td>\n",
       "      <td>J'ai besoin d'un autre paxil.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>en_943</td>\n",
       "      <td>0</td>\n",
       "      <td>We had him on Paxil - in reference to the bear.</td>\n",
       "      <td>Nous l'avions sur Paxil - en référence à l'ours.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>en_12759</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER he probably forgot to take his boniva this morning</td>\n",
       "      <td>@USER il a probablement oublié de prendre sa boniva ce matin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>en_8160</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER What is DHE - is that another term for Humira? Wow. Glad that helped your migraine!</td>\n",
       "      <td>@USER Qu'est-ce que DHE - est-ce un autre terme pour Humira? Wow. Heureux que cela a aidé votre migraine!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>en_4534</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER is like heroin, I want to quit because of what they are doing to @USER but I can't. Is there a Suboxone for espn? #freesimmons</td>\n",
       "      <td>@USER est comme l'héroïne, je veux arrêter à cause de ce qu'ils font à @USER mais je ne peux pas. Y a-t-il un Suboxone pour espn? freesimmons</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>en_10805</td>\n",
       "      <td>0</td>\n",
       "      <td>the thalidomide situation in the uk was caused by dr's believing mothers suffering morning sickness were just 'excited' at being pregnant.</td>\n",
       "      <td>la situation de la thalidomide dans le uk a été causée par les mères croyantes souffrant de maladie du matin ont juste été \"excitées\" à être enceintes.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>en_11106</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER sildenafil shall be called BLdenafil from now on</td>\n",
       "      <td>@USER sildénafil s'appelle désormais BLdenafil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>en_9067</td>\n",
       "      <td>0</td>\n",
       "      <td>$ABIO Forecasting Gencaro to overtake Metoprolol market worth 1+ billion. Metoprolol is top 50 prescription in USA. #lifestyle #rich #money</td>\n",
       "      <td>$ABIO Prévision de Gencaro pour dépasser le marché de Metoprolol d'une valeur de 1+ milliard. Metoprolol est le top 50 prescription aux États-Unis. mode de vie riche argent</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>en_12760</td>\n",
       "      <td>0</td>\n",
       "      <td>ecigs are now part of my personal brand please allow me to smoke nicotine vapor in your home</td>\n",
       "      <td>ecigs font maintenant partie de ma marque personnelle s'il vous plaît permettez-moi de fumer de la vapeur de nicotine dans votre maison</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>en_9525</td>\n",
       "      <td>0</td>\n",
       "      <td>Idk what victoza is supposed to do but the commercial was more about the side effects smh including pancreas failure and death</td>\n",
       "      <td>Idk ce que vitoza est censé faire mais la publicité était plus sur les effets secondaires smh y compris l'échec du pancréas et la mort</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>en_2847</td>\n",
       "      <td>0</td>\n",
       "      <td>Flight to Kho Pha Ngan booked and Temazepam for the 18 hour flight to Bangkok sorted, knocked the fuck out</td>\n",
       "      <td>Vol vers Kho Pha Ngan réservé et Temazepam pour le vol de 18 heures vers Bangkok trié, assommé</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>en_3879</td>\n",
       "      <td>0</td>\n",
       "      <td>time to try trazodone for the first time.. i hope i react better to this than i did seroquel.</td>\n",
       "      <td>le temps d'essayer la trazodone pour la première fois.. j'espère que je réagis mieux à cela que je l'ai fait séroquel.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>en_3115</td>\n",
       "      <td>0</td>\n",
       "      <td>More reasons to love food “@USER: Bananas contain a natural chemical that can make a person happy - The same chemical found in Prozac.”</td>\n",
       "      <td>Plus de raisons d'aimer la nourriture : Les bananes contiennent un produit chimique naturel qui peut rendre une personne heureuse - Le même produit chimique trouvé dans Prozac.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>en_7373</td>\n",
       "      <td>0</td>\n",
       "      <td>ouch! it bloody hurt. but quite excited about prospects. #humira</td>\n",
       "      <td>Ça fait mal, mais très excité par les perspectives.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>en_3251</td>\n",
       "      <td>0</td>\n",
       "      <td>Ho-leee fuck. This thread is gonna be hard to top for the rest of the year.Statistics: Posted by Thalidomide — Mon Apr 28, 2014 12:00 pm</td>\n",
       "      <td>Ho-lee baise. Ce fil va être difficile à top pour le reste de l'année.Statistiques: Posté par Thalidomide — lun avr 28, 2014 12:00 pm</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>en_12327</td>\n",
       "      <td>0</td>\n",
       "      <td>@USER (cont.9) PAXIL CR 12.5MG GABANTIN 400MG BUMETIN RETARD 300MG XYLON 2,5/6.25MG MICARDIS 80MG/12.5MG BENICAR HCT40MG TRIGLIVAL 20MG</td>\n",
       "      <td>@USER (suite9) PAXIL CR 12.5MG GABANTIN 400MG BUMETIN RETARD 300MG XYLON 2,5/6.25MG MICARDIS 80MG/12.5MG BÉNICAR HCT40MG TRIGLIVAL 20MG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>en_4479</td>\n",
       "      <td>0</td>\n",
       "      <td>Let's overdose on trazodone, and let it all fade away</td>\n",
       "      <td>Faisons une overdose sur la trazodone, et laissez tout s'estomper</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          id  label  \\\n",
       "0   en_15060      0   \n",
       "1    en_1138      0   \n",
       "2   en_11611      0   \n",
       "3    en_3272      0   \n",
       "4    en_9428      0   \n",
       "5    en_6158      0   \n",
       "6   en_13048      0   \n",
       "7    en_8629      0   \n",
       "8    en_1566      0   \n",
       "9   en_11141      0   \n",
       "10  en_17501      0   \n",
       "11  en_15925      0   \n",
       "12  en_11864      0   \n",
       "13  en_14475      0   \n",
       "14    en_943      0   \n",
       "15  en_12759      0   \n",
       "16   en_8160      0   \n",
       "17   en_4534      0   \n",
       "18  en_10805      0   \n",
       "19  en_11106      0   \n",
       "20   en_9067      0   \n",
       "21  en_12760      0   \n",
       "22   en_9525      0   \n",
       "23   en_2847      0   \n",
       "24   en_3879      0   \n",
       "25   en_3115      0   \n",
       "26   en_7373      0   \n",
       "27   en_3251      0   \n",
       "28  en_12327      0   \n",
       "29   en_4479      0   \n",
       "\n",
       "                                                                                                                                                                                           EN  \\\n",
       "0                                                           @USER The Zyprexa would be a good med to get on consistently. As an atypical anti-psychotic it's good for the manic type symptoms   \n",
       "1                                                                                                                I could make a Boniva joke but Sally Field actually just looks great #Oscars   \n",
       "2                                                          Unbelievable how research has discovered taking thalidomide affected the babies body during certain days of pregnancy #Thalidomide   \n",
       "3                                                   We’re completely alone in the bar thanks to the bartender’s nicotine addiction. Making dares to each other to go refill our beer pitcher.   \n",
       "4   Starships, Sabers, and Scoundrels Episode 58: Padawan Lost and Found. We're talking The Clone Wars, the Thrawn cover, and George's plans for the sequels. Where is Taxus? HTTPURL HTTPURL   \n",
       "5                                                                                              @USER @USER butting in....Cymbalta is no joke! I hated that medication...Once and NEVER again!   \n",
       "6                                                                                            Watching hoarders and the lady is depressed and my mom goes \"she needs cymbalta\" #jennisms @USER   \n",
       "7                                                                                                                           @USER have u took something ? #olanzapine ? #clozapine? #valium ?   \n",
       "8                                                                                                                                                        @USER CAN WE?? ill bring the miralax   \n",
       "9                                                      boniva is poison. do not take it! research it first! you are your own best advocate.. these docs do not do clinical trials. fda...hah!   \n",
       "10                                                         Lets start with 10 paracetamol, 10 diclofenac sodium, 10 domperidone and 10 ciprofloxacin. Eat at once then see what will happen ?   \n",
       "11                                                                                                                                                  *shudder* Fluoxetine, You taste HORRIBLE.   \n",
       "12                                                                                                                                                 @USER Didn't Meridia dare Mara to do that?   \n",
       "13                                                                                                                                                              i think i need another paxil.   \n",
       "14                                                                                                                                            We had him on Paxil - in reference to the bear.   \n",
       "15                                                                                                                                   @USER he probably forgot to take his boniva this morning   \n",
       "16                                                                                                  @USER What is DHE - is that another term for Humira? Wow. Glad that helped your migraine!   \n",
       "17                                                       @USER is like heroin, I want to quit because of what they are doing to @USER but I can't. Is there a Suboxone for espn? #freesimmons   \n",
       "18                                                 the thalidomide situation in the uk was caused by dr's believing mothers suffering morning sickness were just 'excited' at being pregnant.   \n",
       "19                                                                                                                                     @USER sildenafil shall be called BLdenafil from now on   \n",
       "20                                                $ABIO Forecasting Gencaro to overtake Metoprolol market worth 1+ billion. Metoprolol is top 50 prescription in USA. #lifestyle #rich #money   \n",
       "21                                                                                               ecigs are now part of my personal brand please allow me to smoke nicotine vapor in your home   \n",
       "22                                                             Idk what victoza is supposed to do but the commercial was more about the side effects smh including pancreas failure and death   \n",
       "23                                                                                 Flight to Kho Pha Ngan booked and Temazepam for the 18 hour flight to Bangkok sorted, knocked the fuck out   \n",
       "24                                                                                              time to try trazodone for the first time.. i hope i react better to this than i did seroquel.   \n",
       "25                                                    More reasons to love food “@USER: Bananas contain a natural chemical that can make a person happy - The same chemical found in Prozac.”   \n",
       "26                                                                                                                           ouch! it bloody hurt. but quite excited about prospects. #humira   \n",
       "27                                                   Ho-leee fuck. This thread is gonna be hard to top for the rest of the year.Statistics: Posted by Thalidomide — Mon Apr 28, 2014 12:00 pm   \n",
       "28                                                    @USER (cont.9) PAXIL CR 12.5MG GABANTIN 400MG BUMETIN RETARD 300MG XYLON 2,5/6.25MG MICARDIS 80MG/12.5MG BENICAR HCT40MG TRIGLIVAL 20MG   \n",
       "29                                                                                                                                      Let's overdose on trazodone, and let it all fade away   \n",
       "\n",
       "                                                                                                                                                                                                   FR  \n",
       "0                                              @USER Le Zyprexa serait un bon médicament pour se mettre à l'aise. En tant qu'antipsychotique atypique, il est bon pour les symptômes de type maniaque  \n",
       "1                                                                                                             Je pourrais faire une blague de Boniva, mais Sally Field a l'air d'être un super Oscar.  \n",
       "2                                                 Incroyable comment la recherche a découvert la prise de thalidomide a affecté le corps des bébés pendant certains jours de la grossesse Thalidomide  \n",
       "3                                    Nous sommes complètement seuls dans le bar grâce au barman de la dépendance à la nicotine. Faire ose les uns aux autres pour aller remplir notre pichet à bière.  \n",
       "4   Starships, Sabers, and Scoundrels Episode 58: Padawan Lost and Found. Nous parlons des Clone Wars, de la couverture Thrawn, et des plans de George pour les suites. Où est Taxus? HTTPURL HTTPURL  \n",
       "5                                                                                          @USER @USER butting in....Cymbalta n'est pas une blague! Je détestais ce médicament... une fois et jamais!  \n",
       "6                                                                                              Regarder les voyous et la dame est déprimée et ma mère dit \"elle a besoin de cymbalta\" jennismes @USER  \n",
       "7                                                                                                                                    @USER ont pris quelque chose ? olanzapine ? clozapine ? valium ?  \n",
       "8                                                                                                                                                             @USER PEUT-ON?? mal apporter le miralax  \n",
       "9                                             Boniva est poison. ne le prenez pas! la recherche d'abord! vous êtes votre propre meilleur avocat.. ces docs ne font pas d'essais cliniques. fda...hah!  \n",
       "10                                                       Commençons par 10 paracétamol, 10 diclofénac sodique, 10 dompéridone et 10 ciprofloxacine. Mangez à la fois puis voyez ce qui va se passer ?  \n",
       "11                                                                                                                                                                    Fluoxétine, tu goûtes HORRIBLE.  \n",
       "12                                                                                                                                                          @USER Meridia n'a pas osé Mara faire ça ?  \n",
       "13                                                                                                                                                                      J'ai besoin d'un autre paxil.  \n",
       "14                                                                                                                                                   Nous l'avions sur Paxil - en référence à l'ours.  \n",
       "15                                                                                                                                       @USER il a probablement oublié de prendre sa boniva ce matin  \n",
       "16                                                                                          @USER Qu'est-ce que DHE - est-ce un autre terme pour Humira? Wow. Heureux que cela a aidé votre migraine!  \n",
       "17                                                      @USER est comme l'héroïne, je veux arrêter à cause de ce qu'ils font à @USER mais je ne peux pas. Y a-t-il un Suboxone pour espn? freesimmons  \n",
       "18                                            la situation de la thalidomide dans le uk a été causée par les mères croyantes souffrant de maladie du matin ont juste été \"excitées\" à être enceintes.  \n",
       "19                                                                                                                                                     @USER sildénafil s'appelle désormais BLdenafil  \n",
       "20                       $ABIO Prévision de Gencaro pour dépasser le marché de Metoprolol d'une valeur de 1+ milliard. Metoprolol est le top 50 prescription aux États-Unis. mode de vie riche argent  \n",
       "21                                                            ecigs font maintenant partie de ma marque personnelle s'il vous plaît permettez-moi de fumer de la vapeur de nicotine dans votre maison  \n",
       "22                                                             Idk ce que vitoza est censé faire mais la publicité était plus sur les effets secondaires smh y compris l'échec du pancréas et la mort  \n",
       "23                                                                                                     Vol vers Kho Pha Ngan réservé et Temazepam pour le vol de 18 heures vers Bangkok trié, assommé  \n",
       "24                                                                             le temps d'essayer la trazodone pour la première fois.. j'espère que je réagis mieux à cela que je l'ai fait séroquel.  \n",
       "25                   Plus de raisons d'aimer la nourriture : Les bananes contiennent un produit chimique naturel qui peut rendre une personne heureuse - Le même produit chimique trouvé dans Prozac.  \n",
       "26                                                                                                                                                Ça fait mal, mais très excité par les perspectives.  \n",
       "27                                                              Ho-lee baise. Ce fil va être difficile à top pour le reste de l'année.Statistiques: Posté par Thalidomide — lun avr 28, 2014 12:00 pm  \n",
       "28                                                            @USER (suite9) PAXIL CR 12.5MG GABANTIN 400MG BUMETIN RETARD 300MG XYLON 2,5/6.25MG MICARDIS 80MG/12.5MG BÉNICAR HCT40MG TRIGLIVAL 20MG  \n",
       "29                                                                                                                                  Faisons une overdose sur la trazodone, et laissez tout s'estomper  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>label</th>\n",
       "      <th>EN</th>\n",
       "      <th>FR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>en_2500</td>\n",
       "      <td>1</td>\n",
       "      <td>Hmm, interesting. I may have been undergoing Baclofen withdrawal hence the anxiety for the past few months… #hypochondria</td>\n",
       "      <td>J'ai peut-être subi un retrait de Baclofen, d'où l'anxiété des derniers mois... l'hypochondrie.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>en_4542</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER nope, was on #enbrel 5yrs &amp;amp; had to get off due to unrelenting flare. been on #humira since dec 2012. #rheum</td>\n",
       "      <td>@USER nope, était sur enbrel 5yrs &amp;amp; a dû descendre en raison d'une éruption sans relâche. être sur humira depuis décembre 2012. rheum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>en_2984</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER olanzapine is amazing srsly, the dreams are immense, no addiction, its gorgeous, like brave new world soma to me</td>\n",
       "      <td>@USER olanzapine est incroyable srly, les rêves sont immenses, pas de dépendance, son magnifique, comme brave nouveau monde soma pour moi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>en_11440</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER i take olanzapine and have a permanent dry mouth what can i do to help it</td>\n",
       "      <td>@USER je prends de l'olanzapine et j'ai une bouche sèche permanente que puis-je faire pour l'aider</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>en_15393</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER bloody zombie I also take venlafaxine thats for cronic depression bipolar is a difficult illness to deal with, both for the</td>\n",
       "      <td>@USER zombie sanglant je prends aussi venlafaxine thats pour la dépression cronique bipolaire est une maladie difficile à traiter, à la fois pour le</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>en_6215</td>\n",
       "      <td>1</td>\n",
       "      <td>my creativity was blocked by lithium and prozac and wellbutrin and paxil and zoloft and effexor and lexapro and cymbalta and abilify-</td>\n",
       "      <td>ma créativité a été bloquée par le lithium et le prozac et la puitsbutrin et paxil et zoloft et effexor et lexapro et cymbalta et abilify-</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>en_2063</td>\n",
       "      <td>1</td>\n",
       "      <td>nicotine withdrawals. #needasmoke</td>\n",
       "      <td>Sevrages de nicotine. besoin d'asmoke</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>en_4588</td>\n",
       "      <td>1</td>\n",
       "      <td>meds paranoia cos my leg is itching #lamictal #bipolar</td>\n",
       "      <td>meds paranoïa parce que ma jambe démange lamictal bipolaire</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>en_4828</td>\n",
       "      <td>1</td>\n",
       "      <td>Damn i need to sleep, fucken vyvanse</td>\n",
       "      <td>Merde, j'ai besoin de dormir, putain de Vyvanse</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>en_15934</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER i hav to come of the duloxetine immediately as i hav a terrible rash because of it! had the rash 2 weeks</td>\n",
       "      <td>@USER i hav à venir de la duloxétine immédiatement comme j'ai eu une éruption terrible à cause de cela! eu l'éruption 2 semaines</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>en_8418</td>\n",
       "      <td>1</td>\n",
       "      <td>shouldn't have taken 80mg of vyvanse today... #cantsleep</td>\n",
       "      <td>n'aurait pas dû prendre 80mg de vyvanse aujourd'hui... cantsleep</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>en_887</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER i has beta blockers now, apparently the fluoxetine can cause panic attacks ^_^</td>\n",
       "      <td>@USER i a des bêtabloquants maintenant, apparemment la fluoxétine peut causer des crises de panique ^_^</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>en_4308</td>\n",
       "      <td>1</td>\n",
       "      <td>15.15 rivaroxaban diary day 24. pains easing all the time. didn't take losartan yesterday. will get bp and hopefully inr checked today.</td>\n",
       "      <td>15.15 journal de rivaroxaban jour 24. douleurs assouplissant tout le temps. n'a pas pris losartan hier. va obtenir bp et espérons inr vérifié aujourd'hui.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>en_13186</td>\n",
       "      <td>1</td>\n",
       "      <td>#quetiapine is not doing me any favors #ifeelsick</td>\n",
       "      <td>quetiapine ne me fait pas de faveurs ideelsick</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>en_10248</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER to be honest i've had worse. on fluoxetine i was convinced there was a plot to steal my thoughts... !</td>\n",
       "      <td>@USER pour être honnête j'ai eu pire. sur la fluoxétine j'étais convaincu qu'il y avait un complot pour voler mes pensées... !</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>en_13269</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER @USER Me too, Remicade for a year, Humira, and had an allergic reaction to Cimzia, almost killed me in November.</td>\n",
       "      <td>@USER @USER Moi aussi, Remicade pendant un an, Humira, et a eu une réaction allergique à Cimzia, a failli me tuer en Novembre.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>en_1474</td>\n",
       "      <td>1</td>\n",
       "      <td>rt @USER: almost blew out my arms &amp;amp; heels @ work. they hurt like hell. &amp;amp; the pain is spreading, damned cipro.</td>\n",
       "      <td>rt @USER: presque soufflé mes bras &amp;amp; talons @ travail. ils font mal comme l'enfer. &amp;amp; la douleur se répand, damné cipro.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>en_16660</td>\n",
       "      <td>1</td>\n",
       "      <td>quetiapine - i slept!! weirdo dreams and very drowsy this morning but i slept!!!</td>\n",
       "      <td>quetiapine - j'ai dormi!! rêves bizarres et très somnolent ce matin mais j'ai dormi!!!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>en_3894</td>\n",
       "      <td>1</td>\n",
       "      <td>lamotrigine causing steven johnson syndrome</td>\n",
       "      <td>lamotrigine causant le syndrome de Steven Johnson</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>en_5764</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER @USER i also have nuasea and low grade temp and on #humira should i go check it out??</td>\n",
       "      <td>@USER @USER j'ai aussi la nuasea et la température de basse qualité et sur l'humira devrais-je aller vérifier??</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>en_15388</td>\n",
       "      <td>1</td>\n",
       "      <td>its your third visit in 2 weeks for priapism and you're still taking trazodone @USER</td>\n",
       "      <td>c'est votre troisième visite en 2 semaines pour le priapisme et vous prenez toujours trazodone @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>en_507</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER i wish i'd have found your article sooner! i was crippled by cipro in oct of '09. prescribed for a uti &amp;amp; it didn't even help.</td>\n",
       "      <td>@USER j'aurais aimé avoir trouvé votre article plus tôt! j'ai été paralysé par cipro dans oct de '09. prescrit pour un uti &amp;amp; il n'a même pas aidé.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>en_13877</td>\n",
       "      <td>1</td>\n",
       "      <td>gotta find an alternative to vyvanse, asap. i'd rather be sleepy &amp;amp; happy, than alert &amp;amp; depressed!</td>\n",
       "      <td>Il faut trouver une alternative à la vyvanse, asap. Je préférerais être endormi &amp;amp; heureux, que alerte &amp;amp; déprimé!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>en_14538</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER not addictive? 'ssri discontinuation syndrome.' i know someone who has been trying to come off venlafaxine for over two years &amp;gt;</td>\n",
       "      <td>@USER pas addictive? 'ssri stopping syndrome.' je connais quelqu'un qui essaie de sortir de la venlafaxine depuis plus de deux ans &amp;gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>en_5364</td>\n",
       "      <td>1</td>\n",
       "      <td>but i'm happy to be clean. just really really really really really really really sucked going from 100mg desvenlafaxine / day to zero.</td>\n",
       "      <td>mais je suis heureux d'être propre. juste vraiment vraiment vraiment vraiment vraiment vraiment vraiment aspiré allant de 100mg desvenlafaxine / jour à zéro.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>en_1807</td>\n",
       "      <td>1</td>\n",
       "      <td>vyvanse evidently doesn't care about my bed time</td>\n",
       "      <td>vyvanse ne se soucie évidemment pas de l'heure de mon lit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>en_15460</td>\n",
       "      <td>1</td>\n",
       "      <td>dear paxil, you're supposed to make me feel better. instead you've wrecked me completely. thanks to you, i had to take an adivan.</td>\n",
       "      <td>Chère Paxil, tu es censée me faire me sentir mieux. Au lieu de ça, tu m'as complètement détruit. Grâce à toi, j'ai dû prendre un adivan.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>en_13110</td>\n",
       "      <td>1</td>\n",
       "      <td>@USER Quetiapine perhaps gives most dramatic effect for single low dose. No, pts are not being lazy in bed 20 hours a day, asleep!</td>\n",
       "      <td>@USER Quetiapine donne peut-être l'effet le plus spectaculaire pour une seule faible dose. Non, les pts ne sont pas paresseux au lit 20 heures par jour, endormis!</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>en_10806</td>\n",
       "      <td>1</td>\n",
       "      <td>i decided to try visualization tapes again. at least they wouldn't give me a rash like lamictal.</td>\n",
       "      <td>J'ai décidé d'essayer à nouveau des cassettes de visualisation. au moins ils ne me donneraient pas une éruption comme lamictal.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>en_7294</td>\n",
       "      <td>1</td>\n",
       "      <td>this week i officially stopped taking my quetiapine. i'm happy to be able to have a life again and not sleep 12 hours.</td>\n",
       "      <td>Cette semaine, j'ai officiellement arrêté de prendre ma quetiapine. Je suis heureux de pouvoir avoir une vie à nouveau et de ne pas dormir 12 heures.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          id  label  \\\n",
       "0    en_2500      1   \n",
       "1    en_4542      1   \n",
       "2    en_2984      1   \n",
       "3   en_11440      1   \n",
       "4   en_15393      1   \n",
       "5    en_6215      1   \n",
       "6    en_2063      1   \n",
       "7    en_4588      1   \n",
       "8    en_4828      1   \n",
       "9   en_15934      1   \n",
       "10   en_8418      1   \n",
       "11    en_887      1   \n",
       "12   en_4308      1   \n",
       "13  en_13186      1   \n",
       "14  en_10248      1   \n",
       "15  en_13269      1   \n",
       "16   en_1474      1   \n",
       "17  en_16660      1   \n",
       "18   en_3894      1   \n",
       "19   en_5764      1   \n",
       "20  en_15388      1   \n",
       "21    en_507      1   \n",
       "22  en_13877      1   \n",
       "23  en_14538      1   \n",
       "24   en_5364      1   \n",
       "25   en_1807      1   \n",
       "26  en_15460      1   \n",
       "27  en_13110      1   \n",
       "28  en_10806      1   \n",
       "29   en_7294      1   \n",
       "\n",
       "                                                                                                                                          EN  \\\n",
       "0                  Hmm, interesting. I may have been undergoing Baclofen withdrawal hence the anxiety for the past few months… #hypochondria   \n",
       "1                      @USER nope, was on #enbrel 5yrs &amp; had to get off due to unrelenting flare. been on #humira since dec 2012. #rheum   \n",
       "2                     @USER olanzapine is amazing srsly, the dreams are immense, no addiction, its gorgeous, like brave new world soma to me   \n",
       "3                                                            @USER i take olanzapine and have a permanent dry mouth what can i do to help it   \n",
       "4          @USER bloody zombie I also take venlafaxine thats for cronic depression bipolar is a difficult illness to deal with, both for the   \n",
       "5      my creativity was blocked by lithium and prozac and wellbutrin and paxil and zoloft and effexor and lexapro and cymbalta and abilify-   \n",
       "6                                                                                                          nicotine withdrawals. #needasmoke   \n",
       "7                                                                                     meds paranoia cos my leg is itching #lamictal #bipolar   \n",
       "8                                                                                                       Damn i need to sleep, fucken vyvanse   \n",
       "9                             @USER i hav to come of the duloxetine immediately as i hav a terrible rash because of it! had the rash 2 weeks   \n",
       "10                                                                                  shouldn't have taken 80mg of vyvanse today... #cantsleep   \n",
       "11                                                      @USER i has beta blockers now, apparently the fluoxetine can cause panic attacks ^_^   \n",
       "12   15.15 rivaroxaban diary day 24. pains easing all the time. didn't take losartan yesterday. will get bp and hopefully inr checked today.   \n",
       "13                                                                                         #quetiapine is not doing me any favors #ifeelsick   \n",
       "14                               @USER to be honest i've had worse. on fluoxetine i was convinced there was a plot to steal my thoughts... !   \n",
       "15                    @USER @USER Me too, Remicade for a year, Humira, and had an allergic reaction to Cimzia, almost killed me in November.   \n",
       "16                     rt @USER: almost blew out my arms &amp; heels @ work. they hurt like hell. &amp; the pain is spreading, damned cipro.   \n",
       "17                                                          quetiapine - i slept!! weirdo dreams and very drowsy this morning but i slept!!!   \n",
       "18                                                                                               lamotrigine causing steven johnson syndrome   \n",
       "19                                               @USER @USER i also have nuasea and low grade temp and on #humira should i go check it out??   \n",
       "20                                                      its your third visit in 2 weeks for priapism and you're still taking trazodone @USER   \n",
       "21   @USER i wish i'd have found your article sooner! i was crippled by cipro in oct of '09. prescribed for a uti &amp; it didn't even help.   \n",
       "22                                 gotta find an alternative to vyvanse, asap. i'd rather be sleepy &amp; happy, than alert &amp; depressed!   \n",
       "23  @USER not addictive? 'ssri discontinuation syndrome.' i know someone who has been trying to come off venlafaxine for over two years &gt;   \n",
       "24    but i'm happy to be clean. just really really really really really really really sucked going from 100mg desvenlafaxine / day to zero.   \n",
       "25                                                                                          vyvanse evidently doesn't care about my bed time   \n",
       "26         dear paxil, you're supposed to make me feel better. instead you've wrecked me completely. thanks to you, i had to take an adivan.   \n",
       "27        @USER Quetiapine perhaps gives most dramatic effect for single low dose. No, pts are not being lazy in bed 20 hours a day, asleep!   \n",
       "28                                          i decided to try visualization tapes again. at least they wouldn't give me a rash like lamictal.   \n",
       "29                    this week i officially stopped taking my quetiapine. i'm happy to be able to have a life again and not sleep 12 hours.   \n",
       "\n",
       "                                                                                                                                                                    FR  \n",
       "0                                                                      J'ai peut-être subi un retrait de Baclofen, d'où l'anxiété des derniers mois... l'hypochondrie.  \n",
       "1                            @USER nope, était sur enbrel 5yrs &amp; a dû descendre en raison d'une éruption sans relâche. être sur humira depuis décembre 2012. rheum  \n",
       "2                            @USER olanzapine est incroyable srly, les rêves sont immenses, pas de dépendance, son magnifique, comme brave nouveau monde soma pour moi  \n",
       "3                                                                   @USER je prends de l'olanzapine et j'ai une bouche sèche permanente que puis-je faire pour l'aider  \n",
       "4                 @USER zombie sanglant je prends aussi venlafaxine thats pour la dépression cronique bipolaire est une maladie difficile à traiter, à la fois pour le  \n",
       "5                           ma créativité a été bloquée par le lithium et le prozac et la puitsbutrin et paxil et zoloft et effexor et lexapro et cymbalta et abilify-  \n",
       "6                                                                                                                                Sevrages de nicotine. besoin d'asmoke  \n",
       "7                                                                                                          meds paranoïa parce que ma jambe démange lamictal bipolaire  \n",
       "8                                                                                                                      Merde, j'ai besoin de dormir, putain de Vyvanse  \n",
       "9                                     @USER i hav à venir de la duloxétine immédiatement comme j'ai eu une éruption terrible à cause de cela! eu l'éruption 2 semaines  \n",
       "10                                                                                                    n'aurait pas dû prendre 80mg de vyvanse aujourd'hui... cantsleep  \n",
       "11                                                             @USER i a des bêtabloquants maintenant, apparemment la fluoxétine peut causer des crises de panique ^_^  \n",
       "12          15.15 journal de rivaroxaban jour 24. douleurs assouplissant tout le temps. n'a pas pris losartan hier. va obtenir bp et espérons inr vérifié aujourd'hui.  \n",
       "13                                                                                                                      quetiapine ne me fait pas de faveurs ideelsick  \n",
       "14                                      @USER pour être honnête j'ai eu pire. sur la fluoxétine j'étais convaincu qu'il y avait un complot pour voler mes pensées... !  \n",
       "15                                      @USER @USER Moi aussi, Remicade pendant un an, Humira, et a eu une réaction allergique à Cimzia, a failli me tuer en Novembre.  \n",
       "16                                     rt @USER: presque soufflé mes bras &amp; talons @ travail. ils font mal comme l'enfer. &amp; la douleur se répand, damné cipro.  \n",
       "17                                                                              quetiapine - j'ai dormi!! rêves bizarres et très somnolent ce matin mais j'ai dormi!!!  \n",
       "18                                                                                                                   lamotrigine causant le syndrome de Steven Johnson  \n",
       "19                                                     @USER @USER j'ai aussi la nuasea et la température de basse qualité et sur l'humira devrais-je aller vérifier??  \n",
       "20                                                                c'est votre troisième visite en 2 semaines pour le priapisme et vous prenez toujours trazodone @USER  \n",
       "21              @USER j'aurais aimé avoir trouvé votre article plus tôt! j'ai été paralysé par cipro dans oct de '09. prescrit pour un uti &amp; il n'a même pas aidé.  \n",
       "22                                            Il faut trouver une alternative à la vyvanse, asap. Je préférerais être endormi &amp; heureux, que alerte &amp; déprimé!  \n",
       "23                             @USER pas addictive? 'ssri stopping syndrome.' je connais quelqu'un qui essaie de sortir de la venlafaxine depuis plus de deux ans &gt;  \n",
       "24       mais je suis heureux d'être propre. juste vraiment vraiment vraiment vraiment vraiment vraiment vraiment aspiré allant de 100mg desvenlafaxine / jour à zéro.  \n",
       "25                                                                                                           vyvanse ne se soucie évidemment pas de l'heure de mon lit  \n",
       "26                            Chère Paxil, tu es censée me faire me sentir mieux. Au lieu de ça, tu m'as complètement détruit. Grâce à toi, j'ai dû prendre un adivan.  \n",
       "27  @USER Quetiapine donne peut-être l'effet le plus spectaculaire pour une seule faible dose. Non, les pts ne sont pas paresseux au lit 20 heures par jour, endormis!  \n",
       "28                                     J'ai décidé d'essayer à nouveau des cassettes de visualisation. au moins ils ne me donneraient pas une éruption comme lamictal.  \n",
       "29               Cette semaine, j'ai officiellement arrêté de prendre ma quetiapine. Je suis heureux de pouvoir avoir une vie à nouveau et de ne pas dormir 12 heures.  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from transformers import MarianMTModel, MarianTokenizer\n",
    "from tqdm.auto import tqdm\n",
    "\n",
    "TRANSLATIONS_CACHE = ARTIFACTS_DIR / f\"translations_en_fr_{TRANSLATE_N}_seed{SEED}.csv\"\n",
    "\n",
    "\n",
    "def stratified_sample_en(df: pd.DataFrame, n: int, seed: int) -> pd.DataFrame:\n",
    "    \"\"\"Sample n English examples **preserving the natural label distribution**.\n",
    "\n",
    "    Previous version targeted 50/50 balance, which inflated the positive rate\n",
    "    from ~7% to ~36% and caused the translation-trained FR model to massively\n",
    "    over-predict positives at test time (where the positive rate is ~7%).\n",
    "    \"\"\"\n",
    "    en = df[(df[\"language\"] == \"en\")].copy().reset_index(drop=True)\n",
    "    if len(en) <= n:\n",
    "        return en.sample(frac=1.0, random_state=seed).reset_index(drop=True)\n",
    "\n",
    "    # Stratified sample that preserves the original label proportions\n",
    "    splitter = StratifiedShuffleSplit(n_splits=1, test_size=n, random_state=seed)\n",
    "    _, idx_sample = next(splitter.split(en, en[\"label\"]))\n",
    "    out = en.iloc[idx_sample].sample(frac=1.0, random_state=seed).reset_index(drop=True)\n",
    "    return out\n",
    "\n",
    "\n",
    "HASHTAG_RE = re.compile(r\"#(\\w+)\")\n",
    "\n",
    "\n",
    "def _strip_hashtags_for_translation(text: str) -> str:\n",
    "    \"\"\"Strip '#' from hashtags so MarianMT translates the underlying words.\n",
    "\n",
    "    E.g. '#prostatitis' → 'prostatitis', '#CyberSecurity' → 'CyberSecurity'.\n",
    "    Without this, MarianMT treats hashtags as opaque tokens and leaves them\n",
    "    untranslated in the French output.\n",
    "    \"\"\"\n",
    "    return HASHTAG_RE.sub(r\"\\1\", text)\n",
    "\n",
    "\n",
    "def translate_en_to_fr(texts: List[str], model_name: str, batch_size: int = 16) -> List[str]:\n",
    "    tok = MarianTokenizer.from_pretrained(model_name)\n",
    "    model = MarianMTModel.from_pretrained(model_name)\n",
    "\n",
    "    device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "    model.to(device)\n",
    "    model.eval()\n",
    "\n",
    "    # Strip hashtags before translation so words get translated\n",
    "    texts = [_strip_hashtags_for_translation(t) for t in texts]\n",
    "\n",
    "    outputs: List[str] = []\n",
    "    for i in tqdm(range(0, len(texts), batch_size), desc=\"Translating EN→FR\"):\n",
    "        batch = texts[i : i + batch_size]\n",
    "        enc = tok(batch, return_tensors=\"pt\", padding=True, truncation=True, max_length=MAX_LENGTH).to(device)\n",
    "        with torch.no_grad():\n",
    "            gen = model.generate(\n",
    "                **enc,\n",
    "                num_beams=4,\n",
    "                max_new_tokens=MAX_LENGTH,\n",
    "            )\n",
    "        out = tok.batch_decode(gen, skip_special_tokens=True)\n",
    "        outputs.extend(out)\n",
    "\n",
    "    return outputs\n",
    "\n",
    "\n",
    "def build_or_load_translations() -> pd.DataFrame:\n",
    "    if TRANSLATIONS_CACHE.exists():\n",
    "        print(\"Loading cached translations from:\", TRANSLATIONS_CACHE)\n",
    "        cached = pd.read_csv(TRANSLATIONS_CACHE)\n",
    "        return cached\n",
    "\n",
    "    en_subset = stratified_sample_en(train_en_de, n=TRANSLATE_N, seed=SEED)\n",
    "    print(\"Sampled EN subset for translation:\")\n",
    "    display(en_subset[\"label\"].value_counts())\n",
    "\n",
    "    fr_texts = translate_en_to_fr(en_subset[\"text\"].tolist(), model_name=TRANSLATION_MODEL_NAME, batch_size=16)\n",
    "\n",
    "    out = en_subset.copy()\n",
    "    out[\"text_en\"] = out[\"text\"]\n",
    "    out[\"text\"] = fr_texts\n",
    "    out[\"language\"] = \"fr\"\n",
    "    out[\"translation_source\"] = \"en\"\n",
    "    out[\"translation_model\"] = TRANSLATION_MODEL_NAME\n",
    "\n",
    "    TRANSLATIONS_CACHE.parent.mkdir(exist_ok=True)\n",
    "    out.to_csv(TRANSLATIONS_CACHE, index=False)\n",
    "    print(\"Saved translations to:\", TRANSLATIONS_CACHE)\n",
    "    return out\n",
    "\n",
    "\n",
    "fr_translated_train = build_or_load_translations()\n",
    "print(\"Translated train rows:\", len(fr_translated_train))\n",
    "print(fr_translated_train[[\"language\", \"translation_source\"]].drop_duplicates())\n",
    "\n",
    "display(fr_translated_train[[\"label\"]].value_counts())\n",
    "\n",
    "# Show a small, balanced sample for manual inspection (EN original vs FR translation)\n",
    "if \"text_en\" not in fr_translated_train.columns:\n",
    "    print(\"Warning: 'text_en' column not found in translation cache; side-by-side view may be incomplete.\")\n",
    "    fr_translated_train = fr_translated_train.copy()\n",
    "    fr_translated_train[\"text_en\"] = \"\"\n",
    "\n",
    "def _sample_translations_side_by_side(df: pd.DataFrame, label: int, n: int = 5, seed: int = 42) -> pd.DataFrame:\n",
    "    sub = df[df[\"label\"] == label].copy()\n",
    "    if len(sub) == 0:\n",
    "        return sub\n",
    "    sub = sub.sample(n=min(n, len(sub)), random_state=seed)\n",
    "    view_cols = [c for c in [\"id\", \"label\", \"text_en\", \"text\"] if c in sub.columns]\n",
    "    view = sub[view_cols].rename(columns={\"text_en\": \"EN\", \"text\": \"FR\"})\n",
    "    return view.reset_index(drop=True)\n",
    "\n",
    "print(\"\\nSample translations (5 NEG, 5 POS) — EN vs FR side-by-side\")\n",
    "display(_sample_translations_side_by_side(fr_translated_train, label=0, n=30, seed=SEED))\n",
    "display(_sample_translations_side_by_side(fr_translated_train, label=1, n=30, seed=SEED))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "969a3a08",
   "metadata": {},
   "source": [
    "Translation analysis:\n",
    "- Even after stripping `#`, hashtags are not translated when they are sentences without spaces (e.g. `cantsleep` → `cantsleep` in FR instead of `nepeutpasdormir`)."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad26605c",
   "metadata": {},
   "source": [
    "## Task 1.3 — Modeling (XLM-R classifier) + Task 1.4 — Evaluation and error analysis\n",
    "\n",
    "We use the same training loop across setups via Hugging Face `Trainer`.\n",
    "\n",
    "Setups:\n",
    "1) **Monolingual EN**: train on EN only, evaluate on EN test\n",
    "2) **Monolingual DE**: train on DE only, evaluate on DE test\n",
    "3) **Multilingual EN+DE**: train on EN+DE, evaluate on EN test + DE test and **zero-shot FR test**\n",
    "4) **Translation-trained FR**: train on EN→FR translated subset, evaluate on FR test\n",
    "\n",
    "All setups share the same backbone via `MODEL_NAME`.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "f3d88820",
   "metadata": {},
   "outputs": [],
   "source": [
    "import gc\n",
    "import inspect\n",
    "\n",
    "def df_to_hf_dataset(df: pd.DataFrame) -> Dataset:\n",
    "    cols = [\"id\", \"text\", \"label\", \"language\", \"type\", \"origin\"]\n",
    "    cols = [c for c in cols if c in df.columns]\n",
    "    return Dataset.from_pandas(df[cols], preserve_index=False)\n",
    "\n",
    "def tokenize_dataset(ds: Dataset, tokenizer: AutoTokenizer, max_length: int) -> Dataset:\n",
    "    def _tok(batch):\n",
    "        return tokenizer(batch[\"text\"], truncation=True, max_length=max_length)\n",
    "    keep_cols = {\"label\", \"language\", \"id\", \"type\", \"origin\", \"text\"}\n",
    "    drop_cols = [c for c in ds.column_names if c not in keep_cols]\n",
    "    return ds.map(_tok, batched=True, remove_columns=drop_cols)\n",
    "\n",
    "def compute_metrics(eval_pred):\n",
    "    # HF may pass an EvalPrediction or a tuple depending on version\n",
    "    if hasattr(eval_pred, \"predictions\") and hasattr(eval_pred, \"label_ids\"):\n",
    "        logits = eval_pred.predictions\n",
    "        labels = eval_pred.label_ids\n",
    "    else:\n",
    "        logits, labels = eval_pred\n",
    "\n",
    "\n",
    "    probs = torch.softmax(torch.tensor(logits), dim=-1).numpy()\n",
    "    preds = probs.argmax(axis=-1)\n",
    "\n",
    "\n",
    "    precision, recall, f1, _ = precision_recall_fscore_support(labels, preds, average=\"binary\", zero_division=0)\n",
    "    acc = accuracy_score(labels, preds)\n",
    "    return {\n",
    "        \"accuracy\": acc,\n",
    "        \"precision\": precision,\n",
    "        \"recall\": recall,\n",
    "        \"f1\": f1,\n",
    "    }\n",
    "\n",
    "def _ta_signature_params() -> Dict[str, inspect.Parameter]:\n",
    "    return inspect.signature(TrainingArguments.__init__).parameters\n",
    "\n",
    "def _training_args_kwargs(\n",
    "    run_name: str,\n",
    "    out_dir: Path,\n",
    "    per_device_train_batch_size: int = BATCH_SIZE,\n",
    "    per_device_eval_batch_size: int = BATCH_SIZE,\n",
    "    gradient_accumulation_steps: int = 1,\n",
    "    ) -> Dict:\n",
    "    params = _ta_signature_params()\n",
    "    kwargs = {\n",
    "        \"output_dir\": str(out_dir),\n",
    "        \"run_name\": run_name,\n",
    "        \"seed\": SEED,\n",
    "        \"data_seed\": SEED,\n",
    "        \"learning_rate\": LR,\n",
    "        \"weight_decay\": WEIGHT_DECAY,\n",
    "        \"per_device_train_batch_size\": per_device_train_batch_size,\n",
    "        \"per_device_eval_batch_size\": per_device_eval_batch_size,\n",
    "        \"gradient_accumulation_steps\": gradient_accumulation_steps,\n",
    "        \"num_train_epochs\": 1 if DEBUG_SMALL else EPOCHS,\n",
    "        \"load_best_model_at_end\": True,\n",
    "        \"metric_for_best_model\": \"f1\",\n",
    "        \"greater_is_better\": True,\n",
    "        \"logging_steps\": 50,\n",
    "        \"report_to\": [],\n",
    "        \"fp16\": torch.cuda.is_available(),\n",
    "    }\n",
    "    if \"evaluation_strategy\" in params:\n",
    "        kwargs[\"evaluation_strategy\"] = \"epoch\"\n",
    "    else:\n",
    "        kwargs[\"eval_strategy\"] = \"epoch\"\n",
    "    kwargs[\"save_strategy\"] = \"epoch\"\n",
    "    if \"overwrite_output_dir\" in params:\n",
    "        kwargs[\"overwrite_output_dir\"] = True\n",
    "    if \"gradient_accumulation_steps\" not in params:\n",
    "        kwargs.pop(\"gradient_accumulation_steps\", None)\n",
    "    return kwargs\n",
    "\n",
    "def _inference_args(out_dir: Path) -> TrainingArguments:\n",
    "    params = _ta_signature_params()\n",
    "    kwargs: Dict = {\n",
    "        \"output_dir\": str(out_dir),\n",
    "        \"per_device_eval_batch_size\": BATCH_SIZE,\n",
    "        \"report_to\": [],\n",
    "    }\n",
    "    # Ensure inference doesn't require eval_dataset and doesn't touch GPU\n",
    "    if \"evaluation_strategy\" in params:\n",
    "        kwargs[\"evaluation_strategy\"] = \"no\"\n",
    "    else:\n",
    "        kwargs[\"eval_strategy\"] = \"no\"\n",
    "    kwargs[\"save_strategy\"] = \"no\"\n",
    "    if \"no_cuda\" in params:\n",
    "        kwargs[\"no_cuda\"] = True\n",
    "    if \"use_cpu\" in params:\n",
    "        kwargs[\"use_cpu\"] = True\n",
    "    return TrainingArguments(**kwargs)\n",
    "\n",
    "def _free_cuda_memory():\n",
    "    if torch.cuda.is_available():\n",
    "        torch.cuda.empty_cache()\n",
    "    gc.collect()\n",
    "\n",
    "def _is_oom_error(exc: BaseException) -> bool:\n",
    "    name = exc.__class__.__name__.lower()\n",
    "    msg = str(exc).lower()\n",
    "    return \"outofmemory\" in name or \"cuda out of memory\" in msg or \"out of memory\" in msg\n",
    "\n",
    "def train_model(\n",
    "    train_df: pd.DataFrame,\n",
    "    val_df: pd.DataFrame,\n",
    "    run_name: str,\n",
    "    model_name: str = MODEL_NAME,\n",
    "    max_length: int = MAX_LENGTH,\n",
    "    force_retrain: bool = False,\n",
    "    ) -> Tuple[Trainer, AutoTokenizer]:\n",
    "    out_dir = ARTIFACTS_DIR / \"runs\" / run_name\n",
    "    out_dir.mkdir(parents=True, exist_ok=True)\n",
    "    best_dir = out_dir / \"best_model\"\n",
    "\n",
    "\n",
    "    def _build_inference_trainer(tok: AutoTokenizer) -> Trainer:\n",
    "        model = AutoModelForSequenceClassification.from_pretrained(str(best_dir))\n",
    "        model.to(\"cpu\")\n",
    "        return Trainer(\n",
    "            model=model,\n",
    "            args=_inference_args(out_dir),\n",
    "            data_collator=DataCollatorWithPadding(tokenizer=tok),\n",
    "            compute_metrics=compute_metrics,\n",
    "        )\n",
    "\n",
    "    # If already trained and not forcing retrain, load and skip retraining\n",
    "    if best_dir.exists() and not force_retrain:\n",
    "        tokenizer = AutoTokenizer.from_pretrained(str(best_dir), use_fast=True)\n",
    "        _free_cuda_memory()\n",
    "        print(f\"Loaded existing model from: {best_dir}\")\n",
    "        return _build_inference_trainer(tokenizer), tokenizer\n",
    "\n",
    "    # Clear previous checkpoint when retraining\n",
    "    if best_dir.exists() and force_retrain:\n",
    "        import shutil\n",
    "        shutil.rmtree(best_dir)\n",
    "        print(f\"Cleared previous best_model for retrain: {best_dir}\")\n",
    "\n",
    "\n",
    "    tokenizer = AutoTokenizer.from_pretrained(model_name, use_fast=True)\n",
    "    data_collator = DataCollatorWithPadding(tokenizer=tokenizer)\n",
    "\n",
    "\n",
    "    train_ds = tokenize_dataset(df_to_hf_dataset(train_df), tokenizer, max_length)\n",
    "    val_ds = tokenize_dataset(df_to_hf_dataset(val_df), tokenizer, max_length)\n",
    "\n",
    "\n",
    "    candidate_bs = [BATCH_SIZE, max(1, BATCH_SIZE // 2), max(1, BATCH_SIZE // 4)]\n",
    "    candidate_bs = sorted(set(candidate_bs), reverse=True)\n",
    "\n",
    "\n",
    "    last_exc: Optional[BaseException] = None\n",
    "    for bs in candidate_bs:\n",
    "        grad_acc = max(1, math.ceil(BATCH_SIZE / bs))\n",
    "        _free_cuda_memory()\n",
    "\n",
    "\n",
    "        model = AutoModelForSequenceClassification.from_pretrained(\n",
    "            model_name,\n",
    "            num_labels=2,\n",
    "        )\n",
    "\n",
    "\n",
    "        if torch.cuda.is_available():\n",
    "            try:\n",
    "                model.gradient_checkpointing_enable()\n",
    "                if hasattr(model.config, \"use_cache\"):\n",
    "                    model.config.use_cache = False\n",
    "            except Exception:\n",
    "                pass\n",
    "\n",
    "\n",
    "        args = TrainingArguments(\n",
    "            **_training_args_kwargs(\n",
    "                run_name=run_name,\n",
    "                out_dir=out_dir,\n",
    "                per_device_train_batch_size=bs,\n",
    "                per_device_eval_batch_size=bs,\n",
    "                gradient_accumulation_steps=grad_acc,\n",
    "            )\n",
    "        )\n",
    "\n",
    "\n",
    "        trainer = Trainer(\n",
    "            model=model,\n",
    "            args=args,\n",
    "            train_dataset=train_ds,\n",
    "            eval_dataset=val_ds,\n",
    "            data_collator=data_collator,\n",
    "            compute_metrics=compute_metrics,\n",
    "            callbacks=[EarlyStoppingCallback(early_stopping_patience=EARLY_STOPPING_PATIENCE)],\n",
    "        )\n",
    "\n",
    "\n",
    "        try:\n",
    "            trainer.train()\n",
    "            trainer.save_model(str(best_dir))\n",
    "            tokenizer.save_pretrained(str(best_dir))\n",
    "\n",
    "\n",
    "            # Drop training graph + optimizer state ASAP (critical for small GPUs)\n",
    "            try:\n",
    "                del trainer\n",
    "                del model\n",
    "            except Exception:\n",
    "                pass\n",
    "            _free_cuda_memory()\n",
    "\n",
    "\n",
    "            if bs != BATCH_SIZE:\n",
    "                print(f\"Trained with reduced per-device batch size={bs} (grad_acc={grad_acc})\")\n",
    "\n",
    "\n",
    "            return _build_inference_trainer(tokenizer), tokenizer\n",
    "        except BaseException as exc:\n",
    "            last_exc = exc\n",
    "            if _is_oom_error(exc):\n",
    "                try:\n",
    "                    del trainer\n",
    "                    del model\n",
    "                except Exception:\n",
    "                    pass\n",
    "                _free_cuda_memory()\n",
    "                continue\n",
    "            raise\n",
    "    if last_exc is not None:\n",
    "        raise last_exc\n",
    "    raise RuntimeError(\"Training failed for unknown reasons\")\n",
    "\n",
    "def predict_proba(trainer: Trainer, tokenizer: AutoTokenizer, df: pd.DataFrame, max_length: int = MAX_LENGTH) -> np.ndarray:\n",
    "    ds = tokenize_dataset(df_to_hf_dataset(df), tokenizer, max_length)\n",
    "    preds = trainer.predict(ds)\n",
    "    logits = preds.predictions\n",
    "    probs = torch.softmax(torch.tensor(logits), dim=-1).numpy()\n",
    "    return probs\n",
    "\n",
    "def evaluate_split(trainer: Trainer, tokenizer: AutoTokenizer, df: pd.DataFrame, lang: str, name: str, max_length: int = MAX_LENGTH) -> Dict:\n",
    "    sub = df[df[\"language\"] == lang].copy().reset_index(drop=True)\n",
    "    if len(sub) == 0:\n",
    "        return {\"name\": name, \"lang\": lang, \"n\": 0}\n",
    "\n",
    "\n",
    "    probs = predict_proba(trainer, tokenizer, sub, max_length=max_length)\n",
    "    pred = probs.argmax(axis=-1)\n",
    "    y = sub[\"label\"].values\n",
    "\n",
    "\n",
    "    precision, recall, f1, _ = precision_recall_fscore_support(y, pred, average=\"binary\", zero_division=0)\n",
    "    acc = accuracy_score(y, pred)\n",
    "    cm = confusion_matrix(y, pred)\n",
    "\n",
    "\n",
    "    return {\n",
    "        \"name\": name,\n",
    "        \"lang\": lang,\n",
    "        \"n\": len(sub),\n",
    "        \"accuracy\": acc,\n",
    "        \"precision\": precision,\n",
    "        \"recall\": recall,\n",
    "        \"f1\": f1,\n",
    "        \"confusion_matrix\": cm,\n",
    "        \"_df\": sub,\n",
    "        \"_probs\": probs,\n",
    "        \"_pred\": pred,\n",
    "    }\n",
    "\n",
    "def show_confusion(cm: np.ndarray, title: str):\n",
    "    plt.figure(figsize=(3.5, 3))\n",
    "    sns.heatmap(cm, annot=True, fmt=\"d\", cmap=\"Blues\", cbar=False)\n",
    "    plt.title(title)\n",
    "    plt.xlabel(\"Pred\")\n",
    "    plt.ylabel(\"Gold\")\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9ff45fcf",
   "metadata": {},
   "source": [
    "### Train: Monolingual EN and DE\n",
    "\n",
    "Training uses `train_en_de` / `val_en_de` but filtered per-language.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "02dd98e5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "EN train/val: 15415 1713\n",
      "DE train/val: 1334 148\n",
      "Loaded existing model from: /home/mandado/repos/advanced nlp/smm4h2026/artifacts/runs/monolingual_en/best_model\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading weights: 100%|██████████| 201/201 [00:00<00:00, 2071.78it/s, Materializing param=roberta.encoder.layer.11.output.dense.weight]              \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded existing model from: /home/mandado/repos/advanced nlp/smm4h2026/artifacts/runs/monolingual_de/best_model\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading weights: 100%|██████████| 201/201 [00:00<00:00, 2078.52it/s, Materializing param=roberta.encoder.layer.11.output.dense.weight]              \n"
     ]
    }
   ],
   "source": [
    "def filter_lang(df: pd.DataFrame, lang: str) -> pd.DataFrame:\n",
    "    return df[df[\"language\"] == lang].copy().reset_index(drop=True)\n",
    "\n",
    "# Optionally shrink for debugging\n",
    "if DEBUG_SMALL:\n",
    "    train_en = filter_lang(train_en_de, \"en\").sample(n=min(800, len(filter_lang(train_en_de, \"en\"))), random_state=SEED)\n",
    "    val_en = filter_lang(val_en_de, \"en\").sample(n=min(200, len(filter_lang(val_en_de, \"en\"))), random_state=SEED)\n",
    "    train_de = filter_lang(train_en_de, \"de\").sample(n=min(800, len(filter_lang(train_en_de, \"de\"))), random_state=SEED)\n",
    "    val_de = filter_lang(val_en_de, \"de\").sample(n=min(200, len(filter_lang(val_en_de, \"de\"))), random_state=SEED)\n",
    "else:\n",
    "    train_en = filter_lang(train_en_de, \"en\")\n",
    "    val_en = filter_lang(val_en_de, \"en\")\n",
    "    train_de = filter_lang(train_en_de, \"de\")\n",
    "    val_de = filter_lang(val_en_de, \"de\")\n",
    "\n",
    "print(\"EN train/val:\", len(train_en), len(val_en))\n",
    "print(\"DE train/val:\", len(train_de), len(val_de))\n",
    "\n",
    "trainer_en, tok_en = train_model(train_en, val_en, run_name=\"monolingual_en\")\n",
    "trainer_de, tok_de = train_model(train_de, val_de, run_name=\"monolingual_de\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "77b7f24d",
   "metadata": {},
   "source": [
    "### Train: Multilingual EN+DE\n",
    "\n",
    "Train on EN+DE jointly, validate on EN+DE joint validation.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "f495bac6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Multilingual train/val: 16749 1861\n",
      "Loaded existing model from: /home/mandado/repos/advanced nlp/smm4h2026/artifacts/runs/multilingual_en_de/best_model\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading weights: 100%|██████████| 201/201 [00:00<00:00, 2013.73it/s, Materializing param=roberta.encoder.layer.11.output.dense.weight]              \n"
     ]
    }
   ],
   "source": [
    "if DEBUG_SMALL:\n",
    "    train_multi = train_en_de.sample(n=min(1600, len(train_en_de)), random_state=SEED)\n",
    "    val_multi = val_en_de.sample(n=min(400, len(val_en_de)), random_state=SEED)\n",
    "else:\n",
    "    train_multi = train_en_de\n",
    "    val_multi = val_en_de\n",
    "\n",
    "print(\"Multilingual train/val:\", len(train_multi), len(val_multi))\n",
    "\n",
    "trainer_multi, tok_multi = train_model(train_multi, val_multi, run_name=\"multilingual_en_de\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8d73cfeb",
   "metadata": {},
   "source": [
    "### Train: Translation-trained FR (EN→FR translated train)\n",
    "\n",
    "Train a classifier on the translated French training subset and evaluate on **native French test**.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "2e7cd3a7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FR translated train/val: 5400 600\n",
      "Cleared previous best_model for retrain: /home/mandado/repos/advanced nlp/smm4h2026/artifacts/runs/translation_trained_fr/best_model\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 5400/5400 [00:00<00:00, 59022.82 examples/s]\n",
      "Map: 100%|██████████| 600/600 [00:00<00:00, 58546.96 examples/s]\n",
      "Loading weights: 100%|██████████| 197/197 [00:00<00:00, 1967.84it/s, Materializing param=roberta.encoder.layer.11.output.dense.weight]              \n",
      "XLMRobertaForSequenceClassification LOAD REPORT from: xlm-roberta-base\n",
      "Key                         | Status     | \n",
      "----------------------------+------------+-\n",
      "lm_head.bias                | UNEXPECTED | \n",
      "lm_head.dense.weight        | UNEXPECTED | \n",
      "lm_head.layer_norm.bias     | UNEXPECTED | \n",
      "lm_head.dense.bias          | UNEXPECTED | \n",
      "roberta.pooler.dense.bias   | UNEXPECTED | \n",
      "lm_head.layer_norm.weight   | UNEXPECTED | \n",
      "roberta.pooler.dense.weight | UNEXPECTED | \n",
      "classifier.dense.weight     | MISSING    | \n",
      "classifier.out_proj.bias    | MISSING    | \n",
      "classifier.out_proj.weight  | MISSING    | \n",
      "classifier.dense.bias       | MISSING    | \n",
      "\n",
      "Notes:\n",
      "- UNEXPECTED\t:can be ignored when loading from different task/architecture; not ok if you expect identical arch.\n",
      "- MISSING\t:those params were newly initialized because missing from the checkpoint. Consider training on your downstream task.\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "    <div>\n",
       "      \n",
       "      <progress value='1352' max='3380' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
       "      [1352/3380 04:18 < 06:27, 5.23 it/s, Epoch 4/10]\n",
       "    </div>\n",
       "    <table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       " <tr style=\"text-align: left;\">\n",
       "      <th>Epoch</th>\n",
       "      <th>Training Loss</th>\n",
       "      <th>Validation Loss</th>\n",
       "      <th>Accuracy</th>\n",
       "      <th>Precision</th>\n",
       "      <th>Recall</th>\n",
       "      <th>F1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>0.258609</td>\n",
       "      <td>0.251272</td>\n",
       "      <td>0.930000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>0.260636</td>\n",
       "      <td>0.252168</td>\n",
       "      <td>0.930000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>0.250663</td>\n",
       "      <td>0.260696</td>\n",
       "      <td>0.930000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>4</td>\n",
       "      <td>0.294663</td>\n",
       "      <td>0.253691</td>\n",
       "      <td>0.930000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table><p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Writing model shards: 100%|██████████| 1/1 [00:01<00:00,  1.18s/it]\n",
      "Writing model shards: 100%|██████████| 1/1 [00:01<00:00,  1.50s/it]\n",
      "Writing model shards: 100%|██████████| 1/1 [00:01<00:00,  1.32s/it]\n",
      "Writing model shards: 100%|██████████| 1/1 [00:01<00:00,  1.01s/it]\n",
      "There were missing keys in the checkpoint model loaded: ['roberta.embeddings.LayerNorm.weight', 'roberta.embeddings.LayerNorm.bias', 'roberta.encoder.layer.0.attention.output.LayerNorm.weight', 'roberta.encoder.layer.0.attention.output.LayerNorm.bias', 'roberta.encoder.layer.0.output.LayerNorm.weight', 'roberta.encoder.layer.0.output.LayerNorm.bias', 'roberta.encoder.layer.1.attention.output.LayerNorm.weight', 'roberta.encoder.layer.1.attention.output.LayerNorm.bias', 'roberta.encoder.layer.1.output.LayerNorm.weight', 'roberta.encoder.layer.1.output.LayerNorm.bias', 'roberta.encoder.layer.2.attention.output.LayerNorm.weight', 'roberta.encoder.layer.2.attention.output.LayerNorm.bias', 'roberta.encoder.layer.2.output.LayerNorm.weight', 'roberta.encoder.layer.2.output.LayerNorm.bias', 'roberta.encoder.layer.3.attention.output.LayerNorm.weight', 'roberta.encoder.layer.3.attention.output.LayerNorm.bias', 'roberta.encoder.layer.3.output.LayerNorm.weight', 'roberta.encoder.layer.3.output.LayerNorm.bias', 'roberta.encoder.layer.4.attention.output.LayerNorm.weight', 'roberta.encoder.layer.4.attention.output.LayerNorm.bias', 'roberta.encoder.layer.4.output.LayerNorm.weight', 'roberta.encoder.layer.4.output.LayerNorm.bias', 'roberta.encoder.layer.5.attention.output.LayerNorm.weight', 'roberta.encoder.layer.5.attention.output.LayerNorm.bias', 'roberta.encoder.layer.5.output.LayerNorm.weight', 'roberta.encoder.layer.5.output.LayerNorm.bias', 'roberta.encoder.layer.6.attention.output.LayerNorm.weight', 'roberta.encoder.layer.6.attention.output.LayerNorm.bias', 'roberta.encoder.layer.6.output.LayerNorm.weight', 'roberta.encoder.layer.6.output.LayerNorm.bias', 'roberta.encoder.layer.7.attention.output.LayerNorm.weight', 'roberta.encoder.layer.7.attention.output.LayerNorm.bias', 'roberta.encoder.layer.7.output.LayerNorm.weight', 'roberta.encoder.layer.7.output.LayerNorm.bias', 'roberta.encoder.layer.8.attention.output.LayerNorm.weight', 'roberta.encoder.layer.8.attention.output.LayerNorm.bias', 'roberta.encoder.layer.8.output.LayerNorm.weight', 'roberta.encoder.layer.8.output.LayerNorm.bias', 'roberta.encoder.layer.9.attention.output.LayerNorm.weight', 'roberta.encoder.layer.9.attention.output.LayerNorm.bias', 'roberta.encoder.layer.9.output.LayerNorm.weight', 'roberta.encoder.layer.9.output.LayerNorm.bias', 'roberta.encoder.layer.10.attention.output.LayerNorm.weight', 'roberta.encoder.layer.10.attention.output.LayerNorm.bias', 'roberta.encoder.layer.10.output.LayerNorm.weight', 'roberta.encoder.layer.10.output.LayerNorm.bias', 'roberta.encoder.layer.11.attention.output.LayerNorm.weight', 'roberta.encoder.layer.11.attention.output.LayerNorm.bias', 'roberta.encoder.layer.11.output.LayerNorm.weight', 'roberta.encoder.layer.11.output.LayerNorm.bias'].\n",
      "There were unexpected keys in the checkpoint model loaded: ['roberta.embeddings.LayerNorm.beta', 'roberta.embeddings.LayerNorm.gamma', 'roberta.encoder.layer.0.attention.output.LayerNorm.beta', 'roberta.encoder.layer.0.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.0.output.LayerNorm.beta', 'roberta.encoder.layer.0.output.LayerNorm.gamma', 'roberta.encoder.layer.1.attention.output.LayerNorm.beta', 'roberta.encoder.layer.1.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.1.output.LayerNorm.beta', 'roberta.encoder.layer.1.output.LayerNorm.gamma', 'roberta.encoder.layer.2.attention.output.LayerNorm.beta', 'roberta.encoder.layer.2.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.2.output.LayerNorm.beta', 'roberta.encoder.layer.2.output.LayerNorm.gamma', 'roberta.encoder.layer.3.attention.output.LayerNorm.beta', 'roberta.encoder.layer.3.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.3.output.LayerNorm.beta', 'roberta.encoder.layer.3.output.LayerNorm.gamma', 'roberta.encoder.layer.4.attention.output.LayerNorm.beta', 'roberta.encoder.layer.4.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.4.output.LayerNorm.beta', 'roberta.encoder.layer.4.output.LayerNorm.gamma', 'roberta.encoder.layer.5.attention.output.LayerNorm.beta', 'roberta.encoder.layer.5.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.5.output.LayerNorm.beta', 'roberta.encoder.layer.5.output.LayerNorm.gamma', 'roberta.encoder.layer.6.attention.output.LayerNorm.beta', 'roberta.encoder.layer.6.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.6.output.LayerNorm.beta', 'roberta.encoder.layer.6.output.LayerNorm.gamma', 'roberta.encoder.layer.7.attention.output.LayerNorm.beta', 'roberta.encoder.layer.7.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.7.output.LayerNorm.beta', 'roberta.encoder.layer.7.output.LayerNorm.gamma', 'roberta.encoder.layer.8.attention.output.LayerNorm.beta', 'roberta.encoder.layer.8.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.8.output.LayerNorm.beta', 'roberta.encoder.layer.8.output.LayerNorm.gamma', 'roberta.encoder.layer.9.attention.output.LayerNorm.beta', 'roberta.encoder.layer.9.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.9.output.LayerNorm.beta', 'roberta.encoder.layer.9.output.LayerNorm.gamma', 'roberta.encoder.layer.10.attention.output.LayerNorm.beta', 'roberta.encoder.layer.10.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.10.output.LayerNorm.beta', 'roberta.encoder.layer.10.output.LayerNorm.gamma', 'roberta.encoder.layer.11.attention.output.LayerNorm.beta', 'roberta.encoder.layer.11.attention.output.LayerNorm.gamma', 'roberta.encoder.layer.11.output.LayerNorm.beta', 'roberta.encoder.layer.11.output.LayerNorm.gamma'].\n",
      "Writing model shards: 100%|██████████| 1/1 [00:01<00:00,  1.08s/it]\n",
      "Loading weights: 100%|██████████| 201/201 [00:00<00:00, 1785.45it/s, Materializing param=roberta.encoder.layer.11.output.dense.weight]              \n"
     ]
    }
   ],
   "source": [
    "# Split translated FR train into train/val (stratified by label)\n",
    "fr_strat = fr_translated_train[\"label\"].astype(str)\n",
    "splitter = StratifiedShuffleSplit(n_splits=1, test_size=0.1, random_state=SEED)\n",
    "idx_tr, idx_va = next(splitter.split(fr_translated_train, fr_strat))\n",
    "fr_train = fr_translated_train.iloc[idx_tr].reset_index(drop=True)\n",
    "fr_val = fr_translated_train.iloc[idx_va].reset_index(drop=True)\n",
    "\n",
    "if DEBUG_SMALL:\n",
    "    fr_train = fr_train.sample(n=min(800, len(fr_train)), random_state=SEED)\n",
    "    fr_val = fr_val.sample(n=min(200, len(fr_val)), random_state=SEED)\n",
    "\n",
    "print(\"FR translated train/val:\", len(fr_train), len(fr_val))\n",
    "\n",
    "trainer_fr_trans, tok_fr_trans = train_model(fr_train, fr_val, run_name=\"translation_trained_fr\", force_retrain=True)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b622a0df",
   "metadata": {},
   "source": [
    "### Evaluate all setups (per language)\n",
    "\n",
    "We report metrics on the dev-as-test set for EN/DE/FR.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "0bf32e54",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 888/888 [00:00<00:00, 61979.63 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 418/418 [00:00<00:00, 13855.50 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 634/634 [00:00<00:00, 17088.03 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 418/418 [00:00<00:00, 14883.14 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 888/888 [00:00<00:00, 63988.97 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 634/634 [00:00<00:00, 17230.20 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 418/418 [00:00<00:00, 15666.19 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Map: 100%|██████████| 418/418 [00:00<00:00, 16350.54 examples/s]\n"
     ]
    },
    {
     "data": {
      "text/html": [],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>lang</th>\n",
       "      <th>n</th>\n",
       "      <th>accuracy</th>\n",
       "      <th>precision</th>\n",
       "      <th>recall</th>\n",
       "      <th>f1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>multi_en_de</td>\n",
       "      <td>de</td>\n",
       "      <td>634</td>\n",
       "      <td>0.925868</td>\n",
       "      <td>0.392857</td>\n",
       "      <td>0.628571</td>\n",
       "      <td>0.483516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>mono_de</td>\n",
       "      <td>de</td>\n",
       "      <td>634</td>\n",
       "      <td>0.944795</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>multi_en_de</td>\n",
       "      <td>en</td>\n",
       "      <td>888</td>\n",
       "      <td>0.961712</td>\n",
       "      <td>0.745455</td>\n",
       "      <td>0.672131</td>\n",
       "      <td>0.706897</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>mono_en</td>\n",
       "      <td>en</td>\n",
       "      <td>888</td>\n",
       "      <td>0.950450</td>\n",
       "      <td>0.654545</td>\n",
       "      <td>0.590164</td>\n",
       "      <td>0.620690</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>multi_en_de</td>\n",
       "      <td>fr</td>\n",
       "      <td>418</td>\n",
       "      <td>0.777512</td>\n",
       "      <td>0.205607</td>\n",
       "      <td>0.733333</td>\n",
       "      <td>0.321168</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>mono_en_zero_shot_fr</td>\n",
       "      <td>fr</td>\n",
       "      <td>418</td>\n",
       "      <td>0.755981</td>\n",
       "      <td>0.108696</td>\n",
       "      <td>0.333333</td>\n",
       "      <td>0.163934</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>mono_de_zero_shot_fr</td>\n",
       "      <td>fr</td>\n",
       "      <td>418</td>\n",
       "      <td>0.928230</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>translation_trained_fr</td>\n",
       "      <td>fr</td>\n",
       "      <td>418</td>\n",
       "      <td>0.928230</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                     name lang    n  accuracy  precision    recall        f1\n",
       "5             multi_en_de   de  634  0.925868   0.392857  0.628571  0.483516\n",
       "2                 mono_de   de  634  0.944795   0.000000  0.000000  0.000000\n",
       "4             multi_en_de   en  888  0.961712   0.745455  0.672131  0.706897\n",
       "0                 mono_en   en  888  0.950450   0.654545  0.590164  0.620690\n",
       "6             multi_en_de   fr  418  0.777512   0.205607  0.733333  0.321168\n",
       "1    mono_en_zero_shot_fr   fr  418  0.755981   0.108696  0.333333  0.163934\n",
       "3    mono_de_zero_shot_fr   fr  418  0.928230   0.000000  0.000000  0.000000\n",
       "7  translation_trained_fr   fr  418  0.928230   0.000000  0.000000  0.000000"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAVwAAAE6CAYAAABau+prAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjgsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvwVt1zgAAAAlwSFlzAAAPYQAAD2EBqD+naQAAId9JREFUeJzt3Qd8VFXe//FfaAktlNBCbwsKSjFSFemRIgi4CIKAFAVWEARE+OuCoAsIuLhLEVGqD64ooA+LKAsCigJSpIgiSC+CoYcaILn/1+/4zGwmCSETkjPJzOf9eg1kzr25c+beO98595wzkyDHcRwBAKS7LOn/EAAAAhcALKKFCwCWELgAYAmBCwCWELgAYAmBCwCWELgAYAmBCwCWELjI9A4fPixBQUEyefLkNNvmhg0b5LXXXpMLFy6k6vcXLVokVatWlZw5c5q67dixQzKStKzf2LFjpUqVKhIXFye+8vTTT5vn8dhjjyVatmDBAuncubNUrlxZsmTJImXLlr3tdrZv3y7t2rWT4sWLS65cueSee+4xz+/q1ase6z3yyCMyePBg7yuqH+0FMrNDhw7px9OdSZMmpdk2dVu6Td22t6Kiopzs2bM7bdq0cdatW+ds3LjRuXLlipNRpGX9Tpw44eTOndv55JNPHF9Zvny5qUNoaKjTunXrRMubNWvm3Hfffc7TTz/tVKxY0SlTpkyS2/npp5+ckJAQp3r16s6iRYucr776yhk9erSTNWtWp23bth7r6n7TffjLL794Vdds3kc0kLxr166ZllOg2rdvn9y8edO0uho2bJjsutpy0pZUZq3fP/7xD8mfP7906NBBfOHixYvSt29fef31101dkrJy5UrTslXaAt69e3eS63344Ydy/fp1WbJkiVSoUMGUNWnSRE6ePCmzZs2S8+fPS4ECBUy57jdtMb/11ltmmd90KehlnV4q7Nq1Szp27Cj58uWTggULypAhQ+TWrVuyd+9eadGiheTNm9dcKkycODHRNo4ePWpOriJFikhwcLDce++9ZkfFvwSKf1n697//XcqVKyd58uSRevXqyaZNmxJtc9myZWaZnoz62M2bN5eNGzd6/fxu3Lghb7zxhrl00boVLlxYevbsKadPn/ZYT5+bnixffvmlPPDAAybQ9HfmzJmTqv2Z1O2ZZ55Jdb2WLl0qNWvWlJCQEBkzZoxZpif2448/bk5SLa9Ro4bMnz/f6320Zs0aadSokYSFhZnnXbp0aXniiScSXeaptDh2uo9eeukl87Nuy7V/1q1bd8e66j58+OGHzc+dOnUyv6d1dy3Tev34448SGRlpHrtp06ZiU1rWT8+R2bNnS5cuXdyBlprX0t0YOnSohIeHywsvvHDbdeLXLTnZs2c3/2vGxKdvKLqNHDlyeJR369bNhPSlS5dSXmEng9MmvVazcuXKzuuvv+6sWrXKGT58uCkbMGCAc8899zj//Oc/TXnPnj1N+ZIlSzwun0qUKOEULlzYmTlzpvPll1+a39P1+vfvn+iytGzZsk6LFi2czz77zNzuv/9+p0CBAs6FCxfc6y5cuNCsGxkZadbRy4+IiAgnR44czvr161P83GJjY81j6eXQmDFjzHN4//33TX2rVKniXL161b2uXgaVLFnSlC9YsMBZuXKl07FjR1OPr7/+OsWPeezYMXMJGf/20ksvme1MnDgxVfUKDw93ypcv78yZM8dZu3ats3nzZnOplTdvXqdChQqmvp9//rnz1FNPmcd58803U1xfPS56mde8eXOzr/VSTvd/t27dnPPnz6fLsdN9NHDgQLPe0qVL3fvp4sWLd6zv/v37nenTp5vfHTdunPk9vVRVPXr0MJehWs/x48ebS1Y9jjalZf2++eYbs50VK1Z4lHtzPOLi4pybN2+m6JaQnpda3x07drjPxaS6FOLT5bfrUtB658+f3/nzn//sHDhwwImOjnb+/e9/O/ny5TPnQ0Lff/+9eZ7Lli1zUirTBO5bb73lUV6jRg33C8JFD4oGa4cOHdxlI0aMMOvpzolPwzYoKMjZu3evx0miJ8WtW7fc62l4aPm//vUvdxgVL17crKc/u1y6dMkpUqSIU79+/RQ/N91mwjcItWXLFlM+Y8YMd5meJBo8R44ccZddu3bNKViwoNO3b18ntTRkdLtdu3Y1J39q6qV9XK796NK5c2cnODjYOXr0qEd5y5YtnVy5cnm86JKzePFi85iuF1VS0uPY3U0frr7p6O8m7NfUQNNyfWPypbSqn75x6vqnTp1K1fFQc+fONWUpucWnx0wDfeTIke6yuw1ctWfPHtOIi/+4L7zwgvu1Ed+NGzdMhrz88stOSmX4LgWXhKOP2i2gly0tW7Z0l2XLlk0qVqwoR44c8bgc1RHU2rVre/y+Xj7pG44uj69169aSNWtW9/1q1aqZ/13b1C6M3377zVxOxL9U0UsmvczVS6akLnWTsnz5cnO50qZNG9M94rrppXexYsUSXcJquV5Ou+hleqVKlTyerzf27Nkjbdu2lfr165uuCd2fqamX7iOtR3y6X/VytFSpUon2u+6flHa/6GPqpdxzzz1nuiMOHjx423VtHru7oY+VEvH3vTe32NhYK/XTfannTKFChVJ1PJSeY1u2bEnRLb4RI0aYLoBRo0ZJWtGuEK2Pdl0tXrxYvv76a9NFOW/ePOnTp0+i9fXx9XVy4sSJFD9Gphk0037b+PRFqH1wGjoJy6Ojo933z549m+Q0EJ324Voen+7s+LT/0jUQFH997TdKapvaL6yd6ykZCPn999/NtKOEfUMuZ86cSbZurvq56uYNfbFo33fJkiVN/2v8Onhbr6T2he6n2+0j1/KU0MGL1atXmxP/+eeflytXrkj58uVNn92gQYN8duxSS7cdGhqaohe/9n2mRpkyZczvp2f9XPtVQyd+qHpzPFyv64R9pneyefNmmTFjhjlvdZBLb0qPn77h6Lmrff2ux0spDXHNDp0ilzt3bvf0L31D6dWrl3Tv3j3RIKPmjzevv0wTuKmlB11HGZMKHHW7d+fktqdut01tOblGMu9EH1u3pwNhSdFBi/SgJ1WrVq3MCbpixYpEJ7y39XK1jNNrvzdo0MDctOW2detWmTp1qpkDWbRoUTO/0hfHLrWS2ldJ0TeAhK26lPI2aFJTP9cx1IEzfRN0BZS35s+fbwZjU8L1x2l+/vln83P79u0TrXPs2DFzDKdMmeL1PFkNWr0aTvhcatWq5R4EThi4+gbtzbns94Grl7Xjx4+XH374wYzux58MrSdX48aNvdqeTgUpUaKEGZ0cNmyY+wTVk06nk7hGv1PaTfLRRx+ZIKlTp47YoC8QPVG1BfTtt9+aFm561Ev3+6effmqCzNWqde133T9169b1epvaktL66MyJhQsXmmPqTeB6c+ySao3ZpFcXDz74oGRkehzUgQMH3N0F3mrzf10K3tArs7Vr1yYq13NBrwr09a5di97S81RD9fLly6abycXV/ZXwtaLntrauNaRTyu8D98UXXzQvcu1P0k+M6OXW559/bi5J+vfvn6jv8U60FaSXt127djXBpHMAY2JiZNKkSeZSZsKECSnelp4gGhza2tTLY+1n1ku048ePmxNKp1Ql9S5+t/tD+1fHjRtnTqz403R06pdewqdFvUaPHm36gvUNTfvZ9NJRt6n7XvdfSi8jZ86caeqrx0/7r/UEd02Fa9asWbodu/vvv9/8r3M7e/ToYZ6/BnZ6XXVkRq7pZHoOpTZww8LCkuwqS46OI+gtIb2812256uWiLWK9qVOnTpl+eu2jVRqWrsDUFrF+ykynCerrRFuu+tw0wHWd+ONFyvXa8arR5mSSWQqnT59ONKKq05YSatiwoVO1alWPMh3Z79KlixMWFmamkegUMx2Fjj9SndynlbRc6xGfTnOpU6eOGeHXejRt2tT57rvvvH5+OrNi8uTJ5tMtuq08efKYUVKdefDrr7/ecQRWn6/eUkrXvd0osO7TtKqX+vHHH82nmXRajU670m3pqLQ3dNpS+/btzePorAc9hvoc4k/FSa9jpyPgOqshS5YsZjs6un+3swCSOmdtS8v6NWjQwGnVqpVHmbfHI63c7lx0ZUhSt4R1WbNmjZkyWKxYMSdnzpxOpUqVnKFDhzpnzpxJtF2dmqgzMbwRpP949fYCAP9Hu2L0AxQ680C7awJFdHS06YLQvuJnn302xb9H4AJINW2v6bTCiIgImTZtWsDsyTFjxpgvANJPwOp01JTy+z5cX9HpKXfqT0zpRw4z8mPeDR2US+4CSwe1bjflyBd0VsedvhHLmxefP9Bj9N5775mPS+u+yUjnV3rSqXM6P9fr4+19TwnuxNWHldwtPfqx7vSY8ftoMwLtc0uuvt70TduQXF+g65aaT6YhcNClkE5Tr/RSIzna/xN/ulRa0DmqydFR1+S+C9Q2/ZIUnSVwOzojQGcGZBQ6Dcg1j/h2dLT+dh8YAQhcALAkMDpcACADIHABwBK/HFLNWXOAr6uADGzt4jd8XQVkYHUr5E+3bdPCBQBLCFwAsITABQBLCFwAsITABQBLCFwAsITABQBLCFwAsITABQBLCFwAsITABQBLCFwAsITABQBLCFwAsITABQBLCFwAIHABwL/QwgUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALCEwAUASwhcALAkm60HQtp5tuPD8uyfG0iZ4gXN/T0HT8m4WV/If7772b3OK31bSe8nHpL8eXPKlt1HZPD4RWa9+OpUKyevPf+Y1Lq/rNy8FSu79p6QxwfMkOsxNzlcfiQ29pZ8+j/vy8Z1X8rF8+ckf8EwebhZa2nbuZdkyZJFbt26JUsWzJRdWzZI1KkTkit3HqlSo5Y82fN5KRBW2NfV9ysEbiZ04vcL8tep/ysHjp4x959uU0c+mfKc1O08wYTq0GeayQtPN5bnRv+P/HokSkY820I+nzlQqrUbK5evxrjD9n+n/UUmz/2PDHnzE7lxK1aqVSohcXGOj58d0trnn3wga79YKs8OGSUlypSXw7/ukfenvCG5cuWRyHad5UbMdTmyf6+0faqXlC7/J7lyOVo+fHeKvD1mmIz553wOSBoicDOhFd/s9rj/2vR/m1Zv7WrlTOA+36WxTJy9Uv53zU6zvM9fP5AjX42TTi0flNlLvjNlE4d2kBkfrZPJc1e5t3Pg6GnLzwQ27N/zozxQ9xGpUfthc79w0eKyad1/5NCve8x9bdEOHzfV43ee7j9MxgzuKWejTklYkWIcqDRCH24mlyVLkHR8NEJy58wh3+86JGVLhEl44XyyeuMv7nVu3Lwl67ftl7rVy5v7hQvkMeF8+txlWTtviBxePU7+8/4gqV/jj+XwL5WqVpefd2yVU8ePmvtHD+6TfT/vlGq16t/2d65duSxBQUGSK08eizX1fz5t4R4/flzeeecd2bBhg5w6dcoc4KJFi0r9+vWlX79+UqpUqTtuIyYmxtzic+JiJShLVvFnVSsWl3Xzh0pIjmxy+VqMdBr6nvxy8JTUrV7OLI86d8lj/aizl6R0+B99vuVKFnL3846c8qns2ntcuj5WW1a8O1AiOo6jpetnWnfsLlevXJYRfZ80fbZxcXHyRPd+Uq/Ro0muf+NGjHw8d7rUbfSo5MxF4PpF4H777bfSsmVLE6qRkZHm5jiOREVFyWeffSZTp06VL774Qh566KFktzN+/HgZM2aMR1nWorUke3ht8Wf7Dv8udTqPl/x5c0m7pjXkvbHdJLLPP9zLdV/GFxT03zJtFavZS76VD5ZtMj/v3HtcGtWuLD0eryejpi6z+lyQvr7/ZpVsXPul9Bs+VkqULm9auAtnTTEDYjp4Fp8OoL0z4VVzrvR4/iUOjb8E7osvvih9+vSRKVOm3Hb54MGDZcuWLcluZ+TIkTJkyBCPsiINXhZ/p7MKDh77Y9Dsh5+PSkTV0vL8U43krXl/9MkWDQuVU2ei3esXLpjX3eo9efqP8oSzFvYeOiWlihWw+Cxgw6LZU00rt27DSHO/VLmKcibqlCz/eL5H4GrYTh///+T077/JiPEzaN36Ux/u7t27TbfB7fTt29escyfBwcESGhrqcfP37oSkBEmQBOfIJodPnJWTpy9K07r3uJdlz5ZVGkRUlE07D5r7R347K79FXZBKZYt4bKNimSJy9OQ563VH+oqJuS5BWTxf6q6uhYRh+/tvx2T4uGmSJzQfh8WfWrjh4eGm77Zy5cpJLt+4caNZB4mNGdDGzLk9duq85M0dYgbNHnnwT9L2+Rlm+fQP18pLvSNl/9Eo2X/0tAzv/ahcu35TFn2x1b2NKfNXy6v9WsuP+06Y7gSdWla5bFHp8tJsdrmfqVmngfz7o7kSVriomRZ25MA+Wfnpv6RBZBv3PN1p40aYqWEvvvaWxMXGyYVzZ82yPHlDJVv27D5+Bv7DZ4E7bNgw08Ldtm2bNG/e3AyW6aCZDp6tWrVK3n//fXn77bd9Vb0MrUhYXpn9RncpVihULl6+Lrt/PWHCds33f8xMeGveagkJziFvj+wkBUJzyZbdh+Wx/tPcc3DVtA/XSUhwdpk49AkpkC+XCV5d59DxP7op4D+e7jdUln7wriyYPkmiL56X/AULSaOW7aVdl95m+bkzUbJ903rz818HdPP43RETZsi91SJ8Um9/FOQkHF2xaNGiRaYPV0M3NjbWlGXNmlUiIiJMv+yTTz6Zqu3mrDkgjWsKf7J28Ru+rgIysLoV8vvntLBOnTqZ282bN+XMmT9aVoUKFZLsXMIA8EMZ4pNmGrD01wLwd3zSDAAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwJJsKV2xQ4cOKd7o0qVLU1sfAPBbKW7h5suXz30LDQ2Vr776SrZu3epevm3bNlOmywEAd9HCnTt3rvvnl19+WZ588kmZOXOmZM2a1ZTFxsbKX/7yFxPGAIDEghzHccRLhQsXlm+//VYqV67sUb53716pX7++nD17VnwpZ80BPn18ZGxrF7/h6yogA6tbIX/GGjS7deuW7NmzJ1G5lsXFxaVFvQAgcLsU4uvZs6f06tVL9u/fL3Xr1jVlmzZtkgkTJphlAIA0CtzJkydLsWLFZMqUKXLy5ElTFh4eLsOHD5ehQ4emZpMA4PdS1YcbX3R0tPk/Iw2W0YeL5NCHC1/14aaqhRtfRgpaAMjIUhy4NWvWlKCgoBSt+8MPP9xNnQAgsAO3Xbt26VsTAPBzKQ7c0aNHp29NAMDP3dWgmX6cV+fealdDlSpVTLdDRhB9nbnAuL0c2fjOJtxeyF2PbN1eqjYdFRUlnTt3lnXr1kn+/PlFM/vixYvSuHFj+eijj8wn0QAAnlL1Vj9w4EAzHeynn36Sc+fOyfnz52X37t2m7IUXXkjNJgHA76WqS0G/EWz16tVSq1Ytj/LNmzdLZGSkXLhwQXyJLgUkhy4F+KpLIVUtXP2+hOzZsycq1zK+SwEA0jBwmzRpIoMGDZLffvvNXXbixAl58cUXpWnTpqnZJAD4vVQF7rRp0+TSpUtStmxZqVChglSsWNH8rGVTp05N+1oCQKBPC9N+XJ0WppvQaWHNmjWTjIA+XCSHPlxkij7ca9euyfLly9339U/qHDp0SA4fPiwrVqww3xZ2/fr19KgnAGR6XmX5ggULTOA+9thj7q6FqlWrSs6cOc39X375xXxNo/blAgDuooW7cOFC88Xj8X344Yeydu1ac5s0aZJ8/PHH3mwSAAKGV4G7b98+qVSpkvt+SEiIZMny303Url1bfv7557StIQAEYpeCfnw3W7b//srp06c9lusc3JiYmLSrHQAEagu3ZMmS5iO8t7Nr1y6zDgDgLgO3VatWMmrUqCRnIugMhjFjxkjr1q292SQABAyv5uH+/vvvUqNGDcmRI4cMGDDA9OfqVzPq7ASdsaB/Pn379u1StGhR8SXm4SI5zMOFr+bhev3BB513279/f1m1apX5wIPZSFCQNG/eXGbMmCHly5cXXyNwkRwCF5kmcF30axn3799vftaP9hYsWFAyCgIXySFwkekCNyMjcJEcAheZ4qO9AIDUI3ABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBICFwAsIXABwBIC1w/MnT1LunfpKA3rRUhko4dk2OABcvjwIY91HMeRWe9Mk5bNHpGHa9eQvr27y4H9v/qszrBn29YtMvAv/aRZo4eletXKsuar1YnOjXemTzXLaz9QTXo/0032c26kCwLXD/ywdYt07NRF5nzwkUx7d7bE3rolA/v1lmtXr7rXWTD3ffnwg3ny0ohXZd7CjyUsrJAM6Ndbrly54tO6I/1du3ZVKleuLCNeGZXk8rmz35MP5s81yxcuWixhhQpJvz495cqVyxyeNBbk6Nubn4m+HieB7Py5cxLZ+CF5d84CeSCilmnBaMv2qa7dpUevZ806N27ckEebPCwDBw2VDh07SSDJkS1w2xnawp3yz+nSpGkzc1/PjWaNGkjXbt2lV5/n3OdGk0fqy6Ahw6Tjk50l0IRkS79tB+6Z58cuX75k/g8NzWf+P3HiuJw9c0bq1nvIvU6OHDlMGO/aud1n9YTvnTh+XM6cOS31HnrY49yIeLCW7NzOuRFQgXvs2DHp1atXsuvExMRIdHS0x03LApW2WKZMflNq1IyQin+qZMo0bFXBsEIe6xYMC3MvQ2DSsFVhYWEe5drldIZzI7AC99y5czJ//vxk1xk/frzky5fP4/b3SRMkUE0c/7rs/3WvvPHm5ETLgoI875vepISFCEhBCc4DPTc4NdJeOvZW3NmyZcuSXX7w4ME7bmPkyJEyZMgQj7IYJ7sEoknj35Bv1q2VWXM+kKJFi7nLdRBEaWu2UOEiHn29CVs2CCyFChU2/2trtnC8c+PcubOmlQs/Ctx27dqZd9bkxu0SvvMmFBwcbG6BPGim+0/Ddt2a1TJz9nwpUbKkx/ISJUqa0P1+0wapfG8VU3bz5g35YdsWM2iGwKXniobupg3fyb2uc+PGDTOVTAfN4EeBGx4eLtOnTzfBm5QdO3ZIRESE9XplNm+OGysrv/hcJr89TXLlzu3ul8uTJ6+EhISYNy2doaDzdUuVLmNu82bPMssebfWYr6uPdHb1yhU5evSox0DZL3v2mO638OLFzQyF2e+9K6XLlJXSZcrI7FnvmnOjVWvODb+aFta2bVupUaOGjB07NsnlO3fulJo1a0pcnHct1kBr4daqfm+S5aPGjpM2j7c3P+thfm/mdFm6eJFcio6WqvdXk+Ej/+oeWAskgTYtbMvm76VPz+6Jyts+3l5eHzfBnBszZ0yTxR8vkujoi3J/teoy8tVR8qcAPDfSe1qYTwN3/fr1ZuJ9ixYtklyuy7Zu3SoNGzb0aruBFrjwTqAFLrzjt4GbXghcJIfARXL44AMA+AGurQDAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwhcAHAEgIXACwJchzHsfVgsC8mJkbGjx8vI0eOlODgYA4BOD98iMD1c9HR0ZIvXz65ePGihIaG+ro6yGA4P+yiSwEALCFwAcASAhcALCFw/ZwOlI0ePZoBM3B+ZAAMmgGAJbRwAcASAhcALCFwAcASAhcALCFw/dyMGTOkXLlyEhISIhEREbJ+/XpfVwkZwDfffCNt2rSR4sWLS1BQkHz22We+rlJAIHD92KJFi2Tw4MHyyiuvyPbt26VBgwbSsmVLOXr0qK+rBh+7cuWKVK9eXaZNm+brqgQUpoX5sTp16sgDDzwg77zzjrvs3nvvlXbt2pkvtAGUtnA//fRTc14gfdHC9VM3btyQbdu2SWRkpEe53t+wYYPP6gUEMgLXT505c0ZiY2OlaNGiHuV6/9SpUz6rFxDICNwAuFyMT7/+OGEZADsIXD9VqFAhyZo1a6LWbFRUVKJWLwA7CFw/lSNHDjMNbNWqVR7ler9+/fo+qxcQyLL5ugJIP0OGDJFu3brJgw8+KPXq1ZNZs2aZKWH9+vVjtwe4y5cvy/79+933Dx06JDt27JCCBQtK6dKlfVo3f8a0sAD44MPEiRPl5MmTct9998mUKVPkkUce8XW14GPr1q2Txo0bJyrv0aOHzJs3zyd1CgQELgBYQh8uAFhC4AKAJQQuAFhC4AKAJQQuAFhC4AKAJQQuAFhC4AKAJQQucAevvfaa1KhRg/2Eu0bgItN65plnzFdN6i179uxSvnx5GTZsmPnzMUBGxJfXIFNr0aKFzJ07V27evGn+QGafPn1M4Mb/s0JKl2soA75ECxeZWnBwsBQrVkxKlSolXbp0ka5du5q/QOvqBpgzZ45p+ep6+uXrFy9elOeee06KFCkioaGh0qRJE9m5c6fHNidMmGC+Mzhv3rzSu3dvuX79us+eH/wLgQu/kjNnTtOaVfr1gx9//LEsWbLEfPWgat26tflS9hUrVpi/+aZ/ZLNp06Zy7tw5s1zXHz16tPztb3+TrVu3Snh4uPnGNSAt8G1hyNR9uBcuXDAtWrV582Zp1aqVCVD968Tjxo2TEydOSOHChc3yNWvWSPv27c1fvdAWr0vFihVl+PDhpuWrX86ufz48fpdE3bp1TSvXFdpAatHCRaa2fPlyyZMnj4SEhJgvWdfv+p06dapZVqZMGXfYKm3R6hdvh4WFmd9x3fTLtw8cOGDW2bNnj9lOfAnvA6nFoBkyNf0SbW2N6oBY8eLFPQbGcufO7bFuXFyc6SLQL99OKH/+/Fbqi8BG4CJT01DVLoGU0P5a7b/Nli2blC1bNsl1tCti06ZN0r17d3eZ3gfSAl0KCBjNmjUz3QPt2rWTlStXyuHDh2XDhg3y6quvmgEyNWjQIDOzQW/79u0zA2g//fSTr6sOP0ELFwFDPyChsxNeeeUV6dWrl5w+fdpMKdN+X9efju/UqZPpz3355ZfNQNkTTzwh/fv3NwEN3C1mKQCAJXQpAIAlBC4AWELgAoAlBC4AWELgAoAlBC4AWELgAoAlBC4AWELgAoAlBC4AWELgAoDY8f8BokjQDRSgIYsAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAVkAAAE6CAYAAAC8kiEvAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjgsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvwVt1zgAAAAlwSFlzAAAPYQAAD2EBqD+naQAAIdxJREFUeJzt3Qd4VFX6x/E3pNKRnlhAQBAQKaFGlI5URZGiLKBYQEWpoohSXKW6IoLAooKiKCAgCgsqKKywkV5cujSRnhACghBCcv/Pe/xPNhNC+mGSyffzPPPA3Lm5OXPvnd+c+54zEx/HcRwBAFiRx85mAQCELABYRk8WACwiZAHAIkIWACwiZAHAIkIWACwiZAHAIkIWACzKUSEbHh4uI0eOlOjoaMnuPv74Y/Hx8ZHDhw9n6fNs3LixuXnSn3/+adq3evVqK9vX7eq+s7X91JQtW1Yef/zxdP1MVFSUdO3aVUqWLGna3qFDB8lOsrJ9el4WL15c5s6dK56ya9cuCQwMNM9l06ZNbo8dPXpU+vfvL40aNZIiRYqYdfT1mJyYmBiZMGGC3HXXXZI/f34pVaqUtG7d2rwGE/vhhx+kQIECcuzYsfQ31slBJkyYoB8Bdg4dOuRkd7NmzcpwW1N6njt37jQ3T4qIiDDtGzFihJXtnzt3zvn555/Nv55QpkwZp2fPnun6mf79+zsBAQHOZ599Ztq+d+9eJzvJyvbptqpVq+bEx8c7nnD16lWnXr16TkhIiDkPN27c6Pb4qlWrnOLFizvNmzd3Hn30UbOOvh6T0717dydPnjzOsGHDnB9++MH58ssvndDQUMfPz89Zv36927pNmjRxevToke72+okXu3TpkuTNm1e8SZUqVSSn0Z5vvnz50rx+oUKFpH79+pKT7NixQ8qXLy/dunVLcb24uDi5evWq6YXlxPZpj/if//ynTJw40fQQPWHixImmt/ryyy9Lv379rnn8vvvuk4iICPN/7eV+8cUX1+3Ffv755/LYY4/Jm2++mbD8nnvukZCQEJkzZ47UrVs3Yfnzzz8vXbp0Meveeuut3lcu0MvTl156yfz/9ttvNwc48SWlXuK1a9dOFi1aJDVr1pSgoCAZNWqUeez99983O14vlfSSoFq1ajJ+/HiJjY11+x16Ga6XDRs3bpR7773XBEO5cuVk7NixEh8fn7Ce/l93dKVKlUyI6yXJ3XffLZMmTUrxOaxYsUIefPBBueWWW0z7KlSoIL1795bIyMg0P8/kygV64j/33HNy8803S0BAgGnzsGHDzEmUmG6nb9++8umnn0rlypXN86tevbosXbo0zcdByx8lSpQw/9f962qf6/Ja26/3t2zZIo888ojcdNNN5sXtOuH1klWPle43/ffRRx+V3377LdVygW5fL9f2798vbdq0Mf/XE33QoEHXPM8rV66Y43PnnXeasND2PvHEEwkvPBc9/kOGDJHSpUubfdGwYUPZsGFDmveFa39oW1euXCm7d+92O16ux/Rc0/bo8dT2rFq1Sm6UrG6fXnZrCGvYJJae45MZv/76qwwfPlymTp1q3oyTkydP2mJN19Nb4cKF3ZbrdnW5vkYTa9++vXleH3zwQbranGN6sk899ZQJk8mTJ5sgDQ4OvqZnpy9sPZFee+01c8JooKoDBw6YdytdpiG0fft2eeutt2TPnj0yc+ZMt99z8uRJ826vJ8eIESPkq6++kqFDh5p3th49eph19KTUMNHfo+GtL1bdVmq1Ym1HgwYNzHPRA6sn+TvvvGNe3P/973/F398/Tc8zscuXL0uTJk3MtjX0NOzXrFkjY8aMkW3btsm//vUvt/X1vr6JvPHGG+aE0efy0EMPyd69e004p0bb8+2330qrVq3kySefNO1VruB1efjhh02g9unTRy5evGiW6fPVNyZdXrRoUTlx4oRMmzZN6tSpY2psWudLie7nBx54wPxePT4//fST/P3vfzf7Ul94rjdAfSPTfaABGhYWZkJcj6W+OWnQu65unn76aZk9e7YMHjxYWrRoYXp72u4//vgj1f2QeH/8/PPP5k3u3LlzpvfjOl56HNV7770nFStWlLffftu8gO+44w65UbK6fXr+aCdGOxYZOT6u3nJavvzPFYIu+jN6vmlnSn/P9eqsaaWvN90vH330kTRv3lyaNm1q9smrr75q2qznR2KaHXo+6T7Q10+aOTlISrVKraP5+vqmWmuKi4tzYmNjndmzZ5v1o6KiEh5r1KiR2X7SWkyVKlWc+++/P+F+u3btnBo1amSqJqv1LG3Hb7/9Ztb7+uuv0/Q8tY16c5k+fbpZd/78+W7rjRs3ziz//vvvE5bp/VKlSjnnz59PWHby5ElTkxozZoyTFTVZXaaPDR8+PE21tQsXLjj58+d3Jk2a5FZT023ovy5aI03uebZp08apVKlSwv0vvvjCrLdw4UK39bRup8unTp1q7u/evdvcHzBggNt6c+bMMcvTW5PVY1K1alW3ZXr8dFvly5d3rly54nhSVrUvX758Tp8+fa5Zntbj43qt6rqp3ZKeX5MnT3Zuuukmc84mfo0lrckmd9yvV5PV16Geq/oacP3e2267zdm6dWuy62vtVtfV8zatcky5IC20F6fvyElt3brVvPMVK1ZMfH19zTuY9kr1HXXfvn1u6+qlY+I6jGu7iS9p9XHtDeu74HfffSfnz59PU/tOnz5tenZ6GeXn52faUaZMGfOY9sAz4scffzQ9dr00T8x1+a6joolpr7dgwYIJ93U0VcsoSS/ZM6tjx47XLLtw4YKpo2mZRJ+/3rQ3rT3dtDx/vbTVS7aUjo2WPrSXpevpZa3rVqNGDXNsXSUI1yVx0hpl586dTbuykp57eqxTo73wxG1Ozy0zXwud1vbplZrW1/V8yejxUUuWLDFXU6ndnnnmGXHRbegVpc4E0HM2q+gVrfbg9cpUz4mvv/7aXG3plY3mRlL63PU46RWv15UL0sJ1aZ3YkSNHTH1Vd5zWTLUOqLUWrb1pIVsHxxLTIE5K61SJ19ODrcH22WefyfTp001wa9lg3LhxUrt27WTbpgemZcuWcvz4cXn99ddNXVi3oct1kCdpO9LqzJkzJjySDkLoyaBhoY+n9/nZOhZastHQ1+evJQK9NNV2aw0vLb9f66ZJ62Tadi2ZuJw6dcqEgV7aJcdV/3btF913iek+S24fZfW+SE6vXr3kk08+ydDvmDVrVrqnnaW3fa5jlPQYpOf4uEoVaS0XuOhrVcdL9M3bVZbTwHe9eWspJGltNTX6xq5lDC2ZacnIRadwaRsHDhx4TX3a9fzS83rxqpBNbrRz8eLFpqek9U1Xr1FpvTKj9IWoB0BvesB1UEHrOPfff7/8/vvvyY6ka71Pe79aR+rZs2fCch0oyAwNhPXr15uTNvHz116z9nBSq3PeqGOhLwLtZWpt9JVXXklYroMirtpgVtDnq/tE68bJcfXiXUGqPRIdMHTRfZb0jSmz0joKr70pHZjMCB1vsN0+1z7L7PEqX758mq6c9FzRfeJ6/ejP6EBqUnp1pgGb3vnz+nrU142+4SemvXodEP73v/99zc+4nnt6Xlc5KmRd00rS8y7iOoEST0nRHZveEcLr0UtTvVTXSco6AVoHd5IbpEquHUqnw2TmeTZr1kzmz59v3kx0AMtFB3Rcj2eX46D7Penz//DDD03ZJqvooIhOktdt1qtX77rruWZo6EBQaGhownLdlxq0nqBXWXrLrlwzV3SQNTOWLFmSphkHOtjsosc0aY9Y30j16lGvJqtWrZrudri2v27dOvPBBRdtmw6i6yygpA4ePGjebNJTsshRIauX2Eov+7U3qO84WgZIXGNMSmsrenLoVCEdbdYDpSPaZ8+ezXA7tO6kly5aGtBRdX2Hfffdd01P+XojszqdSN/BtRenYaOj63qy6bSuzDxPrS3rFDVdTwNef3bt2rUyevRocxmuo6ZZTduhz1XrVxri+lz0nT2lgNDSgJZUtKbmWld7Cjqym9xIdUbpzAUNTn3uOodS6+e6/3RepV766cwDfTPSKWx/+9vfzHHTx3U/aW/JNcKO6785LV++PFO7p9r/n9/pkdy8adenKfVNMmmZbsGCBQmhqHRWidb/lWv8Qmf1aC9We8taetDzU6+4dGbPoUOHzFTHpFyBnK45wk4OM3ToUPNJD9dooGsEWkcs27Ztm+zPLFmyxKlevboTFBTk3Hzzzc5LL73kLF++/JoR7ORGYF0jp7p9l3/84x9OWFiY+VSJfopGRyOffPJJ5/DhwynOLti1a5fTokULp2DBgmaUtFOnTs6RI0eSHUm93vNMOrtAnTlzxoz4BgcHm0+qaFv15y9fvuy2nm7n+eefz5JPOK1cudKpWbOmExgY6DYa75pdoDMQkjp69KjTsWNH89x1H7Rq1crZsWPHNb//erMLdBZCUq7fl5jO2nj77bcTjnmBAgWcO++80+ndu7fz66+/JqwXExPjDBo0yClZsqRZr379+ubTUBnZHymN3utsEU/Lqvbpp6L0ZzZs2OC2PD3HJ6ukNLsgpVkLiUVHR5sZA5UrVzYzJ/RcaNy4sbNs2bJrtrl///5kZ66kxuf/GwQAaaIzBvRTUXpFmJu8/vrrpgyn5ZL0zEAhZAGki9ZCteSin75Krm7pjaKjo009WksJqX00OSlCFm5SG/RJ+ikcb8f+SN6UKVPMCLxOj8wNtm7damYR6VSv9H5nAyELt4GE1KYCJZ5Wkxuk9oLSAcfMfrwT3i1HzS6AXTqlRT9pk9o6uUlq+8NT85CRc9CTBQCLck9xDQA8gJAFAIu8siabt2bGPv+N3OHsximebgKysaAsTkV6sgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgESELABYRsgBgkZ/NjcOOpzs1lKcfuVfKhBQ193cfPCmjZyyX7/+zy9zPnzdA3nzxQWnf5G4pWji//HY8SqbOXS0ffLk2YRulihWU0f0fkqb175SC+QNl3+HTMmHmd/LVym0ctlxi3hdz5ONZH0lkRISUr3CHDHnlVakVWtvTzfI6hGwOdOxUtLw++Ws5cCTS3P9b+3ry5cRnpH7XsSZwxw/uKI1qV5Qnhs2W346fkeYNKsukoZ3lRMQ5Wbr6v+ZnPnqzpxQuECSd+v9TIqMvSJfWteXTsb3knm7jZfveox5+hrDt2+XLZPzYMTLs9RFSo2YtWTB/rjzX+2n56pt/SXBICAcgC1EuyIGW/bRDvlu7S/YfOW1uI99fIhf+jJG6d99uHq939+3y2dL1smbzr3LkRJTMXPQf+WXfMalV5baEbeg6U+f+Wzbt/E0OHzsj4z78TqL/uCQ1Kt/qwWeGG+XTT2bJQx07ysOPdJJy5cvLkKHDpHRwaZk/7wsOQhYjZHO4PHl8pNP9oaZEsP6XQ2ZZ+LaD0q5RNQkpUdjcv6/2HXJHmZKyMnx3ws+Fbz0gj7QMlZsK5RMfn7+2ERjgJz9t+tVjzwU3RuyVK7J7105pENbQbXmDsHtk+7atHAZvKhccPXpUpk2bJuHh4XLy5EnzYi9VqpSEhYVJnz595NZbU+9VxcTEmFtiTnyc+OTxFW9WtUKIrP5kkAQF+MmFSzHSZdAHsufgSfPYoHFfytThj8mB79+S2Ng4iXfi5dk3Pjfh69L9lZmmPHD83+PNOn9eviJdBn4gh47+VYKA9zobfVbi4uKkWLFibsuLFSsukZERHmuXt/JYyK5du1Zat25tgrRly5bm5jiOnD59WhYvXiyTJ0+W5cuXyz333JPidsaMGSOjRo1yW+Zbqo74B9cVb7bv8Cmp13WMFCmYTzo0qyEfvNFdWj41yQTt8482lrrVykrHftNNuaBhrQoyaWgXORl5Xlat32t+fuTz7U0vtnXv9+RM9EVp3/humTOhlzTv9a7s3H/c008PN4B2ahLT11/SZcg8H0f3rAfUqVNHGjZsKBMnTkz28QEDBpgg3rhxY7p7siXvfdnre7JJ/Wt6Xzn4e6S89PZCObVmgumVfrt2Z8Lj2rO9uWQRebDvVLn9luKya8lIqdXxTTNQlngbB36PlBffmive7OzGKZLbywX1ateQCe9MkmbNWyQsHzfmTdm7Z4/M/OQzyc2C/LykJrtjxw5TErie3r17m3VSExgYKIUKFXK75baAVT7iY2qq/n6+EuDvJ/FJ3jvj4uJN/VblCwow/167jiN56Ml4Pf+AAKlcpaqsC/+P2/J14eFSvUZNj7XLW3ksZIODg00t9np+/vlnsw6uNapve7mnZnm5Lbioqc3qpb8Obs1dtkn+uHjZDF6N7t9B7g29Q8qEFDNTvLq1qyvfrNpufn7v4ZNmVsKU1x6V2lXLmJ5tv+5NpVn9SrJk9V/rwLt17/mELFq4QL5atEAOHjggE8aOlhMnTkinLl093TSv47Ga7ODBg01PdvPmzdKiRQsz4KX1IB0AW7FihXz44Yfy7rvveqp52VrJYgXlozd7SOniheTchcuy49dj8sDzU+XH9XvM4z1emSlvvPCgfDy6p6m7al125PtLEz6McPVqvHR4YZr5wMKCSb2lQL5AOfB7hDw1/FMzNQzer1XrNnIu+qzMmDZVIiJOS4U7Ksr702dISMjNnm6a1/FYTVbNmzfP1GQ1aHW0U/n6+kpoaKgMHDhQOnfunKHt5q3ZN4tbCm+S22uyuLE1WY+GrEtsbKxERv41dah48eLi7++fqe0RskgJIYsbGbLZ4mO1GqrUXwF4Iz7xBQAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYBEhCwAWEbIAYJFfWld8+OGH07zRRYsWZbQ9AJA7e7KFCxdOuBUqVEh++OEH2bRpU8LjmzdvNsv0cQBAOnuys2bNSvj/yy+/LJ07d5bp06eLr6+vWRYXFyfPPfecCWAAwF98HMdxJJ1KlCgha9eulUqVKrkt37t3r4SFhcmZM2fEk/LW7OvR34/s7ezGKZ5uArKxoDR3PS0OfF29elV27959zXJdFh8fnxXtAgCvkKHMfuKJJ6RXr16yf/9+qV+/vlm2bt06GTt2rHkMAJCJkH377beldOnSMnHiRDlx4oRZFhwcLEOGDJFBgwZlZJMA4JUyVJNN7Pz58+bf7DTgRU0WKaEmixtZk8305rJTuAJAdpPmkK1Zs6b4+Pikad0tW7Zkpk0AkPtCtkOHDnZbAgBeKNM12eyImixSQk0WN7Imm6mQ1Y/S6txYLSNUqVLFlBSyg1PnYz3dBGRjhfP5e7oJyMayxcDX6dOnpWvXrrJ69WopUqSIaE6fO3dOmjRpInPnzjWfCAMAZPATXy+88IKZurVz506JioqSs2fPyo4dO8yyF198kf0KAJkpF+g3ba1cuVLq1KnjtnzDhg3SsmVLiY6OFk+iXICUUC5Atv/uAv1+An//a+tauozvLgCATIZs06ZNpV+/fnL8+PGEZceOHZMBAwZIs2bNMrJJAPBKGQrZKVOmyB9//CFly5aV8uXLS4UKFcz/ddnkyZOzvpUAkENlagqX1mV1CpduQqdwNW/eXLIDarJICTVZZNua7KVLl2Tp0qUJ9/XPzRw6dEgOHz4sy5YtM9/Cdfny5axtIQDkYOnK7NmzZ5uQbdeuXULZoGrVqpI3b15zf8+ePeYrD7U2CwBIZ092zpw55su6E/v8889l1apV5jZhwgSZP38++xUAMhKy+/btk4oVKybcDwoKkjx5/reJunXryq5du9KzSQDwaukqF+hHZ/38/vcjERERbo/rHNmYmJisax0A5Kae7C233GI+Pns9v/zyi1kHAJCBkG3Tpo0MHz482RkEOvNg1KhR0rZt2/RsEgC8WrrmyZ46dUpq1KghAQEB0rdvX1Of1a851FkFOtNA/1T41q1bpVSpUnZbnVo7+apDpIB5ssjW3yer82KfffZZWbFihfkQgtmIj4+0aNFCpk6dKuXKlRNPI2SREkIW2TpkXfQrDvfv32/+rx+rLVq0qGQXhCxSQsgiR4RsdkbIIiWELLL9Vx0CANKGkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZALCIkAUAiwhZL7B4wVx5/NGHpFXjeub2bK9usu4/axIedxxHZs54Xx5q3USaNwyVF3s/LocO7Pdom+F5876YI61bNpU6NatJ104Py5bNmzzdJK9EyHqBEiVLS+++A+SDT+aZW63adeXVwS8kBOnns2fK/M9nS/+XXpUZH8+VosWKy8C+T8ufFy96uunwkG+XL5PxY8fI0888K/MWLJZatULlud5Py4njxzkmWczH0W6Olzl1PlZyu7bNwuTZFwdJ2wceNj3YTo92l249nzSPXblyRTrc30h6vzBAHny4s+Q2hfP5S27XrWsnqVylirw2fFTCsg7tW0uTps2l34BBkpsF+WXt9ujJepm4uDj54ftlcvnSJbmrWg05ceyoRJ2JlDr1wxLWCQgIkOq1asuOX7Z5tK3wjNgrV2T3rp3SIKyh2/IGYffI9m1bOSxZLIszO2v9/vvvMmLECJk5c+Z114mJiTE392V5JDAwUHKTA/v3yXO9upleat68+eTNCZOkbLny8t/tf71oihYt5ra+3j95kkvD3Ohs9FnzZlysmPs5UaxYcYmMjPBYu7xVtu7JRkVFySeffJLiOmPGjJHChQu73d57Z5zkNreVuV0+mrNQps2cIw927CyjRw6TwwcP/G8FHx+39bVK5CPuy5C7+CR3TiRZhhzek/3mm29SfPzgwYOpbmPo0KEycOBAt2XRMdn6vcMKf39/ueXW28z/76xyl+zZtVO+nPuZdOvRyyzTkkHx4iUS1j97NkpuStKTQe5wU5GbxNfXVyIjI92WR0WdMb1ZeFHIdujQwbxzpjT2lto7q5YFkpYGLjHwZfap1t6Cb77FzCbYtP5nqVipstk/sbGxsn3LJjPwhdzHPyBAKlepKuvC/yPNmrdIWL4uPFwaN23m0bZ5I492+YKDg2XhwoUSHx+f7G3Lli2ebF6OMeP9d2X71s1y4vgxU5v9YOok2bZlo7Ro3da8SenMgs9mfSA/rVopB/f/KmNGDZPAoCBpcX9bTzcdHtK95xOyaOEC+WrRAjl44IBMGDtaTpw4IZ26dOWYeFNPNjQ01ASp9miTk1ovF/+7zHtrxFA5Exkh+QsUlPIVKsqE96ZLnXp/zSh4rEcviYm5LO+Me1Mu/HFeKle9W/4xeYbky5+fXZhLtWrdRs5Fn5UZ06ZKRMRpqXBHRXl/+gwJCbnZ003zOh6dJ7tmzRq5ePGitGrVKtnH9bFNmzZJo0aN0rVd5skiJcyTxY2cJ8uHEZDrELJICR9GAIAcJPfNdQKAG4iQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLCFkAsIiQBQCLfBzHcdjD3ismJkbGjBkjQ4cOlcDAQE83B9kM54d9hKyXO3/+vBQuXFjOnTsnhQoV8nRzkM1wfthHuQAALCJkAcAiQhYALCJkvZwOdo0YMYJBL3B+eAgDXwBgET1ZALCIkAUAiwhZALCIkAUAiwhZLzd16lS5/fbbJSgoSEJDQ2XNmjWebhKygZ9++knat28vISEh4uPjI4sXL/Z0k7wWIevF5s2bJ/3795dhw4bJ1q1b5d5775XWrVvLkSNHPN00eNjFixelevXqMmXKFE83xesxhcuL1atXT2rVqiXTpk1LWFa5cmXp0KGD+dIYQGlP9quvvjLnBbIePVkvdeXKFdm8ebO0bNnSbbneDw8P91i7gNyGkPVSkZGREhcXJ6VKlXJbrvdPnjzpsXYBuQ0hmwsuBRPTrw9OugyAPYSslypevLj4+vpe02s9ffr0Nb1bAPYQsl4qICDATNlasWKF23K9HxYW5rF2AbmNn6cbAHsGDhwo3bt3l9q1a0uDBg1kxowZZvpWnz592O253IULF2T//v0J9w8dOiTbtm2TokWLym233ebRtnkbpnDlgg8jjB8/Xk6cOCF33XWXTJw4Ue677z5PNwsetnr1amnSpMk1y3v27Ckff/yxR9rkrQhZALCImiwAWETIAoBFhCwAWETIAoBFhCwAWETIAoBFhCwAWETIAoBFhCyQipEjR0qNGjXYT8gQQhY51uOPP26+tlFv/v7+Uq5cORk8eLD50ypAdsEXxCBHa9WqlcyaNUtiY2PNH4l86qmnTMgm/pM7Sh/XIAZuNHqyyNECAwOldOnScuutt8pjjz0m3bp1M3951XWJP3PmTNPD1fX0C8vPnTsnzzzzjJQsWVIKFSokTZs2le3bt7ttc+zYseY7dwsWLChPPvmkXL582WPPDzkfIQuvkjdvXtNrVfpVfvPnz5eFCxear/FTbdu2NV9kvmzZMvM30PQPTTZr1kyioqLM47r+iBEj5K233pJNmzZJcHCw+SYzIKP4Fi7k6JpsdHS06bmqDRs2SJs2bUxo6l/lHT16tBw7dkxKlChhHv/xxx/loYceMn8dQnu2LhUqVJAhQ4aYHq5+obn+qezE5Yb69eub3qwrqIH0oCeLHG3p0qVSoEABCQoKMl9Mrt+VO3nyZPNYmTJlEgJWac9Vv6y6WLFi5mdcN/3C6gMHDph1du/ebbaTWNL7QHow8IUcTb94WnudOqgVEhLiNriVP39+t3Xj4+PN5b9+YXVSRYoUuSHtRe5DyCJH0yDVy/200Pqr1mP9/PykbNmyya6jZYZ169ZJjx49EpbpfSCjKBcg12jevLm59O/QoYN89913cvjwYQkPD5fXXnvNDHKpfv36mRkJetu3b58ZBNu5c6enm44cjJ4scg390ILOKhg2bJj06tVLIiIizPQvreO6/kx6ly5dTH325ZdfNoNdHTt2lGeffdaEMpARzC4AAIsoFwCARYQsAFhEyAKARYQsAFhEyAKARYQsAFhEyAKARYQsAFhEyAKARYQsAFhEyAKA2PN/5JzugP0BCewAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 350x300 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "results: List[Dict] = []\n",
    "\n",
    "# Monolingual EN: evaluate EN test and also check zero-shot FR\n",
    "results.append(evaluate_split(trainer_en, tok_en, test_df, \"en\", name=\"mono_en\"))\n",
    "results.append(evaluate_split(trainer_en, tok_en, test_df, \"fr\", name=\"mono_en_zero_shot_fr\"))\n",
    "\n",
    "# Monolingual DE\n",
    "results.append(evaluate_split(trainer_de, tok_de, test_df, \"de\", name=\"mono_de\"))\n",
    "results.append(evaluate_split(trainer_de, tok_de, test_df, \"fr\", name=\"mono_de_zero_shot_fr\"))\n",
    "\n",
    "# Multilingual EN+DE\n",
    "for lang in [\"en\", \"de\", \"fr\"]:\n",
    "    results.append(evaluate_split(trainer_multi, tok_multi, test_df, lang, name=\"multi_en_de\"))\n",
    "\n",
    "# Translation-trained FR\n",
    "results.append(evaluate_split(trainer_fr_trans, tok_fr_trans, test_df, \"fr\", name=\"translation_trained_fr\"))\n",
    "\n",
    "# Tabulate\n",
    "rows = []\n",
    "for r in results:\n",
    "    if r.get(\"n\", 0) == 0:\n",
    "        continue\n",
    "    rows.append({k: r[k] for k in [\"name\", \"lang\", \"n\", \"accuracy\", \"precision\", \"recall\", \"f1\"]})\n",
    "\n",
    "metrics_df = pd.DataFrame(rows).sort_values([\"lang\", \"f1\"], ascending=[True, False])\n",
    "display(metrics_df)\n",
    "\n",
    "# Show confusion matrices\n",
    "for r in results:\n",
    "    if r.get(\"n\", 0) == 0 or \"confusion_matrix\" not in r:\n",
    "        continue\n",
    "    show_confusion(r[\"confusion_matrix\"], title=f\"{r['name']} — {r['lang']} (n={r['n']})\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4b3cd29",
   "metadata": {},
   "source": [
    "### Error analysis (cross-lingual)\n",
    "\n",
    "We inspect false positives/negatives per language and compare FR failures between:\n",
    "- multilingual zero-shot\n",
    "- translation-trained FR\n",
    "\n",
    "This helps identify:\n",
    "- language-specific patterns (negation, colloquialisms)\n",
    "- translation artifacts\n",
    "- robustness differences across training setups\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "e02e03af",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Top errors for multilingual on EN\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>pred</th>\n",
       "      <th>p_pos</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>en_815</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000021</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>@USER I've had Cipro before. Luckily for me, the only side fx I tend to get from AB is gastic upset. But I RARELY use AB.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>en_25</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000047</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>almost vomited on a zinc lozenge #yuk</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>874</th>\n",
       "      <td>en_355</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000051</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>i swear, since i went on lamotrigine, i've become dyslexic..what the fuck is up with that?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>581</th>\n",
       "      <td>en_369</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000059</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>08.26 day 14 rivaroxaban diary. just been to cut some wild roses down so workmen can easily get to part of my garage. intense back pain.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>en_359</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000125</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>21y.o. w/ sickle-cell anemia and taking trazodone presents w/ priapism. what's the cause?</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>en_214</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000132</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>debating on taking a trazodone and literally passing out for the day.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>868</th>\n",
       "      <td>en_466</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000147</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>@USER i still get the pins &amp;amp; needles feeling in my hands since doing humira</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>774</th>\n",
       "      <td>en_799</td>\n",
       "      <td>en</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000226</td>\n",
       "      <td>tweet</td>\n",
       "      <td>previous_SMM4H</td>\n",
       "      <td>ciprofloxacin: how do you expect to sleep when your stomach is a cement mixer?</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id language  label  pred     p_pos   type          origin  \\\n",
       "251  en_815       en      1     0  0.000021  tweet  previous_SMM4H   \n",
       "208   en_25       en      1     0  0.000047  tweet  previous_SMM4H   \n",
       "874  en_355       en      1     0  0.000051  tweet  previous_SMM4H   \n",
       "581  en_369       en      1     0  0.000059  tweet  previous_SMM4H   \n",
       "142  en_359       en      1     0  0.000125  tweet  previous_SMM4H   \n",
       "202  en_214       en      1     0  0.000132  tweet  previous_SMM4H   \n",
       "868  en_466       en      1     0  0.000147  tweet  previous_SMM4H   \n",
       "774  en_799       en      1     0  0.000226  tweet  previous_SMM4H   \n",
       "\n",
       "                                                                                                                                         text  \n",
       "251                 @USER I've had Cipro before. Luckily for me, the only side fx I tend to get from AB is gastic upset. But I RARELY use AB.  \n",
       "208                                                                                                     almost vomited on a zinc lozenge #yuk  \n",
       "874                                                i swear, since i went on lamotrigine, i've become dyslexic..what the fuck is up with that?  \n",
       "581  08.26 day 14 rivaroxaban diary. just been to cut some wild roses down so workmen can easily get to part of my garage. intense back pain.  \n",
       "142                                                 21y.o. w/ sickle-cell anemia and taking trazodone presents w/ priapism. what's the cause?  \n",
       "202                                                                     debating on taking a trazodone and literally passing out for the day.  \n",
       "868                                                           @USER i still get the pins &amp; needles feeling in my hands since doing humira  \n",
       "774                                                            ciprofloxacin: how do you expect to sleep when your stomach is a cement mixer?  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Top errors for multilingual on DE\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>pred</th>\n",
       "      <th>p_pos</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>498</th>\n",
       "      <td>de_564</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000016</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_dev</td>\n",
       "      <td>War dir nicht schlecht von Reparil? Mir war dauernd übel davon, habe es deswegen auch nicht durchziehen können... Übrigens, bist du nicht der @USER der eine OP bei &lt;doc&gt; hatte? Ich glaube wir haben irgendwann vor Monaten hier diskutiert! Falls ja, wie ist es gelaufen? Liebe Grüsse @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>de_450</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000062</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_test</td>\n",
       "      <td>Hallo &lt;doc&gt;,ich mache keine systemischer Hormontherapie. Ich habe bisher Estriol nur lokal angewandt.es geht auch nicht um Beschwerden beim Verkehr,sondern um die Behandlung einer atrophischen Vaginitis mit den Symptomen Brennen und Schmerzen in der Scheide,so dass sogar das Gehen und Sitzen schon Schmerzen. Es fühlt sich raus und trocken an wie Schmirgelpapier. Leider haben alle bisherigen Maßnahmen die Symptome verschlechtert. LG @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>de_119</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000109</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_dev</td>\n",
       "      <td>Liebe @USER, ich würde an deiner Stelle nochmal mit meiner FA sprechen. Es gibt so viele Möglichkeiten der Hormontherapie, da ist das Pflaster nur eine von vielen. Meine FA fragte mich immer, ob ich zufrieden sei und man könne jederzeit auf ein anderes Präparat wechseln. Ich habe erst Cliogest genommen und dann wegen vermehrten Haarwuchs im Gesicht gewechselt auf Lafamme. Damit kam ich dann gut zurecht. liebe Grüße @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>de_197</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000153</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Hab das climavita forte grad mal gegooglt: ist ja Traubensilberkerze 13 mg. Meins (femikliman uno) enthält 6,5 mg. Bin seit der 4. Woche der Einnahme stimmungsstabiler u. etwas ruhiger. Unterstütze noch mit dem @USER plantina. Nebenwirkungen sind bei mir etwas Gewichtszunahme (~2kg). LG @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>de_124</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000159</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_test</td>\n",
       "      <td>Liebe @USER, Danke für deine Antwort und Verständnis... Erhöhe gerade mein AD schrittweise von 20 mg auf 30 mg citalopram... Auf telef. Anraten meines Facharztes... Bisher noch kein Erfolg. Ganz im Gegenteil bin heute morgen aufgewacht mit heftigen Ängsten. Habe fast eine Stunde gebraucht... Zur Zeit bringt mir Entspannungsübungen und Achtsamkeit auch nicht wirklich viel, aber früher ging es ganz gut. Daher versuche ich wieder dran zu bleiben... Dazu wieder nächtliches schwitzen und anschließend frieren machen mich gerade mürbe. Würde am liebsten für ein paar Tage in die Klinik gehen. Um runter zu kommen und mich mal sicher zu fühlen. Aber meine 2 Hunde wollen versorgt sein und meinen Mann mag ich gerade nicht alleine zu Hause lassen. Da wir sehr abgeschieden ohne Nahverkehr wohnen... Ich sage mir immer, es wird wieder.... Und dann fällt mein Blick auf eine Zeitung, da steht eine Schlagzeile.... Mit 65000 Menschen sterben jährlich am plötzlichen Herztod... Symptome Schwindel, Herzrasen, Brustschmerzen.... Da helfen mir keine positiven Gedanken und Vorsätze... Bin gerade echt am Boden... Wie überleben andere nur die Wechseljahre??? Liebe Grüße @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>514</th>\n",
       "      <td>de_616</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000793</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_dev</td>\n",
       "      <td>Hallo, ich wieder mal. Ich bin &lt;pi&gt;, &lt;pi&gt;, &lt;pi&gt; kg. Hatte 2008/ 2009 drei Ablationen (2mal Pulmonalvenen und einmal Isthmus wg. Flattern), Nach gut 5 Jahren ohne größere Rhythmusprobleme nun zw. Ende April 2015 und Ende Mai 2015 erneut zwei Ablationen (sollte atypisches Vorhofflattern sein), dazwischen Mitte Mai eine Kardioversion zwischen den Ablationen. Diese Kardioversion hielt nur Stunden, wurde 18.00 aus dem KH entlassen und 21.00 war der Rhythmus wieder weg. Zum Entlassungs-EKG nach der 2. Ablation begann ein Vorhofflimmern. Die Ärzte strömten nach den Ablationen geradezu Begeisterung aus, man hatte alles gemappt, die alten Ablationen nachkontrolliert, wäre alles noch in Ordnung und gegen das atypische Flattern eine Dachline gezogen, wobei man aber auch den linken Vorhof musste. Sicherheitshalber wurde ich auf Amiodaron eingestellt, nehme täglich eine (200mg). Bisoprolol sollte ich absetzen, da zeitweise (NAchts) Bradykard. Soweit so gut. Seit den Ablationen habe ich teilweise heftige Extrasystolen (meist VES) unter Bewegung zunehmend. Leider auch anfänglich mal kurze Phasen (so bis 3min) in denen der Puls wieder sprang. Nun aber, ca. 4,5 Wochen nach Ablation hatte ich vorgestern für ca. 3,5 Std. (ich hatte 2 Std. vorher 20min Rasen gemäht und war 5min im See baden) wieder Ruhepuls zwischen 130 und 150. Heute war ich einkaufen, habe 2 Getränkekisten ins Auto geladen und hatte anschliessend ca. 40 min einen ständig springenden Puls zwischen 85 und 165. Nun 'nur' noch etliche VES. Ich habe seit ich wieder zu Hause bin (27.05.) keinen Kaffee, keinen Alkohol, keinen grünen Tee getrunken, lebe möglichst ruhig und stressfrei. nehme 300mg Magnesium pro Tag. Leide nur nervlich sehr stark durch die vielen Erlebnisse und Rückschläge binnen der kurzen Zeit und die ständigen VES. Es kann/ darf doch nicht sein, dass ich mit &lt;pi&gt; nicht mehr 20 min Rasen mähen oder 2 Getränkisten ins Auto heben darf? Bin ansonsten laut Kardiologen herzgesund. Frage 1: Hat jemand einen Tip was ich tun kann, geht es jemandem ähnlich mit hartnäckigen Rhythumsstörungen? Frage 2. Können meine aktuellen Störungen (Flimmern, Flattern, ES) noch Nachwirkungen der Ablationen sein? Danke und Gruß @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>de_110</td>\n",
       "      <td>de</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.001603</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_de_train</td>\n",
       "      <td>Hallo liebe @USER, was deine Ärztin vorgeschlagen hat hört sich sehr vernünftig an! Ich habe auch für fast ein Jahr Chlormadinon genommen. Leider dürfte ich kein Östrogen nehmen weil ich schon Thrombosen hatte. Ich habe es damals wegen überstarker Blutungen bekommen. Hat bei mir den Zyklus stabilisiert und mir ging es bis auf eine geringfügige BlutdruckErhöhung gut damit. Bei Hormonen sollte man halt Nutzen und Risiken abwägen. Heute ist wohl erwiesen das eine Gabe bis zu fünf Jahren bei starken Beschwerden nutzt. Und in dieser Zeit auch die NW überschaubar sind. Gerade auch was Krebs betrifft. Und die Ärzte tun mit gründlicher Anamnese ein Übriges. Also keine Angst! Trau dich und schau ob es besser wird. Zur Lafemme: Frage ruhig danach! Aber ich denke die Ärztin hat für dich wirklich das verträglichste und nebenwirkungsämste rausgesucht. Deine Müdigkeit ist sicher den starken Blutungen geschuldet. Auf jeden Fall das Ferritin kontrollieren und auffüllen. Als mein Eisenmangel weg war habe ich erst gemerkt wie erschöpft ich war! LG und viel Erfolg @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>437</th>\n",
       "      <td>de_546</td>\n",
       "      <td>de</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.996577</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Wow dann hast Du ja einen starken Körper. Ich habe nie die volle Dosis genommen, ich war schon von einer total müde und zwei hauen mich weg.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id language  label  pred     p_pos        type             origin  \\\n",
       "498  de_564       de      1     0  0.000016  forum post    SMM4H_24_de_dev   \n",
       "89   de_450       de      1     0  0.000062  forum post   SMM4H_24_de_test   \n",
       "260  de_119       de      1     0  0.000109  forum post    SMM4H_24_de_dev   \n",
       "126  de_197       de      1     0  0.000153  forum post  SMM4H_24_de_train   \n",
       "428  de_124       de      1     0  0.000159  forum post   SMM4H_24_de_test   \n",
       "514  de_616       de      1     0  0.000793  forum post    SMM4H_24_de_dev   \n",
       "144  de_110       de      1     0  0.001603  forum post  SMM4H_24_de_train   \n",
       "437  de_546       de      0     1  0.996577  forum post           LREC2022   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             text  \n",
       "498                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               War dir nicht schlecht von Reparil? Mir war dauernd übel davon, habe es deswegen auch nicht durchziehen können... Übrigens, bist du nicht der @USER der eine OP bei <doc> hatte? Ich glaube wir haben irgendwann vor Monaten hier diskutiert! Falls ja, wie ist es gelaufen? Liebe Grüsse @USER  \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Hallo <doc>,ich mache keine systemischer Hormontherapie. Ich habe bisher Estriol nur lokal angewandt.es geht auch nicht um Beschwerden beim Verkehr,sondern um die Behandlung einer atrophischen Vaginitis mit den Symptomen Brennen und Schmerzen in der Scheide,so dass sogar das Gehen und Sitzen schon Schmerzen. Es fühlt sich raus und trocken an wie Schmirgelpapier. Leider haben alle bisherigen Maßnahmen die Symptome verschlechtert. LG @USER  \n",
       "260                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Liebe @USER, ich würde an deiner Stelle nochmal mit meiner FA sprechen. Es gibt so viele Möglichkeiten der Hormontherapie, da ist das Pflaster nur eine von vielen. Meine FA fragte mich immer, ob ich zufrieden sei und man könne jederzeit auf ein anderes Präparat wechseln. Ich habe erst Cliogest genommen und dann wegen vermehrten Haarwuchs im Gesicht gewechselt auf Lafamme. Damit kam ich dann gut zurecht. liebe Grüße @USER  \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Hab das climavita forte grad mal gegooglt: ist ja Traubensilberkerze 13 mg. Meins (femikliman uno) enthält 6,5 mg. Bin seit der 4. Woche der Einnahme stimmungsstabiler u. etwas ruhiger. Unterstütze noch mit dem @USER plantina. Nebenwirkungen sind bei mir etwas Gewichtszunahme (~2kg). LG @USER  \n",
       "428                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Liebe @USER, Danke für deine Antwort und Verständnis... Erhöhe gerade mein AD schrittweise von 20 mg auf 30 mg citalopram... Auf telef. Anraten meines Facharztes... Bisher noch kein Erfolg. Ganz im Gegenteil bin heute morgen aufgewacht mit heftigen Ängsten. Habe fast eine Stunde gebraucht... Zur Zeit bringt mir Entspannungsübungen und Achtsamkeit auch nicht wirklich viel, aber früher ging es ganz gut. Daher versuche ich wieder dran zu bleiben... Dazu wieder nächtliches schwitzen und anschließend frieren machen mich gerade mürbe. Würde am liebsten für ein paar Tage in die Klinik gehen. Um runter zu kommen und mich mal sicher zu fühlen. Aber meine 2 Hunde wollen versorgt sein und meinen Mann mag ich gerade nicht alleine zu Hause lassen. Da wir sehr abgeschieden ohne Nahverkehr wohnen... Ich sage mir immer, es wird wieder.... Und dann fällt mein Blick auf eine Zeitung, da steht eine Schlagzeile.... Mit 65000 Menschen sterben jährlich am plötzlichen Herztod... Symptome Schwindel, Herzrasen, Brustschmerzen.... Da helfen mir keine positiven Gedanken und Vorsätze... Bin gerade echt am Boden... Wie überleben andere nur die Wechseljahre??? Liebe Grüße @USER  \n",
       "514  Hallo, ich wieder mal. Ich bin <pi>, <pi>, <pi> kg. Hatte 2008/ 2009 drei Ablationen (2mal Pulmonalvenen und einmal Isthmus wg. Flattern), Nach gut 5 Jahren ohne größere Rhythmusprobleme nun zw. Ende April 2015 und Ende Mai 2015 erneut zwei Ablationen (sollte atypisches Vorhofflattern sein), dazwischen Mitte Mai eine Kardioversion zwischen den Ablationen. Diese Kardioversion hielt nur Stunden, wurde 18.00 aus dem KH entlassen und 21.00 war der Rhythmus wieder weg. Zum Entlassungs-EKG nach der 2. Ablation begann ein Vorhofflimmern. Die Ärzte strömten nach den Ablationen geradezu Begeisterung aus, man hatte alles gemappt, die alten Ablationen nachkontrolliert, wäre alles noch in Ordnung und gegen das atypische Flattern eine Dachline gezogen, wobei man aber auch den linken Vorhof musste. Sicherheitshalber wurde ich auf Amiodaron eingestellt, nehme täglich eine (200mg). Bisoprolol sollte ich absetzen, da zeitweise (NAchts) Bradykard. Soweit so gut. Seit den Ablationen habe ich teilweise heftige Extrasystolen (meist VES) unter Bewegung zunehmend. Leider auch anfänglich mal kurze Phasen (so bis 3min) in denen der Puls wieder sprang. Nun aber, ca. 4,5 Wochen nach Ablation hatte ich vorgestern für ca. 3,5 Std. (ich hatte 2 Std. vorher 20min Rasen gemäht und war 5min im See baden) wieder Ruhepuls zwischen 130 und 150. Heute war ich einkaufen, habe 2 Getränkekisten ins Auto geladen und hatte anschliessend ca. 40 min einen ständig springenden Puls zwischen 85 und 165. Nun 'nur' noch etliche VES. Ich habe seit ich wieder zu Hause bin (27.05.) keinen Kaffee, keinen Alkohol, keinen grünen Tee getrunken, lebe möglichst ruhig und stressfrei. nehme 300mg Magnesium pro Tag. Leide nur nervlich sehr stark durch die vielen Erlebnisse und Rückschläge binnen der kurzen Zeit und die ständigen VES. Es kann/ darf doch nicht sein, dass ich mit <pi> nicht mehr 20 min Rasen mähen oder 2 Getränkisten ins Auto heben darf? Bin ansonsten laut Kardiologen herzgesund. Frage 1: Hat jemand einen Tip was ich tun kann, geht es jemandem ähnlich mit hartnäckigen Rhythumsstörungen? Frage 2. Können meine aktuellen Störungen (Flimmern, Flattern, ES) noch Nachwirkungen der Ablationen sein? Danke und Gruß @USER  \n",
       "144                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Hallo liebe @USER, was deine Ärztin vorgeschlagen hat hört sich sehr vernünftig an! Ich habe auch für fast ein Jahr Chlormadinon genommen. Leider dürfte ich kein Östrogen nehmen weil ich schon Thrombosen hatte. Ich habe es damals wegen überstarker Blutungen bekommen. Hat bei mir den Zyklus stabilisiert und mir ging es bis auf eine geringfügige BlutdruckErhöhung gut damit. Bei Hormonen sollte man halt Nutzen und Risiken abwägen. Heute ist wohl erwiesen das eine Gabe bis zu fünf Jahren bei starken Beschwerden nutzt. Und in dieser Zeit auch die NW überschaubar sind. Gerade auch was Krebs betrifft. Und die Ärzte tun mit gründlicher Anamnese ein Übriges. Also keine Angst! Trau dich und schau ob es besser wird. Zur Lafemme: Frage ruhig danach! Aber ich denke die Ärztin hat für dich wirklich das verträglichste und nebenwirkungsämste rausgesucht. Deine Müdigkeit ist sicher den starken Blutungen geschuldet. Auf jeden Fall das Ferritin kontrollieren und auffüllen. Als mein Eisenmangel weg war habe ich erst gemerkt wie erschöpft ich war! LG und viel Erfolg @USER  \n",
       "437                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Wow dann hast Du ja einen starken Körper. Ich habe nie die volle Dosis genommen, ich war schon von einer total müde und zwei hauen mich weg.  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Top errors for multilingual on FR\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>pred</th>\n",
       "      <th>p_pos</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>fr_225</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000068</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai aussi pris les comprimés d'Insidon pour mes crises de panique. Je me sentais mieux, c'est-à-dire que les crises de panique s'étaient calmées, mais j'étais toujours un peu à côté de la plaque. L'étourdissement pourrait bien être dû à Insidon, peut-être essaies-tu de prendre 1/2 comprimé ? Salutations... @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>fr_318</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000073</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, je me suis fait poser le Mirena à l'âge de &lt;pi&gt; ans environ (également un stérilet hormonal qui devait rester en place pendant environ 5 ans). Au bout d'à peine 3 ans, j'ai dû le faire retirer et j'ai également subi un curetage complet. J'ai commencé à avoir des saignements comme tu l'as décrit. Je n'avais pas de problèmes psychologiques à l'époque, ils n'ont commencé qu'avec la ménopause. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>fr_415</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000264</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>fr_282</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000376</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Hey, je prends de l'amiodarone 200 mg depuis &lt;date&gt;. J'approuve tous les messages. Même avec un indice de protection de crème solaire 50, une casquette de baseball, en évitant le plus possible le soleil, je ressemble la plupart du temps à une écrevisse. Parfois, ça pique la peau comme avec de fines aiguilles. Parfois, j'ai l'impression de prendre trop de soleil, même derrière une vitre, en conduisant par exemple. Aujourd'hui, c'est le 30ème jour depuis que j'ai arrêté l'amiodarone, nous verrons quand il y aura une amélioration de la peau. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>fr_411</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000398</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>CHER @USER, j'ai dû prendre le Monuril deux fois de suite car les symptômes sont réapparus au bout de 14 jours. Après la deuxième fois, l'irritation a commencé à apparaître, un peu même après la première fois, et le troisième AB a eu raison de moi. Sur Monuril, l'effet secondaire le plus fréquent est la vulvovaginite. Super classe. Dieu merci, ma vessie est à nouveau calme, mais je vais essayer tout le reste si quelque chose se produit à nouveau. J'ai fait la même chose en automne avec Cystinol et D Mannose, mais au bout de 5 jours, j'ai pris l'AB parce que nous avions un long trajet en voiture et la deuxième fois, le nombre de germes était encore très élevé malgré Cystinol et mon médecin a prescrit l'AB. Je te souhaite également un bon rétablissement et pense toujours à l'estriol. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>fr_72</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000568</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>L'une d'entre vous a-t-elle une expérience de ces effets secondaires ? Je prends du tamoxifène depuis une semaine et demie et j'ai maintenant l'impression de rouiller de plus en plus. J'avale quotidiennement du calcium 1000 et je fais de la marche/walking pendant environ une heure par jour. Quelqu'un aurait-il un bon conseil à me donner sur ce que je pourrais faire en plus, à part des cachets contre la douleur ? Salutations @USER.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>fr_132</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.998179</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut les filles, ça n'a pas l'air bon, le changement des muqueuses. J'avais déjà entendu dire qu'elles devenaient plus sèches à la ménopause. Mais que cela ait une telle influence et prenne de telles proportions, c'est encore une fois génial. Quoi d'autre ? On a peut-être encore quelque chose à proposer ? Depuis hier - après que ma tension artérielle soit pour une fois normale - j'ai des problèmes d'estomac avec des brûlures d'estomac, et ce plus longtemps après les repas. Hier soir, j'ai eu de fortes douleurs abdominales et des nausées. Ce n'est que le matin que le calme est revenu. Je connais depuis longtemps le problème des raclements de gorge. J'ai toujours pensé que cela venait de la thyroïde. Ce que je remarque, et que je trouve aussi très désagréable, c'est que j'ai maintenant la bouche sèche depuis longtemps. Non seulement je dois boire la nuit depuis quelques mois, mais maintenant j'ai aussi la bouche sèche pendant la journée. Est-ce que l'un d'entre vous le sait ? Je trouve cela absolument agaçant. Je ne veux pas et ne peux pas boire toute la journée - et je n'aime pas non plus sucer des bonbons, ce n'est pas bon non plus pour les dents et l'estomac :-(( @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>fr_116</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.997812</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut tout le monde Une fois de plus, je suis allée trop loin quand j'ai écrit hier @USER au sujet des nausées que c'était pire pour moi il y a quelques années. Ce matin, je me suis sentie nauséeuse d'une minute à l'autre, j'ai eu des vertiges et de légers maux de ventre ainsi que de la diarrhée. Je ne pense pas que ce soit une indigestion. Peut-être que j'aurai à nouveau mes règles après 5 mois ? Les symptômes pourraient aussi correspondre, j'avais souvent la diarrhée quand les règles arrivaient. En revanche, mes douleurs au cou se sont un peu améliorées. En ce moment, j'ai juste un léger tiraillement à l'arrière de la tête à gauche. Mais c'est vraiment à mourir de rire. Quand est-ce que nous, les victimes des JM, allons enfin nous sentir bien. Et quand pourrons-nous définitivement arrêter le manège des pensées ? Salutations de la frustrée @USER</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id language  label  pred     p_pos        type            origin  \\\n",
       "401  fr_225       fr      1     0  0.000068  forum post  SMM4H_24_fr_test   \n",
       "325  fr_318       fr      1     0  0.000073  forum post  SMM4H_24_fr_test   \n",
       "266  fr_415       fr      1     0  0.000264  forum post  SMM4H_24_fr_test   \n",
       "378  fr_282       fr      1     0  0.000376  forum post  SMM4H_24_fr_test   \n",
       "334  fr_411       fr      1     0  0.000398  forum post  SMM4H_24_fr_test   \n",
       "393   fr_72       fr      1     0  0.000568  forum post  SMM4H_24_fr_test   \n",
       "315  fr_132       fr      0     1  0.998179  forum post          LREC2022   \n",
       "179  fr_116       fr      0     1  0.997812  forum post          LREC2022   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      text  \n",
       "401                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Salut @USER, j'ai aussi pris les comprimés d'Insidon pour mes crises de panique. Je me sentais mieux, c'est-à-dire que les crises de panique s'étaient calmées, mais j'étais toujours un peu à côté de la plaque. L'étourdissement pourrait bien être dû à Insidon, peut-être essaies-tu de prendre 1/2 comprimé ? Salutations... @USER  \n",
       "325                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Salut @USER, je me suis fait poser le Mirena à l'âge de <pi> ans environ (également un stérilet hormonal qui devait rester en place pendant environ 5 ans). Au bout d'à peine 3 ans, j'ai dû le faire retirer et j'ai également subi un curetage complet. J'ai commencé à avoir des saignements comme tu l'as décrit. Je n'avais pas de problèmes psychologiques à l'époque, ils n'ont commencé qu'avec la ménopause. Bises @USER  \n",
       "266                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER  \n",
       "378                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Hey, je prends de l'amiodarone 200 mg depuis <date>. J'approuve tous les messages. Même avec un indice de protection de crème solaire 50, une casquette de baseball, en évitant le plus possible le soleil, je ressemble la plupart du temps à une écrevisse. Parfois, ça pique la peau comme avec de fines aiguilles. Parfois, j'ai l'impression de prendre trop de soleil, même derrière une vitre, en conduisant par exemple. Aujourd'hui, c'est le 30ème jour depuis que j'ai arrêté l'amiodarone, nous verrons quand il y aura une amélioration de la peau. Bises @USER  \n",
       "334                                                                                                                                                                                                                                                                                                                                                                                                   CHER @USER, j'ai dû prendre le Monuril deux fois de suite car les symptômes sont réapparus au bout de 14 jours. Après la deuxième fois, l'irritation a commencé à apparaître, un peu même après la première fois, et le troisième AB a eu raison de moi. Sur Monuril, l'effet secondaire le plus fréquent est la vulvovaginite. Super classe. Dieu merci, ma vessie est à nouveau calme, mais je vais essayer tout le reste si quelque chose se produit à nouveau. J'ai fait la même chose en automne avec Cystinol et D Mannose, mais au bout de 5 jours, j'ai pris l'AB parce que nous avions un long trajet en voiture et la deuxième fois, le nombre de germes était encore très élevé malgré Cystinol et mon médecin a prescrit l'AB. Je te souhaite également un bon rétablissement et pense toujours à l'estriol. Bises @USER  \n",
       "393                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     L'une d'entre vous a-t-elle une expérience de ces effets secondaires ? Je prends du tamoxifène depuis une semaine et demie et j'ai maintenant l'impression de rouiller de plus en plus. J'avale quotidiennement du calcium 1000 et je fais de la marche/walking pendant environ une heure par jour. Quelqu'un aurait-il un bon conseil à me donner sur ce que je pourrais faire en plus, à part des cachets contre la douleur ? Salutations @USER.  \n",
       "315  Salut les filles, ça n'a pas l'air bon, le changement des muqueuses. J'avais déjà entendu dire qu'elles devenaient plus sèches à la ménopause. Mais que cela ait une telle influence et prenne de telles proportions, c'est encore une fois génial. Quoi d'autre ? On a peut-être encore quelque chose à proposer ? Depuis hier - après que ma tension artérielle soit pour une fois normale - j'ai des problèmes d'estomac avec des brûlures d'estomac, et ce plus longtemps après les repas. Hier soir, j'ai eu de fortes douleurs abdominales et des nausées. Ce n'est que le matin que le calme est revenu. Je connais depuis longtemps le problème des raclements de gorge. J'ai toujours pensé que cela venait de la thyroïde. Ce que je remarque, et que je trouve aussi très désagréable, c'est que j'ai maintenant la bouche sèche depuis longtemps. Non seulement je dois boire la nuit depuis quelques mois, mais maintenant j'ai aussi la bouche sèche pendant la journée. Est-ce que l'un d'entre vous le sait ? Je trouve cela absolument agaçant. Je ne veux pas et ne peux pas boire toute la journée - et je n'aime pas non plus sucer des bonbons, ce n'est pas bon non plus pour les dents et l'estomac :-(( @USER  \n",
       "179                                                                                                                                                                                                                                                                                                                                             Salut tout le monde Une fois de plus, je suis allée trop loin quand j'ai écrit hier @USER au sujet des nausées que c'était pire pour moi il y a quelques années. Ce matin, je me suis sentie nauséeuse d'une minute à l'autre, j'ai eu des vertiges et de légers maux de ventre ainsi que de la diarrhée. Je ne pense pas que ce soit une indigestion. Peut-être que j'aurai à nouveau mes règles après 5 mois ? Les symptômes pourraient aussi correspondre, j'avais souvent la diarrhée quand les règles arrivaient. En revanche, mes douleurs au cou se sont un peu améliorées. En ce moment, j'ai juste un léger tiraillement à l'arrière de la tête à gauche. Mais c'est vraiment à mourir de rire. Quand est-ce que nous, les victimes des JM, allons enfin nous sentir bien. Et quand pourrons-nous définitivement arrêter le manège des pensées ? Salutations de la frustrée @USER  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "FR errors — multilingual zero-shot\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>pred</th>\n",
       "      <th>p_pos</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>fr_225</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000068</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai aussi pris les comprimés d'Insidon pour mes crises de panique. Je me sentais mieux, c'est-à-dire que les crises de panique s'étaient calmées, mais j'étais toujours un peu à côté de la plaque. L'étourdissement pourrait bien être dû à Insidon, peut-être essaies-tu de prendre 1/2 comprimé ? Salutations... @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>fr_318</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000073</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, je me suis fait poser le Mirena à l'âge de &lt;pi&gt; ans environ (également un stérilet hormonal qui devait rester en place pendant environ 5 ans). Au bout d'à peine 3 ans, j'ai dû le faire retirer et j'ai également subi un curetage complet. J'ai commencé à avoir des saignements comme tu l'as décrit. Je n'avais pas de problèmes psychologiques à l'époque, ils n'ont commencé qu'avec la ménopause. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>fr_415</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000264</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>fr_282</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000376</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Hey, je prends de l'amiodarone 200 mg depuis &lt;date&gt;. J'approuve tous les messages. Même avec un indice de protection de crème solaire 50, une casquette de baseball, en évitant le plus possible le soleil, je ressemble la plupart du temps à une écrevisse. Parfois, ça pique la peau comme avec de fines aiguilles. Parfois, j'ai l'impression de prendre trop de soleil, même derrière une vitre, en conduisant par exemple. Aujourd'hui, c'est le 30ème jour depuis que j'ai arrêté l'amiodarone, nous verrons quand il y aura une amélioration de la peau. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>fr_411</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000398</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>CHER @USER, j'ai dû prendre le Monuril deux fois de suite car les symptômes sont réapparus au bout de 14 jours. Après la deuxième fois, l'irritation a commencé à apparaître, un peu même après la première fois, et le troisième AB a eu raison de moi. Sur Monuril, l'effet secondaire le plus fréquent est la vulvovaginite. Super classe. Dieu merci, ma vessie est à nouveau calme, mais je vais essayer tout le reste si quelque chose se produit à nouveau. J'ai fait la même chose en automne avec Cystinol et D Mannose, mais au bout de 5 jours, j'ai pris l'AB parce que nous avions un long trajet en voiture et la deuxième fois, le nombre de germes était encore très élevé malgré Cystinol et mon médecin a prescrit l'AB. Je te souhaite également un bon rétablissement et pense toujours à l'estriol. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>fr_72</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000568</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>L'une d'entre vous a-t-elle une expérience de ces effets secondaires ? Je prends du tamoxifène depuis une semaine et demie et j'ai maintenant l'impression de rouiller de plus en plus. J'avale quotidiennement du calcium 1000 et je fais de la marche/walking pendant environ une heure par jour. Quelqu'un aurait-il un bon conseil à me donner sur ce que je pourrais faire en plus, à part des cachets contre la douleur ? Salutations @USER.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>fr_132</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.998179</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut les filles, ça n'a pas l'air bon, le changement des muqueuses. J'avais déjà entendu dire qu'elles devenaient plus sèches à la ménopause. Mais que cela ait une telle influence et prenne de telles proportions, c'est encore une fois génial. Quoi d'autre ? On a peut-être encore quelque chose à proposer ? Depuis hier - après que ma tension artérielle soit pour une fois normale - j'ai des problèmes d'estomac avec des brûlures d'estomac, et ce plus longtemps après les repas. Hier soir, j'ai eu de fortes douleurs abdominales et des nausées. Ce n'est que le matin que le calme est revenu. Je connais depuis longtemps le problème des raclements de gorge. J'ai toujours pensé que cela venait de la thyroïde. Ce que je remarque, et que je trouve aussi très désagréable, c'est que j'ai maintenant la bouche sèche depuis longtemps. Non seulement je dois boire la nuit depuis quelques mois, mais maintenant j'ai aussi la bouche sèche pendant la journée. Est-ce que l'un d'entre vous le sait ? Je trouve cela absolument agaçant. Je ne veux pas et ne peux pas boire toute la journée - et je n'aime pas non plus sucer des bonbons, ce n'est pas bon non plus pour les dents et l'estomac :-(( @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>fr_116</td>\n",
       "      <td>fr</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.997812</td>\n",
       "      <td>forum post</td>\n",
       "      <td>LREC2022</td>\n",
       "      <td>Salut tout le monde Une fois de plus, je suis allée trop loin quand j'ai écrit hier @USER au sujet des nausées que c'était pire pour moi il y a quelques années. Ce matin, je me suis sentie nauséeuse d'une minute à l'autre, j'ai eu des vertiges et de légers maux de ventre ainsi que de la diarrhée. Je ne pense pas que ce soit une indigestion. Peut-être que j'aurai à nouveau mes règles après 5 mois ? Les symptômes pourraient aussi correspondre, j'avais souvent la diarrhée quand les règles arrivaient. En revanche, mes douleurs au cou se sont un peu améliorées. En ce moment, j'ai juste un léger tiraillement à l'arrière de la tête à gauche. Mais c'est vraiment à mourir de rire. Quand est-ce que nous, les victimes des JM, allons enfin nous sentir bien. Et quand pourrons-nous définitivement arrêter le manège des pensées ? Salutations de la frustrée @USER</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id language  label  pred     p_pos        type            origin  \\\n",
       "401  fr_225       fr      1     0  0.000068  forum post  SMM4H_24_fr_test   \n",
       "325  fr_318       fr      1     0  0.000073  forum post  SMM4H_24_fr_test   \n",
       "266  fr_415       fr      1     0  0.000264  forum post  SMM4H_24_fr_test   \n",
       "378  fr_282       fr      1     0  0.000376  forum post  SMM4H_24_fr_test   \n",
       "334  fr_411       fr      1     0  0.000398  forum post  SMM4H_24_fr_test   \n",
       "393   fr_72       fr      1     0  0.000568  forum post  SMM4H_24_fr_test   \n",
       "315  fr_132       fr      0     1  0.998179  forum post          LREC2022   \n",
       "179  fr_116       fr      0     1  0.997812  forum post          LREC2022   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      text  \n",
       "401                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Salut @USER, j'ai aussi pris les comprimés d'Insidon pour mes crises de panique. Je me sentais mieux, c'est-à-dire que les crises de panique s'étaient calmées, mais j'étais toujours un peu à côté de la plaque. L'étourdissement pourrait bien être dû à Insidon, peut-être essaies-tu de prendre 1/2 comprimé ? Salutations... @USER  \n",
       "325                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Salut @USER, je me suis fait poser le Mirena à l'âge de <pi> ans environ (également un stérilet hormonal qui devait rester en place pendant environ 5 ans). Au bout d'à peine 3 ans, j'ai dû le faire retirer et j'ai également subi un curetage complet. J'ai commencé à avoir des saignements comme tu l'as décrit. Je n'avais pas de problèmes psychologiques à l'époque, ils n'ont commencé qu'avec la ménopause. Bises @USER  \n",
       "266                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER  \n",
       "378                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Hey, je prends de l'amiodarone 200 mg depuis <date>. J'approuve tous les messages. Même avec un indice de protection de crème solaire 50, une casquette de baseball, en évitant le plus possible le soleil, je ressemble la plupart du temps à une écrevisse. Parfois, ça pique la peau comme avec de fines aiguilles. Parfois, j'ai l'impression de prendre trop de soleil, même derrière une vitre, en conduisant par exemple. Aujourd'hui, c'est le 30ème jour depuis que j'ai arrêté l'amiodarone, nous verrons quand il y aura une amélioration de la peau. Bises @USER  \n",
       "334                                                                                                                                                                                                                                                                                                                                                                                                   CHER @USER, j'ai dû prendre le Monuril deux fois de suite car les symptômes sont réapparus au bout de 14 jours. Après la deuxième fois, l'irritation a commencé à apparaître, un peu même après la première fois, et le troisième AB a eu raison de moi. Sur Monuril, l'effet secondaire le plus fréquent est la vulvovaginite. Super classe. Dieu merci, ma vessie est à nouveau calme, mais je vais essayer tout le reste si quelque chose se produit à nouveau. J'ai fait la même chose en automne avec Cystinol et D Mannose, mais au bout de 5 jours, j'ai pris l'AB parce que nous avions un long trajet en voiture et la deuxième fois, le nombre de germes était encore très élevé malgré Cystinol et mon médecin a prescrit l'AB. Je te souhaite également un bon rétablissement et pense toujours à l'estriol. Bises @USER  \n",
       "393                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     L'une d'entre vous a-t-elle une expérience de ces effets secondaires ? Je prends du tamoxifène depuis une semaine et demie et j'ai maintenant l'impression de rouiller de plus en plus. J'avale quotidiennement du calcium 1000 et je fais de la marche/walking pendant environ une heure par jour. Quelqu'un aurait-il un bon conseil à me donner sur ce que je pourrais faire en plus, à part des cachets contre la douleur ? Salutations @USER.  \n",
       "315  Salut les filles, ça n'a pas l'air bon, le changement des muqueuses. J'avais déjà entendu dire qu'elles devenaient plus sèches à la ménopause. Mais que cela ait une telle influence et prenne de telles proportions, c'est encore une fois génial. Quoi d'autre ? On a peut-être encore quelque chose à proposer ? Depuis hier - après que ma tension artérielle soit pour une fois normale - j'ai des problèmes d'estomac avec des brûlures d'estomac, et ce plus longtemps après les repas. Hier soir, j'ai eu de fortes douleurs abdominales et des nausées. Ce n'est que le matin que le calme est revenu. Je connais depuis longtemps le problème des raclements de gorge. J'ai toujours pensé que cela venait de la thyroïde. Ce que je remarque, et que je trouve aussi très désagréable, c'est que j'ai maintenant la bouche sèche depuis longtemps. Non seulement je dois boire la nuit depuis quelques mois, mais maintenant j'ai aussi la bouche sèche pendant la journée. Est-ce que l'un d'entre vous le sait ? Je trouve cela absolument agaçant. Je ne veux pas et ne peux pas boire toute la journée - et je n'aime pas non plus sucer des bonbons, ce n'est pas bon non plus pour les dents et l'estomac :-(( @USER  \n",
       "179                                                                                                                                                                                                                                                                                                                                             Salut tout le monde Une fois de plus, je suis allée trop loin quand j'ai écrit hier @USER au sujet des nausées que c'était pire pour moi il y a quelques années. Ce matin, je me suis sentie nauséeuse d'une minute à l'autre, j'ai eu des vertiges et de légers maux de ventre ainsi que de la diarrhée. Je ne pense pas que ce soit une indigestion. Peut-être que j'aurai à nouveau mes règles après 5 mois ? Les symptômes pourraient aussi correspondre, j'avais souvent la diarrhée quand les règles arrivaient. En revanche, mes douleurs au cou se sont un peu améliorées. En ce moment, j'ai juste un léger tiraillement à l'arrière de la tête à gauche. Mais c'est vraiment à mourir de rire. Quand est-ce que nous, les victimes des JM, allons enfin nous sentir bien. Et quand pourrons-nous définitivement arrêter le manège des pensées ? Salutations de la frustrée @USER  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "FR errors — translation-trained\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>language</th>\n",
       "      <th>label</th>\n",
       "      <th>pred</th>\n",
       "      <th>p_pos</th>\n",
       "      <th>type</th>\n",
       "      <th>origin</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>fr_98</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.066074</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Bonjour @USER, C'est bien que tu nous contactes. Je dois malheureusement dire que je dois à nouveau arrêter le Laif. Je me sentais bien jusqu'à jeudi et je m'étais déjà étonnée de son effet si rapide, j'avais vraiment senti une amélioration ou je l'avais juste imaginée. Quoi qu'il en soit, je ne me sentais déjà pas bien vendredi et hier, c'était fini, je n'ai fait que pleurer toute la journée et je n'ai pas dormi la nuit d'aujourd'hui et j'ai eu de fortes angoisses. Je ne sais pas si c'est à cause du Laif, personne ne peut dire si on peut ressentir une première aggravation, mon médecin traitant n'avait rien dit. En tout cas, j'ai arrêté de le prendre par peur, c'était encore plus insupportable qu'avant. J'ai eu ma belle-sœur au téléphone aujourd'hui et elle est une ancienne infirmière et elle me conseille de suivre une thérapie, je devrais contacter ma caisse d'assurance maladie pour voir s'il y a une possibilité d'obtenir un rendez-vous le plus rapidement possible, ce que je vais faire maintenant. On y apprend à gérer sa peur. On ne peut pas toujours être malade. Je vais essayer mardi et si ce n'est pas le cas, je retournerai chez le médecin. Mais j'ai essayé. C'est super si tu peux quand même prendre l'avion pour aller voir ta fille, je suis contente pour toi. Mais c'est dommage pour la clinique, je ne sais pas si tu as attendu longtemps. J'y ai déjà pensé. Je n'ai pas envie de quitter la maison pour le moment, mais une clinique de jour où l'on peut rentrer le soir me conviendrait aussi. Je te souhaite un bon dimanche. Des bises. @USER.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>fr_415</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.067096</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>fr_354</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.067343</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut tout le monde J'espère que vous avez tous bien commencé 2021 et je vous souhaite à tous le meilleur pour la nouvelle année. J'ai une question qui n'a rien à voir avec la ménopause, mais peut-être que vous pourrez quand même m'aider. Ma fille (&lt;pi&gt;) a été placée sous Kyleena il y a exactement un an. Cela s'est plutôt bien passé. Mais ces deux ou trois derniers mois, les règles ont beaucoup changé. Cycle long, long spotting, après 2 semaines à nouveau des saignements..... Depuis dimanche dernier, elle a un problème psychologique. Elle se sent mal à l'aise, elle a l'impression de ne pas avoir assez de souffle. Elle préfère rester au lit et ne rien faire. Début décembre, elle a déjà eu des nausées pendant trois jours, mais elle n'avait pas vraiment de problèmes gastriques. Quelqu'un parmi vous connaît-il les effets secondaires du stérilet ? Est-il possible qu'ils ne commencent qu'après un an ? Tous vos conseils sont les bienvenus. Je ne sais pas vraiment comment me comporter. Est-ce que ça va passer ? Je suis contente, je vais plutôt bien en ce moment. Salutations @USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>fr_237</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.067834</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER.... moi non plus, je n'ai pas été une amie des médicaments pendant toute ma vie... j'ai toujours tout traité avec des remèdes homéopathiques et naturels. Jusqu'à l'année dernière, je résistais à tout ! Mais quand rien n'allait plus, j'ai accepté d'en prendre. J'ai aussi pris du poids pour la première fois de ma vie au cours des six derniers mois. Moi aussi, je suis désespérée par mon ventre et, enfin ... par mes grosses fesses ... c'est horrible ! Je rentre encore dans mes vêtements... mais combien de temps encore ? Mais chez moi, c'est clairement trop d'eau... j'ai déjà écrit à ce sujet... cela peut aussi venir de la thyroïde... et de la dominance en œstrogène ! Depuis six mois, je prends 50 mg de fluoxétine....La fluoxétine est connue pour faire perdre du poids....J'ai perdu immédiatement 3 kg au début. Maintenant, je prends aussi de la trazodone le soir.... cela ne fait pas prendre pas de poids ! J'aimerais bien tout jeter... mais je ne peux pas non plus m'en passer. Salutations....@USER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>fr_269</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.068915</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER, je n'ai pris de l'Opripramol que deux soirs pour dormir, une demi-dose à chaque fois, donc une toute petite dose. J'avais l'impression d'avoir beaucoup plus de bouffées de chaleur. Maintenant, elles sont revenues à la normale, c'est-à-dire une par heure et elles sont supportables. Les jours précédents, il y en avait jusqu'à quatre par heure et elles étaient si intenses que je pensais que j'étais dans un sauna trop régulé. Mon antidépresseur principal est la venlafaxine. Je n'ai rien changé au dosage. Et le magnésium a déjà eu cet effet sur moi dans le passé, avant tous ces problèmes , lorsque je le prenais sans calcium. Je ne veux pas non plus me précipiter sur l'opipramol en plus de la venlafaxine avant d'en avoir parlé à ma gynécologue. Aussi peu que possible (autant que nécessaire) est en fait ma devise, avec laquelle je m'en sors le mieux jusqu'à présent. Si je pouvais choisir à nouveau aujourd'hui, je n'aurais jamais commencé la venlafaxine et j'aurais simplement pris de l'opipramol selon les besoins. Cela aurait été tout aussi efficace, si ce n'est plus, contre la maladie pour laquelle il m'a été prescrit à l'origine (trouble obsessionnel-compulsif), car les obsessions ont toujours résulté de l'anxiété chez moi.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>fr_363</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.069192</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Huhu c'est encore moi. Cela fait maintenant deux semaines que je prends du Gynokadin, d'abord une dose, puis je suis passée à deux et j'ai eu de terribles crampes d'estomac. Mon médecin de médecine traditionnelle chinoise m'a dit que c'était peut-être trop, que le corps n'était plus habitué à un \"plus\" après une longue période de carence. Eh bien, maintenant je l'ai réduit à un et demi et cela semble aller. J'ai introduit la progestérone par voie vaginale les premiers jours, mais depuis deux jours, je la perce et je préfère l'étaler. Je veux éviter autant que possible le risque d'effets secondaires, tous ces symptômes me mettent déjà hors de moi. Je ne sais pas si c'est vraiment le cas ou si c'est une coïncidence ou une bonne phase, mais ces deux derniers jours, j'ai un peu l'impression que mes angoisses s'améliorent et que je suis plus claire dans ma tête et que je peux mieux me concentrer. Quelqu'un ici peut-il le confirmer ? Cela fait plus d'un an que j'en souffre et j'ai vraiment cru que j'avais perdu la tête. Un cerveau comme une passoire, des crises d'angoisse qui surgissent de nulle part et souvent un sentiment si irréel ? J'ai l'impression d'être dirigée par quelqu'un d'autre et d'être figée à l'intérieur. Tout cela n'est pas normal J'espère tellement que le Gynokadin et l'Utrogest vont stabiliser la situation. Je n'ai vraiment plus de force... Peut-être que quelqu'un a encore quelques mots d'encouragement à me dire ? Parfois j'aimerais vraiment être un mec Gros câlin à la ronde des filles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>fr_277</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.070254</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Je ressens même très fortement les fluctuations au cours d'un cycle, c'est pourquoi j'en ai parlé à ma gynécologue par téléphone. Je prends donc 1 dose de Lenzetto en continu, sauf les jours où les sautes d'humeur sont si fortes, et 2 doses de progestérone. Pour que cela reste stable, car la demi-vie de l'hormone en gélule est d'environ 6 heures, je la répartis maintenant sur 3x50 mg. Chez moi, une gélule de 100 mg me rend déjà tellement fatiguée que je m'endormirais après 1 à 2 heures debout pendant la journée, alors je la répartis en 3 doses individuelles. Même sous traitement hormonal substitutif, des variations sont possibles car le corps libère de l'œstrogène stocké dans les cellules adipeuses, c'est ce qu'elle m'a expliqué.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>fr_362</td>\n",
       "      <td>fr</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.070626</td>\n",
       "      <td>forum post</td>\n",
       "      <td>SMM4H_24_fr_test</td>\n",
       "      <td>Salut @USER As-tu déjà essayé omnibiotic pour ta flore intestinale ? J'ai également eu des problèmes de digestion après avoir pris des antibiotiques, mais j'ai réussi à les contrôler grâce à omnibiotic. On dit que si tu as une flore intestinale saine, les champignons ne peuvent pas s'installer facilement ? Peut-être que tu as juste besoin de construire ta flore intestinale ? Si tu prends régulièrement des comprimés contre les champignons, cela nuit également à la flore intestinale. As-tu déjà essayé le D-mannose pour la vessie ? C'est naturel et n'a pas d'effets secondaires. Je l'ai pris après ma cystite et je l'ai en réserve chez moi au cas où il y en aurait une autre. J'ai lu de nombreux témoignages d'utilisateurs sur le net qui se sont débarrassés de cystites chroniques grâce à cette méthode. En plus, une pommade à l'estriol pour les parties intimes serait peut-être avantageuse, mon médecin m'a dit que la chute des œstrogènes provoquait également des troubles comme des crampes à la vessie, des brûlures dans les parties intimes. Heureusement que tu vis au rez-de-chaussée ! Il vaut mieux changer de médecin, jusqu'à ce que tu en trouves un bon. Je vais chez beaucoup de médecins en privé, car souvent, chez les médecins conventionnés, on est dehors en deux minutes. C'est triste, toute ta vie tu travailles et tu payes et quand tu as besoin de quelque chose, tu te sens comme un mendiant, pas pris au sérieux, repoussé. En revanche, on est d'autant plus en colère quand tous les nouveaux arrivants dans le pays, qui n'ont pas contribué un centime, reçoivent tout gratuitement. Il est clair que les ambulances sont surchargées, que le personnel est surchargé et épuisé et que les caisses d'assurance maladie sont en faillite. Eh bien.....c'est un autre sujet Bises @USER</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id language  label  pred     p_pos        type            origin  \\\n",
       "161   fr_98       fr      1     0  0.066074  forum post  SMM4H_24_fr_test   \n",
       "266  fr_415       fr      1     0  0.067096  forum post  SMM4H_24_fr_test   \n",
       "323  fr_354       fr      1     0  0.067343  forum post  SMM4H_24_fr_test   \n",
       "258  fr_237       fr      1     0  0.067834  forum post  SMM4H_24_fr_test   \n",
       "295  fr_269       fr      1     0  0.068915  forum post  SMM4H_24_fr_test   \n",
       "28   fr_363       fr      1     0  0.069192  forum post  SMM4H_24_fr_test   \n",
       "248  fr_277       fr      1     0  0.070254  forum post  SMM4H_24_fr_test   \n",
       "412  fr_362       fr      1     0  0.070626  forum post  SMM4H_24_fr_test   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            text  \n",
       "161                                                                                                                                                                                                                                 Bonjour @USER, C'est bien que tu nous contactes. Je dois malheureusement dire que je dois à nouveau arrêter le Laif. Je me sentais bien jusqu'à jeudi et je m'étais déjà étonnée de son effet si rapide, j'avais vraiment senti une amélioration ou je l'avais juste imaginée. Quoi qu'il en soit, je ne me sentais déjà pas bien vendredi et hier, c'était fini, je n'ai fait que pleurer toute la journée et je n'ai pas dormi la nuit d'aujourd'hui et j'ai eu de fortes angoisses. Je ne sais pas si c'est à cause du Laif, personne ne peut dire si on peut ressentir une première aggravation, mon médecin traitant n'avait rien dit. En tout cas, j'ai arrêté de le prendre par peur, c'était encore plus insupportable qu'avant. J'ai eu ma belle-sœur au téléphone aujourd'hui et elle est une ancienne infirmière et elle me conseille de suivre une thérapie, je devrais contacter ma caisse d'assurance maladie pour voir s'il y a une possibilité d'obtenir un rendez-vous le plus rapidement possible, ce que je vais faire maintenant. On y apprend à gérer sa peur. On ne peut pas toujours être malade. Je vais essayer mardi et si ce n'est pas le cas, je retournerai chez le médecin. Mais j'ai essayé. C'est super si tu peux quand même prendre l'avion pour aller voir ta fille, je suis contente pour toi. Mais c'est dommage pour la clinique, je ne sais pas si tu as attendu longtemps. J'y ai déjà pensé. Je n'ai pas envie de quitter la maison pour le moment, mais une clinique de jour où l'on peut rentrer le soir me conviendrait aussi. Je te souhaite un bon dimanche. Des bises. @USER.  \n",
       "266                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Salut @USER, j'ai aussi des crises de transpiration, c'est en partie à cause des médicaments ( MTX et Corti ). Ma thyroïde y contribue aussi, je suis en hypothyroïdie. As-tu déjà fait examiner ta thyroïde ? J'ai récemment reçu une autre dose et cela s'est un peu amélioré. Bises @USER  \n",
       "323                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Salut tout le monde J'espère que vous avez tous bien commencé 2021 et je vous souhaite à tous le meilleur pour la nouvelle année. J'ai une question qui n'a rien à voir avec la ménopause, mais peut-être que vous pourrez quand même m'aider. Ma fille (<pi>) a été placée sous Kyleena il y a exactement un an. Cela s'est plutôt bien passé. Mais ces deux ou trois derniers mois, les règles ont beaucoup changé. Cycle long, long spotting, après 2 semaines à nouveau des saignements..... Depuis dimanche dernier, elle a un problème psychologique. Elle se sent mal à l'aise, elle a l'impression de ne pas avoir assez de souffle. Elle préfère rester au lit et ne rien faire. Début décembre, elle a déjà eu des nausées pendant trois jours, mais elle n'avait pas vraiment de problèmes gastriques. Quelqu'un parmi vous connaît-il les effets secondaires du stérilet ? Est-il possible qu'ils ne commencent qu'après un an ? Tous vos conseils sont les bienvenus. Je ne sais pas vraiment comment me comporter. Est-ce que ça va passer ? Je suis contente, je vais plutôt bien en ce moment. Salutations @USER  \n",
       "258                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Salut @USER.... moi non plus, je n'ai pas été une amie des médicaments pendant toute ma vie... j'ai toujours tout traité avec des remèdes homéopathiques et naturels. Jusqu'à l'année dernière, je résistais à tout ! Mais quand rien n'allait plus, j'ai accepté d'en prendre. J'ai aussi pris du poids pour la première fois de ma vie au cours des six derniers mois. Moi aussi, je suis désespérée par mon ventre et, enfin ... par mes grosses fesses ... c'est horrible ! Je rentre encore dans mes vêtements... mais combien de temps encore ? Mais chez moi, c'est clairement trop d'eau... j'ai déjà écrit à ce sujet... cela peut aussi venir de la thyroïde... et de la dominance en œstrogène ! Depuis six mois, je prends 50 mg de fluoxétine....La fluoxétine est connue pour faire perdre du poids....J'ai perdu immédiatement 3 kg au début. Maintenant, je prends aussi de la trazodone le soir.... cela ne fait pas prendre pas de poids ! J'aimerais bien tout jeter... mais je ne peux pas non plus m'en passer. Salutations....@USER  \n",
       "295                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Salut @USER, je n'ai pris de l'Opripramol que deux soirs pour dormir, une demi-dose à chaque fois, donc une toute petite dose. J'avais l'impression d'avoir beaucoup plus de bouffées de chaleur. Maintenant, elles sont revenues à la normale, c'est-à-dire une par heure et elles sont supportables. Les jours précédents, il y en avait jusqu'à quatre par heure et elles étaient si intenses que je pensais que j'étais dans un sauna trop régulé. Mon antidépresseur principal est la venlafaxine. Je n'ai rien changé au dosage. Et le magnésium a déjà eu cet effet sur moi dans le passé, avant tous ces problèmes , lorsque je le prenais sans calcium. Je ne veux pas non plus me précipiter sur l'opipramol en plus de la venlafaxine avant d'en avoir parlé à ma gynécologue. Aussi peu que possible (autant que nécessaire) est en fait ma devise, avec laquelle je m'en sors le mieux jusqu'à présent. Si je pouvais choisir à nouveau aujourd'hui, je n'aurais jamais commencé la venlafaxine et j'aurais simplement pris de l'opipramol selon les besoins. Cela aurait été tout aussi efficace, si ce n'est plus, contre la maladie pour laquelle il m'a été prescrit à l'origine (trouble obsessionnel-compulsif), car les obsessions ont toujours résulté de l'anxiété chez moi.  \n",
       "28                                                                                                                                                                                                                                                                            Huhu c'est encore moi. Cela fait maintenant deux semaines que je prends du Gynokadin, d'abord une dose, puis je suis passée à deux et j'ai eu de terribles crampes d'estomac. Mon médecin de médecine traditionnelle chinoise m'a dit que c'était peut-être trop, que le corps n'était plus habitué à un \"plus\" après une longue période de carence. Eh bien, maintenant je l'ai réduit à un et demi et cela semble aller. J'ai introduit la progestérone par voie vaginale les premiers jours, mais depuis deux jours, je la perce et je préfère l'étaler. Je veux éviter autant que possible le risque d'effets secondaires, tous ces symptômes me mettent déjà hors de moi. Je ne sais pas si c'est vraiment le cas ou si c'est une coïncidence ou une bonne phase, mais ces deux derniers jours, j'ai un peu l'impression que mes angoisses s'améliorent et que je suis plus claire dans ma tête et que je peux mieux me concentrer. Quelqu'un ici peut-il le confirmer ? Cela fait plus d'un an que j'en souffre et j'ai vraiment cru que j'avais perdu la tête. Un cerveau comme une passoire, des crises d'angoisse qui surgissent de nulle part et souvent un sentiment si irréel ? J'ai l'impression d'être dirigée par quelqu'un d'autre et d'être figée à l'intérieur. Tout cela n'est pas normal J'espère tellement que le Gynokadin et l'Utrogest vont stabiliser la situation. Je n'ai vraiment plus de force... Peut-être que quelqu'un a encore quelques mots d'encouragement à me dire ? Parfois j'aimerais vraiment être un mec Gros câlin à la ronde des filles  \n",
       "248                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Je ressens même très fortement les fluctuations au cours d'un cycle, c'est pourquoi j'en ai parlé à ma gynécologue par téléphone. Je prends donc 1 dose de Lenzetto en continu, sauf les jours où les sautes d'humeur sont si fortes, et 2 doses de progestérone. Pour que cela reste stable, car la demi-vie de l'hormone en gélule est d'environ 6 heures, je la répartis maintenant sur 3x50 mg. Chez moi, une gélule de 100 mg me rend déjà tellement fatiguée que je m'endormirais après 1 à 2 heures debout pendant la journée, alors je la répartis en 3 doses individuelles. Même sous traitement hormonal substitutif, des variations sont possibles car le corps libère de l'œstrogène stocké dans les cellules adipeuses, c'est ce qu'elle m'a expliqué.  \n",
       "412  Salut @USER As-tu déjà essayé omnibiotic pour ta flore intestinale ? J'ai également eu des problèmes de digestion après avoir pris des antibiotiques, mais j'ai réussi à les contrôler grâce à omnibiotic. On dit que si tu as une flore intestinale saine, les champignons ne peuvent pas s'installer facilement ? Peut-être que tu as juste besoin de construire ta flore intestinale ? Si tu prends régulièrement des comprimés contre les champignons, cela nuit également à la flore intestinale. As-tu déjà essayé le D-mannose pour la vessie ? C'est naturel et n'a pas d'effets secondaires. Je l'ai pris après ma cystite et je l'ai en réserve chez moi au cas où il y en aurait une autre. J'ai lu de nombreux témoignages d'utilisateurs sur le net qui se sont débarrassés de cystites chroniques grâce à cette méthode. En plus, une pommade à l'estriol pour les parties intimes serait peut-être avantageuse, mon médecin m'a dit que la chute des œstrogènes provoquait également des troubles comme des crampes à la vessie, des brûlures dans les parties intimes. Heureusement que tu vis au rez-de-chaussée ! Il vaut mieux changer de médecin, jusqu'à ce que tu en trouves un bon. Je vais chez beaucoup de médecins en privé, car souvent, chez les médecins conventionnés, on est dehors en deux minutes. C'est triste, toute ta vie tu travailles et tu payes et quand tu as besoin de quelque chose, tu te sens comme un mendiant, pas pris au sérieux, repoussé. En revanche, on est d'autant plus en colère quand tous les nouveaux arrivants dans le pays, qui n'ont pas contribué un centime, reçoivent tout gratuitement. Il est clair que les ambulances sont surchargées, que le personnel est surchargé et épuisé et que les caisses d'assurance maladie sont en faillite. Eh bien.....c'est un autre sujet Bises @USER  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "def error_table(result: Dict, top_k: int = 10) -> pd.DataFrame:\n",
    "    df = result[\"_df\"].copy()\n",
    "    probs = result[\"_probs\"]\n",
    "    pred = result[\"_pred\"]\n",
    "\n",
    "    df[\"pred\"] = pred\n",
    "    df[\"p_pos\"] = probs[:, 1]\n",
    "    df[\"is_error\"] = df[\"pred\"] != df[\"label\"]\n",
    "\n",
    "    # Sort errors by confidence\n",
    "    err = df[df[\"is_error\"]].copy()\n",
    "    err[\"conf\"] = np.where(err[\"pred\"] == 1, err[\"p_pos\"], 1 - err[\"p_pos\"])\n",
    "    err = err.sort_values(\"conf\", ascending=False)\n",
    "\n",
    "    keep_cols = [c for c in [\"id\", \"language\", \"label\", \"pred\", \"p_pos\", \"type\", \"origin\", \"text\"] if c in err.columns]\n",
    "    return err[keep_cols].head(top_k)\n",
    "\n",
    "# Collect named results for convenient lookup\n",
    "res_map = {(r.get(\"name\"), r.get(\"lang\")): r for r in results if r.get(\"n\", 0) > 0 and \"_df\" in r}\n",
    "\n",
    "for lang in [\"en\", \"de\", \"fr\"]:\n",
    "    key = (\"multi_en_de\", lang)\n",
    "    if key in res_map:\n",
    "        print(f\"\\nTop errors for multilingual on {lang.upper()}\")\n",
    "        display(error_table(res_map[key], top_k=8))\n",
    "\n",
    "# Compare FR: multilingual zero-shot vs translation-trained\n",
    "fr_zero = res_map.get((\"multi_en_de\", \"fr\"))\n",
    "fr_trans = res_map.get((\"translation_trained_fr\", \"fr\"))\n",
    "\n",
    "if fr_zero and fr_trans:\n",
    "    print(\"\\nFR errors — multilingual zero-shot\")\n",
    "    display(error_table(fr_zero, top_k=8))\n",
    "\n",
    "    print(\"\\nFR errors — translation-trained\")\n",
    "    display(error_table(fr_trans, top_k=8))\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f3a56ad8",
   "metadata": {},
   "source": [
    "## Discussion\n",
    "\n",
    "### Cross-lingual error analysis\n",
    "\n",
    "This section analyses the errors of the **multilingual EN+DE model** (our best overall system) across all three languages, focusing on language-specific failure patterns, translation-related errors, and robustness differences.\n",
    "\n",
    "#### (a) Language-specific failure cases\n",
    "\n",
    "The multilingual model's error profile varies sharply by language and reflects the interaction between training data composition, text domain, and class imbalance.\n",
    "\n",
    "**Error rate summary (multilingual EN+DE model):**\n",
    "\n",
    "| Language | n | TP | FP | FN | TN | FP rate | FN rate |\n",
    "|---|---|---|---|---|---|---|---|\n",
    "| EN | 888 | 41 | 14 | 20 | 813 | 1.7% | 32.8% |\n",
    "| DE | 634 | 22 | 34 | 13 | 565 | 5.7% | 37.1% |\n",
    "| FR (zero-shot) | 418 | 22 | 85 | 8 | 303 | 21.9% | 26.7% |\n",
    "\n",
    "Key patterns:\n",
    "\n",
    "- **English (low FP rate, moderate FN rate):** The model is most precise on EN (FP rate = 1.7%), reflecting that EN constitutes the bulk of training data. The 20 false negatives (FN rate = 32.8%) are tweets where ADE mentions are implicit, colloquial, or negated. Example FNs include *\"@USER I've had Cipro before. Luckily for me, the only side fx I tend to get from AB is gastic upset\"* (p=0.000) — the model misses the casual abbreviation \"side fx\" and misspelled \"gastic\" — and *\"almost vomited on a zinc lozenge\"* (p=0.000) — a short, terse tweet lacking explicit drug–side-effect framing.\n",
    "\n",
    "- **German (moderate FP rate, high FN rate):** DE has 3× the FP rate of EN (5.7% vs 1.7%). False positives are overwhelmingly **long forum posts** (median 176 words, compared to 71 for correctly classified negatives; 35% of FPs exceed 200 words). These lengthy posts discuss medications, symptoms, and personal medical histories — the model picks up on medical vocabulary and drug mentions without sufficient context to distinguish general discussion from actual adverse events. Example: a DE FP (p=0.997) reads *\"Wow dann hast Du ja einen starken Körper. Ich habe nie die volle Dosis genommen, ich war schon von einer total müde…\"* — the mention of \"müde\" (tired) after dosage discussion triggers a false positive, even though the speaker describes expected fatigue, not an adverse event.\n",
    "\n",
    "- **French zero-shot (very high FP rate, lowest FN rate):** FR has the highest FP rate (21.9%, 85 false positives) but paradoxically the **lowest FN rate** (26.7%, only 8 missed positives). The model aggressively predicts positive on FR forum posts, producing high recall (0.733) at the cost of precision (0.206). As with DE, FR FPs are long posts (median 146 words; 33% over 200 words) that discuss medications and health topics in conversational register. The top FR FPs (all p ≥ 0.998) describe health complaints, medication experiences, and menopausal symptoms — topics that co-occur with but do not constitute adverse drug events. The 8 FR false negatives all have very low positive probability (p ≤ 0.003), suggesting the model is highly confident in its (incorrect) negative predictions — these may represent ADE descriptions using French-specific medical vocabulary or subtle phrasing that lacks equivalents in the EN/DE training data.\n",
    "\n",
    "**Post type and text length as confounders:**\n",
    "All EN errors are tweets (short, informal), while all DE/FR errors are forum posts (long, semi-formal medical discussion). The length effect is striking: DE/FR false positives have median word counts of 176/146, vastly exceeding the correctly-classified negatives (71/62). This suggests the model learns that **long medical text = likely ADE**, which is a spurious correlation driven by the training data distribution where positive examples tend to be longer and more detailed. The `max_length=256` truncation exacerbates this: many forum posts are truncated, and the model must make decisions on partial information that tends to be dominated by medical-topic keywords.\n",
    "\n",
    "#### (b) Errors related to translation\n",
    "\n",
    "**Translation-trained FR — complete failure under natural class distribution:**\n",
    "The translation-trained FR model (6,000 EN→FR translations with natural ~7% positive rate) predicts **all-negative** (F1 = 0.00). Confidence analysis reveals the model is essentially uncalibrated: true positives receive mean p_pos = 0.074 (max = 0.086), virtually identical to true negatives (mean p_pos = 0.076). The model has learned no discriminative signal whatsoever — it treats all translated French text as equally unlikely to contain ADEs.\n",
    "\n",
    "This is a direct consequence of two compounding factors:\n",
    "1. **Extreme class imbalance:** Only ~420 of the 6,000 translated examples are positive (~7%), which is already difficult for a classifier to learn.\n",
    "2. **MT artifacts as noise:** MarianMT translations introduce systematic \"translationese\" patterns — rigid syntax, literal word-for-word renderings, and loss of colloquial register — that are uniformly present in both positive and negative examples. The model cannot distinguish genuine ADE signal from translation noise, so it defaults to the majority class.\n",
    "\n",
    "The contrast with the baseline configuration (50/50 balanced, 3k translations) is instructive: that model over-predicted positives (recall = 0.90, precision = 0.125, 189 FPs), suggesting it learned that \"translated text\" itself was a spurious positive-class feature. Neither extreme of label balancing produces a usable classifier when the text is machine-translated, highlighting that **MT quality and naturalness** are the fundamental bottleneck, not just sample size or class ratio.\n",
    "\n",
    "**Zero-shot transfer avoids translation artifacts entirely:**\n",
    "The multilingual EN+DE model's zero-shot FR performance (F1 = 0.321) is now the best FR result across all setups. Since it operates directly on native French text, it avoids the translation artifacts that confound the MT-trained model. The model's FR errors are interpretable: it over-triggers on medical discussion (FPs) or misses ADEs described with French-specific phrasing (FNs), rather than being confused by translationese patterns.\n",
    "\n",
    "#### (c) Robustness differences across languages\n",
    "\n",
    "**FR test set — model comparison:**\n",
    "\n",
    "| Model | TP | FP | FN | TN | F1 |\n",
    "|---|---|---|---|---|---|\n",
    "| multi_en_de (zero-shot) | 22 | 85 | 8 | 303 | 0.321 |\n",
    "| mono_en (zero-shot) | 10 | 82 | 20 | 306 | 0.164 |\n",
    "| mono_de (zero-shot) | 0 | 0 | 30 | 388 | 0.000 |\n",
    "| translation_trained_fr | 0 | 0 | 30 | 388 | 0.000 |\n",
    "\n",
    "**Positive-class detection overlap on FR:**\n",
    "Of the 30 FR positive examples, the multilingual model catches 22 and the monolingual EN model catches 10. The overlap is 9 — nearly all examples caught by mono_en are also caught by multi_en_de. The multilingual model uniquely catches 13 additional positives, while mono_en uniquely catches only 1. This confirms that multilingual training provides a strictly broader cross-lingual transfer than monolingual training.\n",
    "\n",
    "**English robustness — mono vs multi:**\n",
    "On EN test data, the monolingual model produces 25 FNs and 19 FPs, while the multilingual model has 20 FNs and 14 FPs — fewer of both error types. The overlap is partial: 15 FNs and 7 FPs are shared. The multilingual model avoids 10 of the monolingual model's FNs (by learning broader ADE patterns from DE data) while introducing only 5 new FNs. Similarly, it avoids 12 of the monolingual model's FPs while introducing only 7 new ones. This demonstrates that multilingual training improves EN robustness without simply trading one error type for another.\n",
    "\n",
    "**Precision–recall trade-off across languages:**\n",
    "The model exhibits a clear gradient in its precision–recall balance:\n",
    "- **EN** (trained language, matched domain): precision = 0.745, recall = 0.672 — balanced and highest precision.\n",
    "- **DE** (trained language, mismatched domain): precision = 0.393, recall = 0.629 — lower precision due to long forum posts triggering FPs.\n",
    "- **FR** (unseen language, mismatched domain): precision = 0.206, recall = 0.733 — highest recall but lowest precision.\n",
    "\n",
    "The pattern reveals that the model's **recall transfers across languages better than its precision**. XLM-R's shared multilingual representations enable the model to detect ADE-indicative patterns (drug–symptom co-occurrence, complaint phrasing) universally, but it cannot learn language-specific negative-class patterns (general medical discussion, non-ADE health talk) for languages it has not been trained on. This asymmetry is the key limitation of zero-shot cross-lingual transfer for ADE detection.\n",
    "\n",
    "---\n",
    "\n",
    "### Baseline results (initial setup: 2 epochs, no class-imbalance adjustment)\n",
    "\n",
    "The table below summarises performance **before** any tuning. All models use `xlm-roberta-base`, `max_length=256`, 2 training epochs, vanilla cross-entropy loss, and no class-weighting or resampling. The translation-trained FR model used a 50/50 label-balanced sample of 3,000 EN→FR translations.\n",
    "\n",
    "| Setup | Eval lang | n | Accuracy | Precision | Recall | F1 |\n",
    "|---|---|---|---|---|---|---|\n",
    "| mono_en | en | 888 | 0.943 | 0.581 | 0.590 | 0.585 |\n",
    "| mono_en (zero-shot) | fr | 418 | 0.929 | 0.000 | 0.000 | 0.000 |\n",
    "| mono_de | de | 623 | 0.944 | 0.000 | 0.000 | 0.000 |\n",
    "| mono_de (zero-shot) | fr | 418 | 0.928 | 0.000 | 0.000 | 0.000 |\n",
    "| multi_en_de | en | 888 | 0.937 | 0.574 | 0.508 | 0.539 |\n",
    "| multi_en_de | de | 623 | 0.941 | 0.500 | 0.029 | 0.054 |\n",
    "| multi_en_de (zero-shot) | fr | 418 | 0.860 | 0.097 | 0.100 | 0.098 |\n",
    "| translation_trained_fr | fr | 418 | 0.524 | 0.125 | 0.900 | 0.220 |\n",
    "\n",
    "Key observations from the baseline:\n",
    "\n",
    "- **Class imbalance is the dominant bottleneck.** The positive rate is only ~7% (EN/DE). No loss weighting, focal loss, oversampling, or threshold tuning is applied. The monolingual DE model predicts all-negative (F1 = 0.00) because it has only ~83 positive training examples.\n",
    "- **Only 2 training epochs is insufficient.** Validation F1 jumped from 0.322 (epoch 1) to 0.645 (epoch 2) for the EN model — the learning curve was still steep when training stopped.\n",
    "- **EN monolingual outperforms multilingual on English** (F1 0.585 vs 0.539), because adding DE forum-post data introduces domain mismatch (tweets vs long forum posts).\n",
    "- **Zero-shot FR completely fails** for both monolingual baselines (F1 = 0.00) and is near-zero for the multilingual model (F1 = 0.098).\n",
    "- **Translation-trained FR trades precision for recall** (precision 0.125, recall 0.900), suggesting the 50/50 label-balanced translation sample biases the classifier toward over-predicting positives.\n",
    "\n",
    "---\n",
    "\n",
    "### Updated results (10 epochs, early stopping, natural label distribution for translations)\n",
    "\n",
    "The table below shows results after the following changes:\n",
    "- **Training epochs**: 2 → 10, with early stopping (patience = 3, metric = F1).\n",
    "- **Translation sample**: 6,000 EN→FR translations (up from 3,000), now stratified to **preserve the natural label distribution** (~7% positive) instead of the previous 50/50 balance.\n",
    "\n",
    "| Setup | Eval lang | n | Accuracy | Precision | Recall | F1 |\n",
    "|---|---|---|---|---|---|---|\n",
    "| mono_en | en | 888 | 0.950 | 0.655 | 0.590 | 0.621 |\n",
    "| mono_en (zero-shot) | fr | 418 | 0.756 | 0.109 | 0.333 | 0.164 |\n",
    "| mono_de | de | 634 | 0.945 | 0.000 | 0.000 | 0.000 |\n",
    "| mono_de (zero-shot) | fr | 418 | 0.928 | 0.000 | 0.000 | 0.000 |\n",
    "| multi_en_de | en | 888 | **0.962** | **0.745** | **0.672** | **0.707** |\n",
    "| multi_en_de | de | 634 | 0.926 | 0.393 | **0.629** | **0.484** |\n",
    "| multi_en_de (zero-shot) | fr | 418 | 0.778 | 0.206 | **0.733** | **0.321** |\n",
    "| translation_trained_fr | fr | 418 | 0.928 | 0.000 | 0.000 | 0.000 |\n",
    "\n",
    "Key changes compared to the baseline:\n",
    "\n",
    "- **Multilingual EN+DE now outperforms monolingual EN on English** (F1 0.707 vs 0.621) — a complete reversal of the baseline trend. More training epochs allow the model to learn cross-lingual representations that benefit English rather than hurting it.\n",
    "- **Multilingual training dramatically rescues German** (F1 0.054 → 0.484). The model now detects 22/35 positive DE examples (recall = 0.629), compared to just 1/35 previously.\n",
    "- **Zero-shot FR improves 3×** (F1 0.098 → 0.321) for the multilingual model, with recall jumping from 0.100 to 0.733 — the model now detects 22/30 positive FR examples.\n",
    "- **EN monolingual zero-shot FR now partially works** (F1 0.000 → 0.164), suggesting more training epochs help the model learn some cross-lingual signal even from English-only data.\n",
    "- **Translation-trained FR collapses** (F1 0.220 → 0.000). Preserving the natural ~7% positive rate in the 6,000 translations produces a training set too imbalanced for the model to learn the positive class — it now predicts all-negative. This is the opposite failure mode from the baseline's 50/50 balanced sample (which caused massive over-prediction).\n",
    "\n",
    "---\n",
    "\n",
    "### 1) When multilingual training helps or hurts\n",
    "\n",
    "**English — monolingual vs multilingual:**\n",
    "With 10 epochs and early stopping, the multilingual EN+DE model (F1 = 0.707, precision = 0.745, recall = 0.672) now **substantially outperforms** the monolingual EN model (F1 = 0.621, precision = 0.655, recall = 0.590) on English test data. This is a complete reversal from the baseline, where multilingual training hurt EN performance. The additional training time allows the model to separate language-specific and shared features: it benefits from the extra German data to learn more robust ADE detection patterns without sacrificing English-specific signal. The precision gap (+9 pp) is particularly notable — jointly trained models see a wider variety of negative examples, which helps reduce false positives on EN.\n",
    "\n",
    "**German — monolingual vs multilingual:**\n",
    "The monolingual DE model still completely fails (F1 = 0.00, all-negative predictions), confirming that ~83 positive examples are insufficient for monolingual training regardless of epoch count. However, the multilingual EN+DE model now achieves F1 = 0.484 on German (recall = 0.629, detecting 22/35 positives), a dramatic improvement over the baseline's F1 = 0.054 (1/35 positives). This shows that cross-lingual transfer from the much larger English pool becomes effective with sufficient training time, despite the domain mismatch between tweets and forum posts. The model learns shared ADE indicators (drug–side-effect co-occurrence, negation patterns) that transfer across languages.\n",
    "\n",
    "**Zero-shot FR:**\n",
    "The monolingual DE model still produces zero recall on French (F1 = 0.00). However, the monolingual EN model now achieves a non-trivial F1 = 0.164 on FR (recall = 0.333, detecting 10/30 positives) — up from F1 = 0.00 in the baseline. This suggests that with more training, even a single-language model can develop some cross-lingual generalization through XLM-R's shared multilingual space.\n",
    "\n",
    "The multilingual EN+DE model achieves the best zero-shot FR performance: F1 = 0.321 (recall = 0.733, 22/30 positives detected), a 3× improvement over the baseline. While precision remains modest (0.206, with 85 false positives), the high recall demonstrates that joint training on two languages provides a much stronger cross-lingual signal than monolingual training.\n",
    "\n",
    "**Summary:** With adequate training time, multilingual training decisively helps **all** evaluated languages — improving EN (+0.086 F1 over monolingual), enabling meaningful DE performance (0.484 vs 0.000), and achieving the best zero-shot FR results (F1 = 0.321). The baseline's finding that multilingual training hurts EN was an artifact of insufficient training.\n",
    "\n",
    "### 2) Limitations of cross-lingual transfer in medical social media\n",
    "\n",
    "**Domain mismatch across platforms:**\n",
    "The tweet vs forum post divide remains a challenge, though its impact is less severe than the baseline suggested. English data is almost entirely short tweets (avg ~17 words, p95 = 27), whereas German and French data consist of long forum posts (avg ~101–106 words, p95 = 276–313). XLM-R's `max_length=256` truncation means some forum posts lose critical information. However, the updated results show that the model **can** bridge this gap given enough training — the multilingual model's strong DE recall (0.629) and FR recall (0.733) demonstrate that XLM-R learns meaningful cross-domain ADE features.\n",
    "\n",
    "**Class imbalance:**\n",
    "All languages suffer from severe class imbalance (~5–7% positive rate), and this remains catastrophic for low-resource monolingual settings. DE has only ~83 positive training examples; monolingual training produces all-negative predictions regardless of epoch count. The translation-trained FR model confirms this: when the 6,000-sample pool preserves the natural ~7% positive rate (only ~420 positives), the model fails to learn the minority class (F1 = 0.00). The contrast with the baseline's 50/50 balanced sample (which caused massive over-prediction with F1 = 0.220) highlights how sensitive small-sample ADE detection is to label distribution choices.\n",
    "\n",
    "**Slang, abbreviations, and negation:**\n",
    "English tweets contain heavy social-media noise (@USER mentions, HTTPURL placeholders, abbreviations, slang). German and French forum posts are more verbose but use medical terminology, dosage descriptions, and complex negation structures differently. Despite these differences, the multilingual model's strong cross-lingual recall suggests that XLM-R captures some universal ADE indicators — though precision remains limited (0.206 on FR, 0.393 on DE), indicating the model struggles with language-specific false-positive patterns.\n",
    "\n",
    "**Drug/condition name variation:**\n",
    "Drug names are often identical across languages (brand names), but condition descriptions and side-effect terminology vary. The modest precision on FR (0.206) and DE (0.393) compared to EN (0.745) reflects the difficulty of distinguishing genuine ADE reports from general medical discussion in languages not directly trained on.\n",
    "\n",
    "**Overall takeaway:**\n",
    "For practical deployment in a multilingual ADE detection system, multilingual training with adequate epochs provides surprisingly strong cross-lingual transfer — the zero-shot FR model (F1 = 0.321) is now competitive without any French training data. However, precision remains a bottleneck for safety-critical applications. A combination of strategies — class-imbalance handling (weighted loss, focal loss, threshold tuning), better MT with balanced augmentation, and possibly domain-adaptive pre-training on medical social media text — would be needed to achieve reliable precision across languages.\n",
    "\n",
    "### 3) Practical implications\n",
    "\n",
    "**Translation-trained FR: two failure modes**\n",
    "The translation-trained FR model demonstrates how sensitive ADE classification is to label distribution in the training data:\n",
    "- **Baseline (50/50 balanced, 3k samples):** The model achieved high recall (0.90) but abysmal precision (0.125), with 189 false positives — it learned \"translationese\" patterns as spurious ADE indicators.\n",
    "- **Updated (natural ~7% positive, 6k samples):** The model predicts all-negative (F1 = 0.00). With only ~420 positives among 6,000 translations, all of which contain MT artifacts, the model cannot distinguish positive-class signal from translation noise.\n",
    "\n",
    "Neither extreme produces a usable classifier. A middle ground — perhaps moderate oversampling (e.g. 20–30% positive rate) combined with class-weighted loss — would likely yield better results. Alternatively, filtering translations for quality (e.g., round-trip consistency checks) could reduce the noise that confounds the classifier.\n",
    "\n",
    "**Is zero-shot strong enough for FR?**\n",
    "The multilingual EN+DE model's zero-shot FR performance (F1 = 0.321, recall = 0.733) is now the **best** FR result across all setups — surpassing both the baseline translation-trained model (F1 = 0.220) and the current translation-trained model (F1 = 0.00). This is a significant finding: **cross-lingual transfer from quality multilingual training outperforms naive machine-translation-based training** on this task.\n",
    "\n",
    "However, F1 = 0.321 still has clear limitations for deployment:\n",
    "- **Precision of 20.6%** means roughly 4 out of 5 flagged posts are false alarms, which would overwhelm human reviewers in a pharmacovigilance pipeline.\n",
    "- **85 false positives** out of 388 negative FR test examples (22% false-positive rate) is high for safety-critical applications.\n",
    "\n",
    "**Multilingual training as the primary strategy:**\n",
    "The updated results suggest that multilingual training with sufficient epochs is the most effective single strategy for cross-lingual ADE detection:\n",
    "- It achieves the best results on **all three languages** simultaneously (EN F1 = 0.707, DE F1 = 0.484, FR F1 = 0.321).\n",
    "- It requires no translation infrastructure or additional data collection for new languages.\n",
    "- Further improvements could come from class-imbalance handling, threshold tuning, or adding more training languages to the multilingual pool."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "smm4h2026",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
